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Summary  
 
In eukaryotes, protein-encoding genes are transcribed in the nucleus by RNA 
polymerase II (RNAP II). Before the gene transcript (pre-mRNA) is transported to the 
cytoplasm and can function in translation, it has to undergo three specific maturation 
steps: capping, splicing and 3’ end processing. It is well established now that pre-
mRNA processing events occur cotranscritpionally, while RNAP II is still 
transcribing the gene.  
 Pre-mRNA 3’ end formation is an essential step in gene expression. With the 
exception of mRNAs coding for replication-dependent histone proteins, all eukaryotic 
pre-mRNAs are processed at their 3’ end by a coupled two-step reaction that involves 
a specific endonucleolytic cleavage at the poly(A) site and subsequent poly(A) tail 
addition to the upstream cleavage fragment catalyzed by poly(A) polymerase (Pap1p). 
The complete maturation of the pre-mRNA 3’ end is directed by the presence of cis-
acting sequence elements on the pre-mRNA that recruit protein factors. Surprisingly, 
3’ end processing is accomplished by a complex protein machinery, which is highly 
conserved from yeast to mammals. Indeed, most of the polypeptides involved in 3’ 
end formation in mammals have homologues in yeast. In S. cerevisiae, the cleavage 
and polyadenylation factor (CPF), cleavage factor IA (CF IA), cleavage factor IB (CF 
IB or Nab4p/Hrp1p) and the poly(A) binding protein (Pab1p) are required for specific 
and accurate 3’ end processing activities.  
 The main pre-mRNA 3’ end processing factor, CPF, is a multiprotein complex 
that consists of 15 polypeptides and is required for both pre-mRNA 3’ end processing 
reactions. Most of its subunits are essential (only two are not essential) and all the 
components are involved in RNA recognition or protein-protein interactions within 
CPF or with other protein complexes, such as CF IA or RNAP II. Biochemical studies 
of all CPF subunits have confirmed that they belong to the complex and allowed 
characterization of their function in the context of pre-mRNA 3’ end formation. 
 Affinity purification of CPF identified a novel protein that co-purified with the 
previously known components and was therefore proposed to be a new subunit of the 
complex. This putative new component is non-essential and was named Cpf11p. In 
this work, we showed that Cpf11p is not stably associated with CPF, as TAP tag 
purification of Cpf11p did not result in the purification of CPF components (Chapter 
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3). Furthermore, in vitro cleavage and polyadenylation assays performed with 
Cpf11p-depleted extracts did not show any defect, indicating that Cpf11p is not 
involved in pre-mRNA 3’ end formation. We also found that expression of Cpf11p, in 
contrast to the expression of CPF subunits, is controlled in a sugar-dependent manner. 
Taken together, our results strongly suggest that Cpf11p has no function in pre-
mRNA 3’ end processing.  
 CPF plays a central role in pre-mRNA 3’ end processing. Its requirement for 
cleavage and polyadenylation reactions is mediated by cooperative interactions with 
CF IA and recognition of cis-acting polyadenylation signals on the primary transcript. 
Despite every polypeptide involved in pre-mRNA 3’ end processing was 
characterized, the mechanism by which the pre-mRNA is cleaved and polyadenylated 
is not known. One aim of this thesis is to provide insight into the three-dimensional 
structure of CPF. This would allow a better understanding in the arrangement of the 
subunits in the complex and provide information on the molecular mechanism of pre-
mRNA 3’ end processing. We have developed an efficient purification procedure that 
yields highly pure and active CPF. Here we report for the first time the 3D structure 
of the complex at a resolution of 25 Å, determined by single-particle electron 
microscopy on natively purified CPF using angular reconstitution and random conical 
tilt (Chapter 4). The 3D model reveals a rough globular shape of the complex and a 
strikingly large central cavity. We discuss the possibility that the inner cavity 
represents a reaction chamber in which pre-mRNA 3’ end processing reactions could 
take place. Furthermore, we have determined the mass of CPF particles by scanning 
transmission electron microscopy (STEM) at approximately one megaDalton.  
 The work reported in this thesis should contribute to a better understanding of 
the mechanism by which pre-mRNAs are processed at their 3’ end by presenting the 
first 3D model of the CPF complex, and by refining the protein composition of CPF. 
In addition, a part of this work is dedicated to investigation of in vivo interconnections 
between transcription and 3’ end processing of pre-mRNAs (Chapter 2).   
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Chapter 1: Introduction  
 
1.1 Three processing events lead to the maturation of messenger RNAs  
 
In metazoans, protein-encoding genes are exclusively transcribed by the RNA 
polymerase II (RNAP II). The eukaryotic messenger RNA (mRNA) precursors (pre-
mRNAs) are synthesized in the nucleus and have to systematically undergo three 
modification steps to become mature and functional: capping, splicing and 3’ end 
processing. The mature mRNA is exported to the cytoplasm where it is translated into 
proteins by the ribosomes. The processing reactions do not occur independently in the 
nucleus but cotranscriptionally, in connection to RNAP II transcription.  
 The first processing event is capping that modifies the 5’ triphosphate end of 
the primary transcript, by adding a 7-methyl guanine cap structure as soon as the 
nascent transcript has reached 20-25 nucleotides (nt) in length (Jove and Manley, 
1984; Rasmussen and Lis, 1993). In both metazoans and unicellular eukaryotes, three 
enzymatic activities are required for cap formation (Figure 1.1). The 5’ triphosphate 
end of the pre-mRNA is first hydrolyzed by a RNA 5’ triphosphatase, generating a 5’ 
diphosphate end that is then capped with GMP by a RNA guanylyltransferase, and 
finally methylated by a (guanine-N7) methyltransferase. In Caenorhabditis elegans 
and mammals, a bifunctional protein that contains both the RNA 5’ triphosphatase 
and guanylyltransferase activities catalyzes the first two steps, whereas in the yeast 
Saccharomyces cerevisiae (S. cerevisiae), three separate proteins catalyze the three 
different steps: the RNA 5’ triphosphatase Cet1p, RNA guanylyltransferase Ceg1p 
and (guanine-N7) methyltransferase Abd1p (for reviews, see Gu and Lima, 2005; 
Shatkin and Manley, 2000). 5’ capping is an essential process and has important 
effects for mRNAs export and stability, translation initiation, and efficient splicing 
(Furuichi and Shatkin, 2000; Shibagaki et al., 1992).  
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Figure 1.1. Messenger RNA cap 
structure and its metabolism (from 
Gu and Lima, 2005). 
(A) Chemical structure of the mRNA 
cap. The cap consists of N7-methyl 
guanosine linked by an inverted 5’-5’ 
triphosphate bridge to the first 
nucleoside of the mRNA.  
(B) Synthesis and degradation of the 
mRNA cap (enzymes involved at 
each step are indicated next to the 
arrows. Dcps are decapping 
enzymes).  
 
 
 
 In eukaryotic pre-mRNAs, exons are interrupted by noncoding introns. The 
second processing event, splicing, removes noncoding introns from newly synthesized 
pre-mRNAs and joins the coding exon segments together in a two-step 
transesterification reaction (Kramer, 1996). During the first step, an adenosine residue 
located in the branchpoint sequence near the 3′ end of the intron, carries out a 
nucleophilic attack on the 5′ splice site (Figure 1.2). This reaction generates a free 
exon 1 and a lariat-exon 2 as splicing intermediates. During the second step, the exon 
1 attacks at the 3′ splice site to generate the final splicing products, the spliced exons 
1-2 and the lariat intron. These two catalytic steps are accomplished by the 
spliceosome, a large and dynamic multi-component complex consisting of the U1, 
U2, U4/U6, and U5 small nuclear ribonucleoproteins (snRNPs) and a multitude of 
non-snRNP proteins (Will and Luhrmann, 2001).  
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Figure 1.2. Schematic view of the two transesterification steps in pre-mRNA splicing.  
The splicing products are the exons joined together and the intron removed as a lariat. For 
explanation of the reactions, see the text.  
 
 
 Finally, to complete the series of pre-RNAs modifications, the majority of 
primary transcripts are processed at their 3’ end by a coupled cleavage and 
polyadenylation reaction (Figure 1.3). The 3’ end of mature mRNAs is generated by a 
site-specific endonucleolytic cleavage of an internal phosphodiester bond of the 
primary transcript. The upstream cleavage product generated is subsequently 
polyadenylated at its 3’ hydroxyl end, whereas the downstream cleavage product is 
rapidly degraded (Wahle and Ruegsegger, 1999; Zhao et al., 1999a). In eukaryotic 
cells, the only known exceptions to this pathway are small nucleolar RNAs 
(snoRNAs) and the major histone mRNAs, which are endonucleolytically cleaved 
downstream of a stem-loop structure by the stem-loop binding protein (SLBP) but are 
not polyadenylated (Dominski and Marzluff, 1999; Perumal and Reddy, 2002). The 
length of the poly(A) tails depends on the species and reaches 250 nt in mammals, 
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whereas in yeast the poly(A) tail has an average length of about 70 nt. Poly(A) tails 
have important roles in mRNA stability and cytoplasmic export, and are also required 
for efficient translation initiation (Tarun and Sachs, 1996).  
 Pre-mRNA 3’ end processing involves several protein factors that are well 
conserved from mammals to yeast, although their organization is different. In 
mammals, the protein factors are: the cleavage and polyadenylation specificity factor 
(CPSF), cleavage stimulation factor (CstF), cleavage factors Im and IIm (CF Im and CF 
IIm), poly(A) polymerase (PAP) and nuclear poly(A) binding protein (PABPN1). In 
yeast, Pap1p, the enzyme that catalyzes the polyadenylation reaction, and Ysh1p, the 
putative endonuclease, both belong to the large multiprotein cleavage and 
polyadenylation factor (CPF). Other protein factors, such as cleavage factor IA (CF 
IA), cleavage factor IB (CF IB) and poly(A) binding protein (Pab1p) act in 
cooperation with CPF and recognize specific cis-acting sequences located on the pre-
mRNA to accurately process its 3’ end. 3’ end processing reactions can be 
reconstituted in vitro by incubating protein cell extracts or purified factors with 
suitable RNA substrates (Butler and Platt, 1988; Butler et al., 1990).  
 
Figure 1.3. Pre-mRNA 3’ end processing is a coupled two-step reaction. 
The primary RNAP II transcript is endonucleolytically cleaved at the poly(A) site. Then, the 
3’-hydroxyl end of the upstream cleavage product is polyadenylated, while the downstream 
cleavage product is degraded (dashed lines). The length of the poly(A) tails varies with the 
species to 70 nt in yeast and 250 nt in mammals. The protein factors responsible for each step 
of the reaction in mammals and in S. cerevisiae are indicated on the left and on the right 
respectively. 
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1.2 3’ end processing of pre-mRNAs in mammals 
 
3’ end processing of pre-mRNAs is a seemingly simple two-step reaction that 
involves a site-specific endonucleolytic cleavage of the mRNA precursor followed by 
the addition of a poly(A) tail to the upstream cleavage product. Thus, only two 
enzymes are predicted to be necessary and sufficient to generate the 3’ end of mature 
mRNAs. However, intensive biochemical characterization of polypeptides involved in 
3’ end processing in mammals and in S. cerevisiae has revealed an unexpectedly 
complex protein composition (for reviews, see Keller and Minvielle-Sebastia, 1997; 
Wahle and Ruegsegger, 1999; Zhao et al., 1999a). The development of in vitro 
processing assays allowed the identification of 3’ end processing factors via 
fractionation of cell extracts from mammalian cells (Moore and Sharp, 1985) and 
yeast cells (Butler and Platt, 1988). Both organisms require multiprotein complexes to 
perform 3’ end processing of pre-mRNAs and most of the mammalian polypeptides 
involved have yeast counterparts, indicating conservation during evolution (Keller 
and Minvielle-Sebastia, 1997). Cis-acting sequences located in the 3’ untranslated 
region (3’ UTR) of the primary transcript recruit the protein factors and guide them to 
the site of cleavage and polyadenylation. These sequence elements have been defined 
as conserved blocks of nucleotides situated in the proximity of the cleavage site.  
 
1.2.1 Cleavage and polyadenylation signals in mammals 
 
In mammalian cells, the cis-acting signals required for 3’ end formation consist of a 
core of three sequence elements in the pre-mRNA (Figure 1.4). 
 The first element is the hexanucleotide AAUAAA that is located 10-30 nt 
upstream of the poly(A) site (also called cleavage site). This sequence is one of the 
most highly conserved sequence known and is found in almost all mRNAs 
(Proudfoot, 1991; Wahle and Kuhn, 1997). This hexanucleotide sequence is 
specifically bound by CPSF. AUUAAA is the only active variant that can also be 
found (Graber et al., 1999a). Mutagenesis studies have established the essential 
requirement of this sequence in both cleavage and polyadenylation (Manley et al., 
1985; Wahle and Keller, 1992).  
 The downstream element (DSE) is the second element of the core 
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polyadenylation signal and is located 30 nt downstream of the poly(A) site. It is less 
conserved and two different types are found: a U-rich element with short stretches of 
U residues (Chou et al., 1994) and a GU-rich element with the consensus sequence 
YGUGUUYY (Y = pyrimidine). Point mutations or small deletions in the DSE have 
only weak effects, and larger deletions are required to abolish function. Nevertheless, 
the proximity of the DSE to the poly(A) site can affect the cleavage site position 
(MacDonald et al., 1994) and the efficiency of cleavage (Gil and Proudfoot, 1987). 
Importantly, the position of this element ensures that the transcript is not cleaved 
again, as it is removed during cleavage.  
 The third element is the poly(A) site itself. The distance between the 
hexanucleotide AAUAAA sequence and the DSE usually determines the selection of 
the cleavage site (Chen et al., 1995). In 70% of vertebrate mRNAs, endonucleolytic 
cleavage occurs downstream of an adenosine, whereas the preceding nucleotide is a C 
in 59% of the cases, defining the dinucleotide CA as the poly(A) site consensus 
(Sheets et al., 1990).  
 In addition, other sequences called auxiliary sequences can modulate the 
efficiency of the processing, but are not essential (Gilmartin et al., 1995). As an 
example, CF Im was found to specifically bind to the sequence UGUAA surrounding 
the cleavage site (Brown and Gilmartin, 2003).  
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Figure 1.4. Polyadenylation regulatory signals in mammals and yeast.  
AAUAAA sequence, downstream element (DSE), efficiency element, positioning element, 
near-upstream and near-downstream elements are indicated in boxes on the RNA (black line). 
The boxes below contain examples of functional sequences for each of the elements. The 
distances between the different sequence elements relative to the poly(A) site are indicated 
below. The black arrow marks the position of cleavage and polyadenylation.  
 
 
1.2.2 Cleavage and polyadenylation factors in mammals 
 
By fractionating cell extracts, six protein factors have been identified to be involved 
in 3’ end processing of pre-mRNAs in mammals (Figure 1.5). Cleavage of 
mammalian pre-mRNA substrates requires the combination of five of those factors 
(Christofori and Keller, 1988; Takagaki et al., 1989): CPSF, CstF, CF Im , CF IIm and 
PAP. For polyadenylation, CPSF, PAP and nuclear PABPN1 are required.  
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1.2.2.1 Cleavage and polyadenylation specificity factor  
 
CPSF specifically binds to the highly conserved hexanucleotide AAUAAA signal 
located 10-30 nt upstream of the cleavage site. Purification of this complex from 
HeLa cells and calf thymus has led to the identification of five subunits: CPSF-160, 
CPSF-100, CPSF-73, CPSF-30 and hFip1, which all have homologues in yeast 
(Barabino et al., 1997; Bienroth et al., 1991; Jenny et al., 1994; Kaufmann et al., 
2004; Murthy and Manley, 1995).  
 The biggest subunit CPSF-160 is responsible for the interaction with the 
AAUAAA sequence on the pre-mRNA (Jenny et al., 1994), and in addition interacts 
with PAP and the 77 kDa subunit of CstF (Murthy and Manley, 1995).  
 CPSF-100 and CPSF-73 share similarities with the metallo-β-lactamase / β-
CASP (named for metallo-β-lactamase, CPSF, Artemis, Snm1, Pso2) enzymes 
involved in the cleavage of nucleic acids (Callebaut et al., 2002). Nevertheless, CPSF-
100 has no endonucleolytic activity, as a part of the conserved motif necessary for 
activity is lacking. The function of CPSF-100 is still unknown. For a long time, 
CPSF-73 has been suspected to be the endonuclease responsible for cleavage of pre-
mRNAs (Ryan et al., 2004). However, the first direct experimental evidence for 
endonucleolytic activity was provided in a recent publication together with a crystal 
structure of CPSF-73 at a 2.1 Å resolution (Mandel et al., 2006).  
 CPSF-30 contains five zinc-finger domains and a zinc knuckle (DuBois et al., 
1990), both being involved in RNA-binding (Barabino et al., 1997). CFSF-30 was 
shown to bind to poly(U) sequences of RNA (Barabino et al., 1997).  
 hFip1 was recently identified as a component of CPSF (Kaufmann et al., 
2004). It directly interacts with CPSF-30, CstF-77 and PAP. Furthermore, it binds 
preferentially to U-rich sequences on the pre-RNA and contributes to CPSF-mediated 
stimulation of PAP activity (Kaufmann et al., 2004).  
 
1.2.2.2 Cleavage stimulation factor  
 
Composed of the three polypeptides CstF-77, CstF-64 and CstF-50, the CstF factor 
binds to the U-rich or GU-rich sequence elements downstream of the cleavage site of 
the pre-mRNA (MacDonald et al., 1994; Takagaki et al., 1990).  
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 CstF-77 contains HAT repeats that mediate protein-protein interactions 
(Colgan and Manley, 1997). Consistently, CstF-77 bridges the other CstF subunits 
and directs interaction with CPSF-160, possibly stabilizing the CPSF-CstF-RNA 
complex (Murthy and Manley, 1995).  
 CstF-64 has an RNA-binding domain that binds the DSE of pre-mRNAs 
(MacDonald et al., 1994), and interacts with symplekin (Hofmann et al., 2002).  
 CstF-50 is composed of seven WD-40 repeats, which were shown to bind the 
phosphorylated C-terminal domain (CTD) of the largest subunit of RNAP II 
(McCracken et al., 1997b).  
 
1.2.2.3 Cleavage factors Im and IIm  
 
CF Im is composed of the 25 kDa, 59 kDa and 68 kDa subunits and possibly a fourth 
subunit of 72 kDa (Ruegsegger et al., 1996). CF Im has no known homologues in 
yeast. CF Im 59 kDa and CF Im 68 kDa subunits contain three distinct domains: a 
RNP-type RNA-binding domain at the N-terminus, a central proline-rich domain and 
a C-terminal RS-like domain similar to that of the SR proteins involved in splicing. 
The 25 kDa subunit binds to RNA and was shown to associate with the largest subunit 
of CF Im, with PAP and with PABNP1 (Dettwiler et al., 2004; Kim and Lee, 2001). 
The 68/25 kDa heterodimer was shown to bind the sequence UGUAA that surrounds 
the cleavage site on the pre-mRNA (Brown and Gilmartin, 2003). The nature of the 
72 kDa protein is still unclear. Furthermore, CF Im was shown to increase stability of 
the CPSF-CstF-RNA complex (Ruegsegger et al., 1996).  
 During purification of CF IIm from HeLa cells the activity could be separated 
into a CF IIAm fraction and a CF IIBm fraction. The essential CF IIAm contained 
hClp1 and hPcf11, two proteins with yeast homologues, whereas CF IIB was shown 
to be non-essential but stimulatory for cleavage (de Vries et al., 2000).  
 hPcf11 has a DSI consensus motif, which was shown to bind the CTD in yeast 
(Sadowski et al., 2003). hPcf11 also contains two zinc finger motifs and 30 repeats of 
the consensus sequence LRFDG. In addition, hPcf11 was shown to play a role in 
cleavage, but is dispensable for polyadenylation.  
 hClp1 is evolutionary conserved and contains Walker A and B motifs, 
suggesting that hClp1 is a nucleotide binding protein (de Vries et al., 2000). 
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Furthermore, hClp1 is involved in the cleavage reaction. Recently, hClp1 was 
proposed to be a novel human RNA-kinase that phosphorylates siRNAs and 3’ exons 
during tRNA splicing (Leuschner et al., 2006).  
 
1.2.2.4 Poly(A) polymerase  
 
PAP is the enzyme that catalyzes the polyadenylation reaction on cleaved pre-mRNAs 
and is therefore a key player in 3’ end formation of mRNAs in eukaryotes. The N-
terminal part of the protein is highly conserved and contains the catalytic domain that 
is characteristic for the superfamily of nucleotidyltransferases (Holm and Sander, 
1995; Martin and Keller, 1996). The crystal structure of the bovine PAP was solved at 
a resolution of 2.5 Å (Martin et al., 2000). The catalytic site contains three conserved 
aspartate residues that are absolutely essential for activity. Furthermore, a RNA-
binding domain is present in the C-terminal part of the polymerase, overlapping with 
a region needed for AAUAAA-dependent activity (Thuresson et al., 1994). The C-
terminal part of PAP also contains a bipartite nuclear localization signal (NLS), and a 
region rich in serine and threonine residues allowing regulation of PAP activity by 
phosphorylation (Abuodeh et al., 1998; Colgan et al., 1996). PAP alone has a low 
level of activity, which is enhanced when manganese is substituted for magnesium 
(Wahle, 1991). PAP specifically uses ATP and has no specificity for RNA. Finally, 
PAP specifically polyadenylates RNAs containing the AAUAAA sequence in the 
presence of CPSF and is also required for the cleavage of most pre-mRNAs.  
 
1.2.2.5 Nuclear poly(A) binding protein  
 
CPSF and PAP are sufficient to allow poly(A) addition to the precleaved RNA 
substrate. However, fast and processive activity requires PABPN1, which also 
controls poly(A) tail length (Bienroth et al., 1993). This small protein of 33 kDa 
contains a very acidic N-terminal domain, a very basic C-terminal domain and a 
single RNP domain in the center. PABPN1 interacts with CPSF-30 in vitro (Chen et 
al., 1999) and specifically binds to poly(A) and poly(G) with a binding site length of 9 
nt (Nemeth et al., 1995).  
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Figure 1.5. Schematic representation of the mammalian and yeast 3’ end processing 
machineries.  
Multiprotein complexes and their subunit composition are represented with their respective 
points of contact to the poly(A) signal elements (white rectangles) of the pre-mRNA (black 
line). Homologous factors between mammals and yeast are colour coded. Proteins in white 
have no known homologues. Site of cleavage is denoted by a black arrow. Double-headed 
arrows represent contacts between proteins of different factors. CA: cleavage site; DSE: 
downstream sequence element; EE: efficiency element; PE: positioning element; NU: near 
upstream element; ND: near downstream element; ?: putative signal element.  
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1.3 3’ end processing of pre-mRNAs in yeast 
 
1.3.1 Cis-acting signals required for pre-mRNA 3’ end processing in yeast 
 
In contrast to mammalian polyadenylation signals that are highly conserved, cis-
acting signals in pre-mRNA 3’ end processing in the yeast S. cerevisiae are more 
degenerate and redundant. Consequently, analysis of cis-acting regulatory sequences 
has been more complicated than in mammalian cells. Nevertheless, mutagenesis 
studies and computational analysis of a large set of known and predicted processing 
sites have allowed the definition of a general pattern of cis-acting signals required for 
3’ end processing (Graber et al., 1999b). Five blocks of sequences have been defined 
as follow (Figure 1.4): (i) The efficiency element (EE); (ii) The positioning element 
(PE); (iii) The near upstream element; (iv) The near downstream element; (v) The 
poly(A) site (or cleavage site) itself. It has been suggested that these cis-acting signals 
act cooperatively, since a deletion of one element only reduced the efficiency of 3’ 
end processing (Beyer et al., 1997; Zhao et al., 1999a). Thus, the presence of one 
weak signal in the 3’ UTR of a transcript can be compensated by stronger signals in 
other sequence elements.   
 The EE is typically found between 35 and 70 nt upstream of the cleavage site. 
The consensus sequence for this element was identified by mutagenesis studies and 
computational analysis as UAUAUA, as the most efficient sequence to direct 3’ end 
processing (Guo et al., 1995), but can be variable with U-rich stretches (Guo and 
Sherman, 1995). The U residues at the first and fifth positions are the most critical 
nucleotides in this sequence. The EE enhances cleavage and has been shown to have a 
more important role than the PE in the cleavage site selection (Guo and Sherman, 
1996). Finally, the EE is specifically bound by CF IB, which acts in cleavage site 
selection (Minvielle-Sebastia et al., 1998) and functions to activate the PE.   
 The PE is an “A-rich” element that is typically found between 10 and 30 nt 
upstream of the cleavage site. As the EE, the sequence of the PE is variable. However, 
the most efficient motifs were found to be AAUAAA and AAAAAA. The PE is 
present in all organisms and directs the position of the cleavage site. It also 
contributes to the efficiency of the processing as single point mutations or deletion of 
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the motif resulted in the reduction in the use of the cleavage site (Abe et al., 1990; 
Hyman et al., 1991).  
 The near upstream and downstream elements occur within 10 nt upstream and 
downstream of the cleavage site (Graber et al., 1999a). They are best characterized as 
“U-rich elements”, as the most common sequences immediately surrounding the 
cleavage site are long runs of uracils (UUUUUU or UUUUCU, etc). They were found 
to contribute to cleavage site selection and to enhance cleavage in vitro (Dichtl and 
Keller, 2001). Surprisingly, they don’t have counterparts in animals (Graber et al., 
1999a). Yhh1p, Ydh1p and Yth1p, three components of CPF have been shown to bind 
to these U-rich elements (Barabino et al., 2000; Dichtl et al., 2002a; Dichtl and Keller, 
2001; Keller et al., 1991).  
 Mapping of the poly(A) sites of numerous genes allowed the definition of the 
consensus sequence as a dinucleotide that consists of a pyrimidine followed by one or 
more A residues (Heidmann et al., 1994; Russo et al., 1993). Cleavage takes place on 
the 3’ side of an adenosine residue. In contrast to animal genes that use a single 
poly(A) site downstream of the hexanucleotide AAUAAA, numerous yeast genes use 
a cluster of poly(A) sites (Zhao et al., 1999a). Thus, even if the dinucleotide CA is the 
sequence of choice for cleavage, adjacent sub-optimal poly(A) sites, also called 
cryptic cleavage sites, can be used if the dinucleotide CA is mutated or destroyed. T-
rich motifs are frequently found immediately before and after the poly(A) site (Graber 
et al., 1999b).  
 It is unclear whether yeast uses a specific motif downstream of the cleavage 
site, as in higher eukaryotes. Very few genes require a downstream sequence for 
efficient processing in vivo as exemplified by the ADH2 transcript (Hyman et al., 
1991). Nevertheless, in most of the cases, deletions of the downstream sequences 
have no effect (Aranda et al., 1998).  
 Thus, the polyadenylation signals in yeast are degenerate and redundant, as 
described by the sequence flexibility of the main motifs. The redundancy of the 
sequences provides an explanation to the fact that mutations or deletions in these 
motifs have only weak effects in 3’ end processing. Furthermore, the cis-acting 
signals are believed to act in cooperation, as shown for some genes (like the CYC1 
gene) that use multiple weak signals to act additively to provide a strong signal (Guo 
et al., 1995). The presence of secondary structures in the primary transcripts may also 
be important, at least in some genes (Sadhale and Platt, 1992). The role of putative 
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RNA folding has not been intensively investigated, but together with redundancy of 
the regulatory sequences, it could well contribute to the complexity of 
polyadenylation signals in yeast.  
 
1.3.2 Trans-acting factors involved in pre-mRNA 3’ end processing in S. 
cerevisiae  
 
In the yeast S. cerevisiae, cleavage requires CPF, CF IA and CF IB. In addition to 
these protein factors, Pab1p is required for specific polyadenylation. Although the 
polyadenylation cis-acting signals used by mammals and yeast are different in their 
sequence and organization, protein factors of the 3’ end processing apparatus of both 
organisms exhibit high conservation (Figure 1.5 and Table 1.1).  
 Fractionation of yeast cell extracts have allowed the identification of the 
different factors involved in pre-mRNA 3’ end processing (Chen and Moore, 1992; 
Dichtl et al., 2002b; Kessler et al., 1996; Nedea et al., 2003). Reconstitution of 3’ end 
processing assays with partially purified chromatographic fractions have initially 
defined five protein factors: cleavage factors I and II (CF I and CF II), 
polyadenylation factor PF I, poly(A) polymerase (Pap1p) and poly(A) binding protein 
(Pab1p). CF II and PF I had several polypeptides in common and were later shown to 
be part of the same functional unit renamed CPF (Ohnacker et al., 2000). 
Furthermore, analysis of the protein composition of CPF has revealed the presence of 
Pap1p, which was shown to be much more active in the context of CPF than as a 
separate polypeptide. In addition, further purification of CF I led to the separation into 
CF IA and CF IB (Kessler et al., 1996). Thus, the contemporary view of the yeast 3’ 
end processing machinery involves the four protein factors CPF, CF IA, CF IB and 
Pab1p. The large majority of genes encoding for 3’ end processing polypeptides is 
essential for cell viability, confirming the essential function of their products in pre-
mRNA 3’ end formation. All of these factors have now been purified to homogeneity 
and are described in details below.  
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Table 1.1. Yeast pre-mRNA 3’ end processing factors are evolutionary conserved.  
Size (in kDa), sequence features and mammalian homologues are indicated. 
 
1.3.2.1 The cleavage and polyadenylation factor  
 
Comprising 15 polypeptides, including both enzymes that catalyze the cleavage and 
polyadenylation steps, CPF is the main 3’ end processing factor. It is the yeast 
counterpart of the mammalian CPSF factor involved in the recognition of the highly 
conserved AAUAAA hexamer sequence of pre-mRNAs. CPF composition was 
analyzed by affinity purification combined to mass spectrometry (MS) procedures 
(Dichtl et al., 2002b; Gavin et al., 2002; Nedea et al., 2003) and was shown to contain 
the following proteins, from the largest to the smallest subunit: Yhh1p/Cft1p (150 
kDa), Ydh1p/Cft2p (105 kDa), Ysh1p/Brr5p (100 kDa), Pta1p (85 kDa), Pap1p (64 
kDa), Ref2p (60 kDa), Mpe1p (58 kDa), Fip1p (55 kDa), Pfs2p (53 kDa), Pti1p (47 
kDa), Swd2p (37 kDa), Glc7p (36 kDa), Yth1p (26 kDa), Ssu72 (23 kDa), Syc1p (20 
kDa). Recently, it was proposed that Swd2p, Glc7p, Ref2p, Pti1p, Ssu72p, Syc1p and 
Pta1p can form a distinct unit called APT (associated with Pta1p) that would 
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independently direct snoRNAs (also transcribed by RNAP II) 3’ end processing 
(Nedea et al., 2003). Therefore, CPF can be divided in two subcomplexes, the APT 
and the core-CPF that contains all the other subunits.  
 Yhh1p, the largest subunit of CPF, is the homologue to the mammalian 
AAUAAA interacting protein CPSF-160. Both proteins share 24% identity and 51% 
similarity in the amino acid sequence level (Stumpf and Domdey, 1996). Yhh1p is a 
RNA-binding protein that binds the pre-mRNA at U-rich sequences surrounding the 
poly(A) site and is involved in poly(A) site recognition (Dichtl et al., 2002a). The 
RNA-binding domain is composed of β-propeller repeats in the central region of the 
protein. Furthermore, Yhh1p specifically interacts with the phosphorylated CTD, and 
was therefore proposed to have a role in the coupling of 3’ end formation and 
transcription (Dichtl et al., 2002a). In addition, Yhh1p has been shown to interact 
directly with almost all of the CPF and CF IA subunits. Finally, in cell free extracts 
immunodepleted with antibodies directed against Yhh1p and extracts of temperature-
sensitive yhh1 mutant alleles, both cleavage and polyadenylation reactions were 
abolished.  
 Ydh1p shares significant homology to CPSF-100 (24% identity and 43% 
similarity), but is also related to Ysh1p and CPSF-73 (Jenny et al., 1996). Ydh1p does 
not contain any known RNA-binding domains. Nevertheless, Ydh1p was successfully 
UV cross-linked to wild type pre-mRNAs in the presence of ATP, but not to 
precleaved RNAs or substrates lacking the EE (Zhao et al., 1997). Furthermore, this 
protein was shown to bind with high affinity at U-rich sequences surrounding the 
cleavage site and to the EE to a weaker extent (Dichtl and Keller, 2001). Ydh1p was 
shown to interact with several 3’ end processing polypeptides but also with the CTD 
of RNAP II (Kyburz et al., 2003). Recently, the crystal structure of Ydh1p at 2.5 Å 
resolution was reported (Mandel et al., 2006).  
 Ysh1p is the yeast homologue of mammalian CPSF-73 (23% identity and 48% 
similarity), and shares up to 53% identity in the first 500 amino acids (Chanfreau et 
al., 1996; Jenny et al., 1996). It is essential for both cleavage and polyadenylation 
activities in vivo and in vitro. Ysh1p contains a β-CASP motif and is therefore a 
member of the metallo-β-lactamase superfamily that comprises enzymes acting on 
nucleic acid substrates (Callebaut et al., 2002). Supported by the facts that β-
lactamase motifs are common to metal-dependent hydrolases, and that CPSF-73 has 
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been reported to be the mammalian 3’ end processing endonuclease (Mandel et al., 
2006; Ryan et al., 2004), Ysh1p has been proposed to be the endonuclease that acts on 
yeast pre-mRNAs. However, a direct proof of nuclease activity is still missing.  
 Pta1p has been originally identified as protein encoded by a gene affecting 
pre-tRNA processing (O'Connor and Peebles, 1992) and has been shown to be 
involved in both cleavage and poly(A) addition reactions (Zhao et al., 1999b). The 
phosphorylation status of Pta1p is regulated by the phosphatase Glc7p and influences 
polyadenylation activity of CPF: phosphorylated Pta1p inhibits poly(A) addition, 
whereas the unphosphorylated form does not (He and Moore, 2005). Furthermore, 
addition of Pta1p can restore polyadenylation activity in defective Glc7-depleted 
extracts (He and Moore, 2005).  
 Pap1p belongs to the large superfamily of nucleotidyl transferases and was the 
first 3’ end processing factor to be purified (Lingner et al., 1991a; Lingner et al., 
1991b). Pap1p is the enzyme that catalyzes polyadenylation of cleaved pre-mRNAs. 
The mammalian and yeast proteins share 47% identity in the first 400 amino acids, a 
region that comprises the catalytic domain containing three aspartate residues highly 
conserved across species (Martin et al., 2000). The yeast Pap1p lacks a C-terminal 
domain that carries a nuclear localization signal and a serine/threonine rich domain in 
mammals. However, an RNA-binding site (C-RBS) at the C-terminus is essential for 
activity (Zhelkovsky et al., 1998). Moreover, Pap1p contains two Fip1p binding sites, 
one of them overlapping with C-RBS and allowing Fip1p to regulate the processivity 
of the polymerase (Zhelkovsky et al., 1998). Two other binding sites also exist, one 
being involved in the recognition of the last three nucleotides of the RNA primer, the 
other one helping the enzyme to discriminate against deoxyribonucleotide substrates. 
Interestingly, studies have shown that Pap1p undergoes phosphorylation and 
ubiquitination during the S-G2 transition of the cell cycle, and that the phosphorylated 
form of the enzyme was inactive (Mizrahi and Moore, 2000). In contrast to the 
mammalian system, Pap1p is not involved in the cleavage step (Mandart and Parker, 
1995).  
 Ref2p is one of the only two non-essential polypeptides of the 3’ end 
processing machinery. Ref2p is an RNA-binding protein that is directly involved in 
the cleavage step of 3’ end processing (Russnak et al., 1995) and plays the role of 
negative regulator of poly(A) synthesis (Mangus et al., 2004). Besides its functions in 
pre-mRNA 3’ end processing, Ref2p is an essential actor in snoRNAs 3’ end 
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formation (Dheur et al., 2003). Finally, Ref2p was proposed to recruit the phosphatase 
Glc7p, and Swd2p in CPF (Nedea et al., 2003).   
 Mpe1p is an evolutionary conserved protein that is exclusively involved in 
polyadenylation of pre-mRNAs (Vo et al., 2001). The MPE1 gene genetically 
interacts with PCF11 and the protein may contribute to the poly(A) site selection (Vo 
et al., 2001). Furthermore, Mpe1p contains a RNA-binding zinc knuckle motif (CX2 
CX4 HX4 C). Although this zinc finger motif has been implicated in the interaction 
between proteins and single-stranded nucleic acids, its deletion had no effect on the 
capability of Mpe1p to bind RNAs.  
 Fip1p was originally identified as a protein interacting with Pap1p and is 
exclusively involved in polyadenylation (Preker et al., 1995). Indeed, Fip1p has a key 
regulatory function in polyadenylation by inhibiting the processive activity of Pap1p 
through multiple interactions (Helmling et al., 2001). Association of Fip1p with 
Pap1p inhibits polyadenylation activity by limiting access of the RNA substrate to the 
C-RBS of the polymerase. Individual functional domains of Fip1p have been 
identified. The Fip1p domain responsible for binding and inhibition of Pap1p 
comprises the amino acids 80-105, which are essential for cell viability. Furthermore, 
the amino acids 206-220 are responsible for interaction with Yth1p and for 
polyadenylation of the mRNA precursor. Finally, the region comprising amino acids 
105-206 promotes limitation of RNA-binding to the C-RBS of Pap1p. Another feature 
of Fip1p is that it helps the recruitment of Pap1p to CPF by interacting with Yth1p 
(Barabino et al., 2000). Interactions with Ysh1p, Psf2p and Rna14p have also been 
reported (Barabino et al., 2000; Ohnacker et al., 2000; Preker et al., 1995). Finally, it 
was found that Fip1p can be phosphorylated by the creatine kinase CK2 (Zielinski et 
al., 2006), and that phosphorylation decreased the association of Fip1p with CPF (He 
and Moore, 2005).  
 Pfs2p is a 53 kDa protein that contains seven WD-40 repeats between amino 
acids 90 and 380 (Ohnacker et al., 2000). WD repeats, also called transducin repeats, 
are found in many polypeptides that are involved in diverse cellular processes and that 
often belong to multiprotein complexes (Smith et al., 1999). Although removal of the 
C-terminal extension following the last WD repeat is dispensable for cell viability, 
deletion of one WD repeat is lethal (Ohnacker et al., 2000). The same authors 
demonstrated that Pfs2p directly interacts with subunits of CPF and CF IA, and thus 
proposed that Pfs2p functions in the assembly and stabilization of the 3’ end 
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processing apparatus. Consistently, it is essential for both cleavage and poly(A) 
addition activities.  
 Pti1p was originally identified by two-hybrid screen interacting with Pta1p as 
bait and shows significant similarities to the CF IA subunit Rna15p and the 
mammalian CstF-64 (W. Hübner, unpublished data). Pti1p contains a RNA 
recognition motif and directly binds Pta1p and Rna14p (Skaar and Greenleaf, 2002). 
It is not essential for 3’ end processing activities, nevertheless, mutations were shown 
to affect the cleavage site choice (Dheur et al., 2003; Skaar and Greenleaf, 2002). 
Furthermore, Pti1p plays an essential role in snoRNAs 3’ end formation and has been 
shown to uncouple cleavage and polyadenylation upon overexpression (Dheur et al., 
2003). Finally, Pti1p seems to be phosphorylated upon cell growth arrest (W. Hübner, 
unpublished data).  
 Swd2p contains seven WD-40 repeats and is associated with two different 
multiprotein complexes: CPF and the SET1 complex (SET1C) that methylates lysine 
4 of histone 3 (H3-K4). In the context of the SET1C, Swd2p is required for H3-K4 di 
and trimethylation that acts in regulation of gene expression (Dichtl et al., 2004; 
Jenuwein and Allis, 2001). In the context of CPF, Dichtl et al. (2004) have found that 
Swd2p was required for 3’ end formation of specific mRNAs and snoRNAs. In 
contradiction, Cheng et al. (2004) did not find direct involvement in cleavage and 
polyadenylation (Cheng et al., 2004). Furthermore, it has been proposed that the roles 
of Swd2p in 3’ end formation and in histone tail modifications are independent 
(Dichtl et al., 2004).  
 Glc7p is a type 1 serine/threonine protein phosphatase (PP1), for which it is 
the only isoform in yeast (Feng et al., 1991). Amino acid sequences of catalytic 
subunits of PP1 are highly conserved across many species (Ramaswamy et al., 1998). 
Like mammalian PP1 catalytic subunits, Glc7p regulates many physiological 
processes, including glycogen metabolism, glucose repression, transcription, 
membrane fusion, mitosis, sporulation, ion homeostasis, and cell wall organization 
(Peggie et al., 2002; Stark, 1996; Tan et al., 2003; Williams-Hart et al., 2002). 
Recently, Glc7p has been shown to have an important role in mRNA export by 
dephosphorylating Npl3p, a factor involved in mRNA transport (Gilbert and Guthrie, 
2004). In the context of pre-mRNA 3’ end processing, the requirement of the 
phosphatase for polyadenylation but not for cleavage has been demonstrated (He and 
Moore, 2005). Furthermore, phosphorylated Pta1p was found to be a substrate of 
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Glc7p within the CPF complex (He and Moore, 2005). In addition, the presence of 
Glc7p within CPF has suggested that the activity of the complex could be regulated 
by cycles of phosphorylation and dephosphorylation (He and Moore, 2005). 
Additional studies also highlighted the role of Glc7p in snoRNA transcription 
termination (S. Röck, unpublished data).  
 Yth1p contains five zinc fingers of the C3-H type, among which the second 
and fourth zinc fingers were shown to be essential (Barabino et al., 2000; Tacahashi et 
al., 2003), and is 40% identical to the mammalian 30 kDa polypeptide of CPSF 
(Barabino et al., 1997). Yth1p is an essential RNA-binding component of the cleavage 
and polyadenylation factor and binds to the pre-mRNA in the vicinity of the cleavage 
site (Barabino et al., 2000). Yth1p also binds directly to Fip1p and Ysh1p and is 
essential for both steps of pre-mRNA 3'-end processing (Barabino et al., 2000; 
Barabino et al., 1997).  
 Ssu72p was initially identified based on genetic and physical interaction with 
the general transcription factor TFIIB and the Rpb2p subunit of RNAP II (Dichtl et 
al., 2002b; Pappas and Hampsey, 2000; Sun and Hampsey, 1996). Ssu72p is involved 
in transcription termination of both pre-mRNAs and snoRNAs (Ganem et al., 2003; 
Nedea et al., 2003; Steinmetz and Brow, 2003) and affects start site selection during 
transcription initiation. Furthermore, Ssu72p is directly involved in pre-mRNA 
cleavage but not in polyadenylation (He et al., 2003). In addition, evidence was 
provided that Ssu72p is a CTD phosphatase specific for phosphorylated serine 5 
(Ganem et al., 2003; Krishnamurthy et al., 2004). Chromatin immunoprecipitation 
experiments also revealed that Ssu72p is present at both terminator and promoter 
regions of RNAP II genes (Nedea et al., 2003). Exploiting these observations, Ssu72p 
and its phosphatase activity were proposed to mediate gene looping (juxtaposition of 
promoter and terminator regions) of some yeast genes (Ansari and Hampsey, 2005).  
 Together with Ref2p (see above), Syc1p is one of the two non-essential 
protein involved in 3’ end processing in yeast (Gavin et al., 2002; Nedea et al., 2003). 
Its amino acid sequence is highly similar to the C-terminal region of Ysh1p that is 
essential for cell viability (35% identity and 52% similarity over 199 amino acids). 
The presence of Syc1p was shown to exacerbate the processing and growth defects of 
many processing mutants, suggesting a role in regulating 3’ end formation efficiency 
(Zhelkovsky et al., 2006).  
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1.3.2.2 The cleavage factor IA  
 
CF I was originally identified as a factor required for both the cleavage and 
polyadenylation reactions (Chen and Moore, 1992), and was further separated into 
two factors, CF IA and CF IB (Kessler et al., 1996). CF IA contains four essential 
subunits: Rna14p (76 kDa), Pcf11p (72 kDa), Clp1p (50 kDa) and Rna15p (38 kDa). 
CF IB consists of the single polypeptide Nab4p. Numerous protein-protein 
interactions have been reported between CF IA and CPF, indicating a high degree of 
crosstalk between these two complexes.  
 Rna14p and Rna15p are tightly associated, forming an heterodimeric complex 
required for RNA-binding (Noble et al., 2004), and are essential for both steps of 3’ 
end formation (Kessler et al., 1997). Rna14p has sequence homology to mammalian 
CstF-77 (24% identity) and contains 10 HAT repeats (Takagaki and Manley, 1994). 
Rna14p interacts with Pcf11p and Nab4p (Gross and Moore, 2001), but also with the 
CPF subunits Pfs2p and Yhh1p (Kyburz et al., 2003; Ohnacker et al., 2000).  
 Rna15p is the yeast homologue of CstF-64 (Takagaki and Manley, 1994) and 
contains a canonical single RNA recognition motif (RRM) at its N-terminus and a C-
terminal region that is essential for polyadenylation and transcription termination 
(Minvielle-Sebastia et al., 1994). Although the protein has affinity for U-rich 
sequences and can be UV cross-linked to RNA substrate (Kessler et al., 1996; 
Minvielle-Sebastia et al., 1991; Takagaki and Manley, 1994), the sequence that is 
recognized by Rna15p is still unclear. However, UV cross-linked experiments 
suggested that Rna15p binds to the PE in the presence of Rna14p and Nab4p/Hrp1p 
(Gross and Moore, 2001).  
 Pcf11p is involved in both steps of 3’ end formation and was initially 
identified in two-hybrid screens as a polypeptide interacting with Rna14p and Rna15p 
(Amrani et al., 1997). A CTD-interaction domain (CID) located at the N-terminus of 
Pcf11p is responsible for the direct interaction of Pcf11p with the CTD 
phosphorylated on serine 2 and by this couples 3’ end processing and transcription 
termination (Barilla et al., 2001; Licatalosi et al., 2002; Sadowski et al., 2003). 
Furthermore, Pcf11p is involved in the dismantling of the RNAP II elongation 
complex (Zhang et al., 2005). Pcf11p has only low affinity for the CTD and efficient 
interaction probably requires multiple binding sites (Noble et al., 2005). Interestingly, 
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pre-mRNA 3′ end processing activities and CTD binding of Pcf11p could be 
functionally uncoupled from each other (Sadowski et al., 2003). Pcf11p has putative 
homologues in many species that all contain a N-terminal CID (Barilla et al., 2001; 
Steinmetz and Brow, 1996; Yuryev et al., 1996). The high-resolution X-ray structure 
of the Pcf11p CID in complex with a CTD-derived peptide has been reported, 
identifying eight α-helices in a right-handed superhelical arrangement in the CID 
(Meinhart and Cramer, 2004). The central region of Pcf11p contains binding sites for 
the three other CF IA subunits and two putative zinc-finger motifs (Amrani et al., 
1997; Sadowski et al., 2003).  
 Clp1p is the yeast homologue of the mammalian hClp1 (de Vries et al., 2000). 
The amino acid sequence contains a Walker A motif that is predicted to bind adenine 
or guanine nucleotides, suggesting a role in nucleotide binding or catalysis. Clp1p 
binds to Pcf11p but not to the other CF IA subunits (Gross and Moore, 2001) and also 
contacts the Ysh1p subunit of CPF (Kyburz et al., 2003) that is believed to be the 
endonuclease responsible for pre-mRNA cleavage (Dominski et al., 2005; Ryan et al., 
2004). A recent publication reports the structure of the ternary complex formed by the 
association of Clp1p with ATP and the Clp1p-binding region of Pcf11p (Noble et al., 
2007). This structure revealed that Clp1p contains three domains: a small N-terminal 
β sandwich domain, a C-terminal domain containing a novel α/β-fold and a central 
region that binds ATP. The nucleotide binding site contains a canonical P-loop motif 
similar to SIMIBI-class ATP/GTPases subunits (Leipe et al., 2002). The central 
domain also contains the binding site to Pcf11p.  
 
1.3.2.3 The cleavage factor IB  
 
CF IB consists of the single polypeptide Nab4p/Hrp1p (Kessler et al., 1997; Kessler et 
al., 1996). The factor is required for polyadenylation but not for cleavage, however, it 
regulates cleavage site selection by suppressing the use of cryptic poly(A) sites 
(Minvielle-Sebastia et al., 1998) and specifically binds the pre-mRNA on the cis-
acting EE (Chen and Hyman, 1998; Valentini et al., 1999). The central region of 
Nab4p contains two RNP-type RNA-binding domains (RBDs) arranged in tandem 
(Henry et al., 1996). The solution structure of Nab4p in complex with an RNA 
sequence G(UA)4 mimicking the EE sequence showed that only six bases (UA)3 form 
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specific contacts to the factor (Perez-Canadillas, 2006). The C-terminal part of Nab4p 
is rich in arginine and glycine, with putative methylation sites. Interestingly, 
methylation of Nab4p facilitates the protein to shuttle between the nucleus and the 
cytoplasm (Henry et al., 1996; Kessler et al., 1997; Shen et al., 1998). The NAB4 gene 
is genetically linked to the NPL3 gene that encodes a protein involved in mRNA 
export, thus suggesting a role for Nab4p in this process (Henry et al., 1996). 
Furthermore, Nab4p is implicated in modulating the activity of the nonsense-mediated 
mRNA decay (NMD) pathway, a surveillance mechanism that monitors premature 
translation termination and degrades aberrant mRNAs (Gonzalez et al., 2000).  
 
1.3.2.4 The poly(A) binding protein  
 
Polyadenylated mRNAs are bound by Pab1p that is a protein highly conserved across 
species. Pab1p contains four N-terminal RNA recognition motifs (RRMs), which are 
connected to a C-terminal helical domain via a segment rich in proline and 
methionine (Mangus et al., 2004; Sachs et al., 1986). The main role of Pab1p is 
poly(A) tail length control (Kessler et al., 1997; Minvielle-Sebastia et al., 1997). 
Regulation of poly(A) tail length is achieved through two different functions: Pab1p 
inhibits Pap1p activity by limiting its access to the pre-mRNA (Zhelkovsky et al., 
1998), and recruits a poly(A)-specific nuclease, PAN (Deardorff and Sachs, 1997; 
Lowell et al., 1992). Association with the pre-mRNA occurs in the nucleus but also in 
the cytoplasm (Adam et al., 1986; Setyono and Greenberg, 1981). A minimum of 12 
adenosines is required as a binding site for one polypeptide. The association of Pab1p 
with the poly(A) tail also leads to stimulation of mRNA translation in vivo and in 
vitro by interacting with eIF4G, a component of the yeast translation initiation factor 
(Tarun and Sachs, 1996; Tarun et al., 1997). Furthermore, Pab1p has an inhibitory 
function in mRNA decapping and deadenylation (Caponigro and Parker, 1995).  
 
1.3.3 Poly(A) tail functions in yeast  
 
Polyadenylation is an essential processing step for most eukaryotic mRNAs. Poly(A) 
tails are synthesized in the nucleus within a defined size range depending on the 
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organism: from 70 nt in yeast to 250 nt in mammals. The length of the poly(A) tract 
added to the messengers is tightly regulated by Pab1p. Why poly(A) tails have a 
defined size is not understood, however, it appears that the functions of poly(A) tails 
are linked to the poly(A) binding protein.  
 
1.3.3.1 Poly(A) tails stimulate translation initiation 
 
A combination of in vivo and in vitro data obtained during the last 20 years led to the 
observation that the poly(A) tail added to the 3’ end of mRNAs stimulates translation 
initiation of the transcripts (Iizuka et al., 1994; Jacobson and Favreau, 1983; Sachs 
and Davis, 1989). Translation stimulation is mediated by Pab1p that acts 
synergistically with the 5’ end cap structure to enhance the binding of the 40S small 
ribosomal subunit to the mRNA (Tarun and Sachs, 1995; Tarun and Sachs, 1996). 
The recruitment of the 40S small ribosomal subunit to the mRNA is mediated by a 
physical interaction between Pab1p and the translation initiation factor eIF4F. 
Furthermore, it was found that this interaction with Pab1p occurs through a contact to 
the eIF4G component of the eIF4F complex, only when Pab1p was bound to the 
poly(A) tail, resulting in the circularization of the mRNA molecule (Tarun and Sachs, 
1996; Tarun et al., 1997). These combined cooperative interactions enhance the 
affinity of eIF4F for the 5’ cap of the mRNA (Borman et al., 2000; Haghighat and 
Sonenberg, 1997; Luo and Goss, 2001) and the RNA-binding capacity of Pab1p (Le 
et al., 1997; Munroe and Jacobson, 1990a; Munroe and Jacobson, 1990b).  Translation 
initiation enhancement by poly(A) tails is also found in higher eukaryotes (Munroe 
and Jacobson, 1990a). Poly(A) tails then also have a role in development by 
regulating the expression of certain gene products. Indeed, poly(A) tail shortening or 
extension was shown to regulate the translation level of some mRNAs (Curtis et al., 
1995).  
 
1.3.3.2 The role of Poly(A) tails in mRNA stability 
 
The process of mRNA decay can be initiated by three distinct events: removal of the 
5’ cap, endonucleolytic cleavage and poly(A) shortening (Jacobson and Peltz, 1996). 
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Poly(A) tails have a role in the regulation of mRNA stability by preventing 
degradation by exonucleases, as deadenylation is often the first step of mRNA decay 
in yeast (Beelman and Parker, 1995; Caponigro and Parker, 1996; Sachs and Wahle, 
1993). Poly(A) tail shortening in yeast is followed by decapping of the transcript by 
the Dcp1p-Dcp2p complex (Figure 1.1) and 5' to 3' exonucleolytic degradation by 
Xrn1p or the exosome (Decker and Parker, 2002).  
 As in translation initiation, Pab1p has a role in mRNA decay. Yeast pab1 
mutant strains contain mRNAs with abnormally long poly(A) tails, indicating that 
Pab1p is also involved in poly(A) tail shortening (Sachs and Davis, 1989). 
Furthermore, Pab1p is recruited by the poly(A) nuclease PAN that shortens the 
excessively long newly synthesized poly(A) tails in an mRNA-specific manner 
(Boeck et al., 1996; Brown et al., 1996). The 3’ to 5’ exoribonuclease activity of PAN 
was shown to be stimulated by Pab1p (Lowell et al., 1992).  
 
1.3.3.3 Poly(A) tails are involved in mRNA export 
 
Poly(A) tails are also implicated in mRNA export of the transcripts from the nucleus 
to the cytoplasm (Huang and Carmichael, 1996; Long et al., 1995). After complete 
maturation, mRNA molecules are translocated into the cytoplasm through the nuclear 
pore complex to serve as template for translation into proteins. Translation per se is an 
essential step in the expression of genetic information. Pab1p, which coats the nascent 
poly(A) tails, has been shown to interact with specific nucleoporins and the nuclear 
export signal export receptor Xpo1p (Allen et al., 2001; Hammell et al., 2002). 
Furthermore, Pab1p was found to localize in the nucleus and in the cytoplasm by 
immunofluorescence studies, consistently with the fact that the protein shuttles 
between both compartments (Anderson et al., 1993). The role of poly(A) tails in 
export reflects a quality control mechanism, which retains the mRNAs that were not 
correctly processed, and that helps the mature mRNAs to reach the cytoplasm 
(Hammell et al., 2002; Hilleren et al., 2001).  
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1.3.3.4 Poly(A) tails are involved in RNA quality control  
 
Pap1p is the canonical nuclear poly(A) polymerase that catalyzes the polyadenylation 
step during pre-mRNA 3’ end processing. Recent studies have shed light on another 
type of nuclear poly(A) polymerase in yeast belonging to the polymerase β-type 
nucleotidyltransferase superfamily (Aravind and Koonin, 1999), Trf4p, which is 
conserved throughout eukaryotes (LaCava et al., 2005; Vanacova et al., 2005). 
Genetic and biochemical studies of this novel poly(A) polymerase demonstrated a 
new function for poly(A) tails in degrading aberrant RNAs (tRNAs, rRNAs, snRNAs 
and some intergenic mRNAs). Trf4p stably associates with a RNA helicase, Mtr4p, 
and with one of two RNA-binding proteins, Air1p or Air2p, to form the 
Trf4p/Air1p/Mtr4p polyadenylation complex (TRAMP). It was shown that TRAMP 
has polymerase activity that can polyadenylate in vitro small RNAs, including tRNAs. 
Interestingly, poly(A) addition to aberrantly structured RNAs was then shown to 
stimulate degradation by the exosome, a complex of multiple 3’-5’ exonucleases that 
degrade numerous RNAs (Mitchell et al., 1997), revealing a novel involvement of 
poly(A) tails in RNA quality control (LaCava et al., 2005; Vanacova et al., 2005). 
This property is reminiscent of the poly(A) tail function in prokaryotes, in which the 
poly(A) tail promotes the degradation of the RNA (Grunberg-Manago, 1999). Thus, 
Trf4p and the TRAMP complex are involved in a nuclear surveillance mechanism 
that prevents the export and subsequent expression, in the case of mRNAs, of 
misfolded RNAs. How does TRAMP discriminate a substrate that has to be degraded 
from a substrate that has to undergo conventional polyadenylation is still an open 
question. It was however suggested that the TRAMP complex could recognize 
structural features induced by the misfolded RNAs.  
 In summary, the roles of poly(A) tails illustrate the interdependence of the 
different steps in gene expression and the regulatory effects of these coupling events.  
 
1.4 Interconnections between pre-mRNA processing events and RNAP II 
transcription  
 
Eukaryotic gene expression is a complex stepwise process that includes transcription, 
pre-mRNA processing and translation into active proteins. The complexity of each 
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step in the pathway required them to be studied independently of the others. The 
establishment of in vitro assays first allowed to reconstitute the activity of each 
individual process and to characterize the proteins involved. Therefore, as the 
different steps were analyzed separately, gene expression has been traditionally 
viewed as a linear series of events, with each one going to the end before the next 
starts. However, recent analyses have demonstrated that many of the steps involved in 
this pathway are connected (Figure 1.6). 
 In the recent years, a growing number of genetic and biochemical studies have 
revealed that the protein machineries that perform the different steps in the gene 
expression pathway interact both physically and functionally (for reviews, see 
Bentley, 1999; Cramer et al., 2001a; Hirose and Manley, 2000; Proudfoot, 2000; 
Shatkin and Manley, 2000). By such a connection, the different processes influence 
one another’s efficiency and specificity. In addition, this coupling ensures the 
efficient transfer of the genetic information from one step to the next.  
 All three pre-mRNA processing steps are coupled to transcription (Bentley, 
2005; Cramer et al., 2001a; Hirose and Manley, 2000; Kornblihtt et al., 2004; 
Maniatis and Reed, 2002; Orphanides and Reinberg, 2002; Proudfoot, 2004). It has 
been demonstrated that the transcription machinery actively recruits the capping 
enzymes (Shatkin and Manley, 2000), and that splicing and 3’ end formation promote 
transcription termination (Fong and Bentley, 2001; Zaret and Sherman, 1982). Those 
coupling events are mediated by the C-terminal domain of the largest subunit (Rpb1p 
in yeast) of RNAP II.  
 
1.4.1 The CTD is a recruitment platform for pre-mRNA processing factors 
 
Optimal pre-mRNA 3’ end processing is achieved by coupling with RNAP II only 
and not other polymerases. The reason for this specificity resides in the presence of a 
unique and unusual domain in the largest subunit of RNAP II, called the C-terminal 
domain (CTD), which provides a landing pad for reversible interactions with pre-
mRNA processing factors (Hirose and Manley, 1998; McCracken et al., 1997b; 
Proudfoot et al., 2002). The binding of specific processing factors depends on the 
phosphorylation state of the CTD, which is dynamic during the transcription cycle 
(Dahmus, 1995). 
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 The CTD is an essential domain in RNAP II, but is absent in RNA pol I and 
RNA pol III. The CTD consists of multiple heptapeptide repeats whose the amino 
acid consensus sequence, Y1S2P3T4S5P6S7, is identical across animals, plants and 
some protozoa. The number of repeats depends on the species, and is 52 in human and 
26 in yeast, from which 8 are essential for yeast viability (Nonet et al., 1987). The 
importance of the CTD in the processing steps is illustrated by the fact that certain 
CTD mutations that have no effect on transcription significantly affect capping (Cho 
et al., 1997; McCracken et al., 1997a), splicing and 3’ end polyadenylation 
(McCracken et al., 1997b). In crystallographic studies, the CTD appears as an 
unstructured tail-like extension directly adjacent to the exit groove for the pre-mRNA 
and is linked to Rpb1p through a flexible linker of 80 residues (Cramer et al., 2001b). 
This flexibility apparently facilitates interaction with the processing factors.   
 The CTD can undergo several kinds of modifications, such as 
phosphorylation, cis/trans isomerization of prolines and glycosylation (Meinhart et 
al., 2005). Site-specific phosphorylation and dephosphorylation is the most important 
modification and is critical for CTD function (Cho et al., 2001; Dahmus, 1996; 
Komarnitsky et al., 2000). The current paradigm is that the phosphorylation pattern of 
RNAP II changes during the transcription cycle and that different proteins bind to 
specific phosphorylated forms of the CTD. The heptapeptide repeat contains five 
potential phosphorylation sites: Y1, S2, T4, S5 and S7. However, phosphorylation 
occurs mainly on serines at position 2 and 5 (Corden et al., 1985; Zhang and Corden, 
1991), giving rise to four possible phosphorylation states of the CTD 
(unphosphorylated form; phosphorylated at S2; phosphorylated at S5; phosphorylated 
at S2 and S5). These phosphorylations involve two specific cyclin associated kinases: 
in yeast, the TFIIH subunit Kin28p specifically phosphorylates S5 (Feaver et al., 
1991), whereas S2 is phosphorylated by Ctk1p. Several phosphatases are also known, 
including Ssu72p (a subunit of CPF) that is specific for S5 (Ganem et al., 2003) and 
Fcp1p that can dephosphorylate both S2 and S5 (Cho et al., 2001). The 
phosphorylation pattern is dynamic during the transcription cycle and thus controls 
the recruitment of processing factors. S5 posphorylation occurs early in the 
transcription cycle and promotes promoter release, the formation of the elongation 
complex, and leads to the recruitment of capping enzymes (Cho et al., 1997; Ho et al., 
1998; Komarnitsky et al., 2000; McCracken et al., 1997a). In contrast, posphorylation 
of S2 is predominant when RNAP II transcribes the gene, including at the 3’ end, and 
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triggers association with splicing and 3’ end processing factors (Cho et al., 1997; 
Komarnitsky et al., 2000). Furthermore, the dephosphorylated form stimulates the 
recruitment of RNAP II in the preinitiation complex (Cho et al., 1999). Thus, relating 
to the posphorylation pattern, a “CTD code” can define the position of RNAP II 
within the transcription cycle (Buratowski, 2003).  
 The CTD code consists of all the possible states that the CTD can adopt. 
Taking into account four different phosphorylation states and four possible proline 
configurations (cis or trans conformations of P3 and P6), a combination of 16 different 
states is obtained for only one repeat (Buratowski, 2003). Moreover, the complexity 
of the CTD code is extended by the facts that a functional unit of the CTD is a pair of 
repeats (Stiller and Cook, 2004), that the residue Y1 can also be phosphorylated 
(Baskaran et al., 1993), and by possible CTD glycosylation (Kelly et al., 1993).  
 
Figure 1.6. Transcriptional coupling of pre-mRNA processing events (from 
Orphanides et al., 2002).  
The transcription cycle is depicted starting at the bottom left. Each maturation step 
(capping, splicing and 3’ end processing) is physically and functionally connected to 
transcription.  
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1.4.2 Coupling between capping and transcription 
 
Capping of pre-mRNAs occurs cotranscriptionally soon after transcription initiation, 
when the nascent transcript has reached 20-40 nt in length (Coppola et al., 1983; 
Rasmussen and Lis, 1993). The cap structure plays an important roles in mRNA 
stability by preventing 5’-3’ exonucleolytic degradation, in stimulating splicing and 3’ 
end formation, but also in transport and cytoplasmic translation (Lewis et al., 1995).  
 The capping enzymes are in fact the first processing factors to be recruited to 
the CTD during the transcription cycle. Phosphorylation of the CTD on S5 by Kin28p 
is required for the binding of the three capping enzymes (Cho et al., 1997; 
Komarnitsky et al., 2000; McCracken et al., 1997a). Moreover, activity of the 
mammalian guanylyltransferase is significantly enhanced upon CTD binding, as the 
Km for GTP was reduced (Ho and Shuman, 1999). After addition of the cap, the 
dephosphorylation of S5 in the early transcription elongation phase is coupled to the 
release of the capping enzymes. As shown by chromatin immunoprecipitation 
experiments (ChIP), Ceg1p-Cet1p is rapidly removed, whereas the methyltransferase, 
Abd1p, remains unexpectedly associated with RNAP II even at the 3’ end of the 
genes (Komarnitsky et al., 2000; Schroeder et al., 2000). This might be due to the 
other function of Abd1p in the stimulation of transcription elongation (Schroeder et 
al., 2004), whereas the RNA triphosphatase, Cet1p, was shown to inhibit re-initiation 
of transcription (Myers et al., 2002).  
 Hence, capping enzymes not only fulfil the first pre-mRNA processing step, 
but are also able to modulate transcription activity. Therefore, they are though to act 
as a checkpoint to make sure that the cap has been added to the primary transcript 
before going on in the gene expression pathway.    
 
1.4.3 Coupling between splicing and transcription 
 
Most eukaryotic genes are interrupted by noncoding sequences, also called introns. To 
generate a functional mRNA, introns have to be removed and exons joined together 
during the splicing reaction (for a review, see Kramer, 1996). Like capping enzymes, 
splicing factors are recruited to the nascent transcript to cotranscriptionally remove 
introns (Beyer et al., 1981), and can enhance transcription elongation (Fong and 
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Zhou, 2001). Of the three pre-mRNA processing events, splicing is the most 
complicated, as reflected by the involvement and the stepwise integration of five 
snRNPs composed of U1, U2, U4, U5, and U6 small nuclear RNAs (snRNAs) and 
more than 200 proteins in the dynamic spliceosome complex (Jurica and Moore, 
2003). Consistent with this complexity, the recruitment of the splicing apparatus is 
still largely misunderstood, and the role of the CTD less fully documented than for 
capping. A link between splicing and transcription was demonstrated by the 
coimmunoprecipitation of spliceosomal snRNPs and RNAP II by using a specific 
antibody for the phosphorylated CTD. The phospho-CTD was shown to stimulate the 
spliceosome assembly in vitro and in vivo, whereas the unphosphorylated form 
inhibited the reaction (Fong and Bentley, 2001; Hirose et al., 1999). The simplest 
situation is found in the budding yeast S. cerevisiae, where only 3% of the genes 
contain introns (Ares et al., 1999; Lopez and Seraphin, 1999). Moreover, in most 
cases, these genes have only one single and short intron.  
 In yeast, U1snRNP, which binds to the 5’ splice site, interacts with the 
transcription elongation complex in the intron and remains bound to the downstream 
exon, suggesting that U1snRNP is recruited to the intronic RNA rather than to the 
RNAP II CTD (Kotovic et al., 2003). In contradiction with this observation, 
U1snRNP was also found on some genes lacking introns, raising the hypothesis that 
splicing factors can be recruited either by binding to the pre-mRNA or to the 
transcription machinery. Consistently, the association of the U1snRNP protein 
Prp40p, of another splicing factor Sub2p and of a set of splicing-related factors 
(SCAFs) with the phosphorylated CTD was reported (Abruzzi et al., 2004; Corden 
and Patturajan, 1997; Morris and Greenleaf, 2000). These interactions suggest a role 
for these proteins in linking RNAP II transcription to splicing.  
 However, it is still questionable whether the functional link between 
transcription and splicing observed in mammals can be extended to yeast. Because 
very few genes have more than one intron, it is conceivable that yeast does not use a 
spliceosome recycling mechanism, as metazoans require to tackle their highly 
fragmented genes. Indeed, most of the data indicating interactions between splicing 
components and RNAP II come from mammalian cells studies (Carty and Greenleaf, 
2002; Emili et al., 2002; Mortillaro et al., 1996; Robert et al., 2002). ChIP 
experiments suggest that different snRNPs are recruited at different times during 
elongation. Furthermore, the CTD has only very little influence on splicing in yeast 
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(Licatalosi et al., 2002), whereas the phosphorylated CTD enhances the reaction in 
mammals (Bird et al., 2004; Millhouse and Manley, 2005).  
 
1.4.4 Coupling between 3’ end formation and transcription 
 
Most pre-mRNAs are processed at their 3’ end by a two-step reaction that cleaves at 
the poly(A) site and then polyadenylates the upstream cleavage product. This 
processing phase is carried out by the multiprotein apparatus described above. Like 
the two other processing steps, 3’ end formation is intimately coupled to transcription. 
Indeed, it was shown that correct transcription termination requires an intact poly(A) 
site (Whitelaw and Proudfoot, 1986; Zaret and Sherman, 1982), and that deletion of 
the RNAP II CTD has a detrimental effect on 3’ end formation (McCracken et al., 
1997b).  
 Surprisingly, the recruitment of polyadenylation factors not only occurs at the 
3’ end, but also at the 5’ end and through the entire gene. Indeed, ChIP experiments 
indicated that this recruitment is progressively increased from the promoter to the end 
of the gene, suggesting that 3’ end processing factors associate with transcribing 
RNAP II from the 5’ end to the 3’ end of the gene (Calvo and Manley, 2005; Kim et 
al., 2004a; Licatalosi et al., 2002). The unexpected presence of 3’ end processing 
factors at the promoter region is correlated to some early transcriptional events. 
Rna15p (a CF IA subunit) interacts with the coactivator Sub1p that has a role in the 
definition of the transcriptional start site (Calvo and Manley, 2005) and Ssu72p (a 
CPF subunit) interacts with the general transcription factor TF IIB (Calvo and 
Manley, 2005; Krishnamurthy et al., 2004). In addition, Ssu72p, which is a CTD 
phosphatase specific for S5, has been involved in 3’ end formation and transcription 
termination (Dichtl et al., 2002b; Ganem et al., 2003; Krishnamurthy et al., 2004). 
The interactions between components of the initiation and termination transcription 
machineries suggest that both transcription phases are connected, possibly to facilitate 
reinitiation of transcription.   
 Strikingly, this distribution of 3’ end processing factors over the gene is 
similar to that of S2 phosphorylation of the CTD, which is high at the 3’ end region 
(Komarnitsky et al., 2000). CTD phosphorylation of S2 by Ctk1p plays an important 
role in 3’ end maturation. Indeed, a strong connection has been established between 
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the CTD phosphorylated on S2 and the recruitment of 3’ end formation factors. 
Among evidences, overexpression of the CPF subunit Pti1p was shown to suppress 
the mutant phenotype of strains that carry a deletion of the CTK1 gene (Skaar and 
Greenleaf, 2002). Moreover, the recruitment of polyadenylation factors to 3' end 
regions of genes was disrupted in yeast strains lacking Ctk1p (Ahn et al., 2004). 
Furthermore, S2 phosphorylation significantly increased the in vitro CTD binding of 
Pcf11p, a CF IA component (Licatalosi et al., 2002). The crystal structure of this 
interaction shows that there is no direct contact between the S2 phosphate group and 
Pcf11p, but instead that the interaction induces a stable conformation of the structure 
(Meinhart and Cramer, 2004). Pcf11p contains a specific CTD interaction domain 
(CID) that mediates the binding to the CTD. Other 3’ end processing factors were also 
shown to preferentially bind to the phosphorylated CTD, as Yhh1p (Dichtl et al., 
2002a), Ydh1p (Kyburz et al., 2003), Pta1p (Rodriguez et al., 2000), Rna14p (Barilla 
et al., 2001) and Nab4p (Komarnitsky et al., 2000), but also to the CTD without 
known preference for a phosphorylated state, as the CPF subunits Pap1p, Pfs2p, 
Yth1p and the CF IA subunits Rna14p and Rna15p. Interestingly, both 
unphosphorylated and phosphorylated forms of the CTD are able to activate 3’ end 
cleavage even in the absence of on-going transcription (Hirose and Manley, 1998). 
Since RNAP II undergoes changes in its phosphorylation status when the end of the 
gene is reached, this absence of discrimination may allow the 3’ end processing 
factors to stay attached to the polymerase to complete their task.  
 The final step in the production of a mature mRNA is transcription 
termination that is critical for successful gene expression. It involves the release of the 
transcript from the site of transcription and the release of RNAP II from the DNA 
template, so that the polymerase can be recycled for a new round of transcription. A 
functional link between pre-mRNA 3’ end processing and transcription termination 
was initially demonstrated by the finding that both a functional poly(A) signal (Zaret 
and Sherman, 1982) and 3’ end processing factors (Birse et al., 1998; Hirose and 
Manley, 1998; McCracken et al., 1997b) are required for correct transcription 
termination (reviewed in Proudfoot, 1989). These data were obtained by using 
transcription run-on analysis showing that mutations in the poly(A) signal led both to 
loss of mRNA and to the continued transcription of the 3’ flanking regions of the gene 
(Connelly and Manley, 1988; Whitelaw and Proudfoot, 1986). Hence, loss of the 
poly(A) signal leads to read-through into downstream genes by polymerases that have 
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failed to terminate at upstream genes. This is of particular importance in yeast where 
genes are closely spaced. Furthermore, mutant strains defective in the expression of 
subunits of CPF and CF IA were tested for defects in RNAP II termination also by 
run-on analysis. Rna14p, Rna15p and Pcf11p subunits of CF IA (Birse et al., 1998) 
and CPF subunit Yhh1p were found to be required for transcription termination 
(Dichtl et al., 2002a). It is striking that some domains of these factors are devoted to 
transcription termination, whereas others are specific for 3’ end formation. Thus, 
Rna15p and its S. pombe homologue ctf1 contain a domain which when deleted leads 
to termination defect, but has no effect on polyadenylation (Aranda and Proudfoot, 
2001). In addition, Yhh1p binds to the phospho-CTD via a domain, which is different 
than the one used for RNA binding. Moreover, Pcf11p possesses a specific CTD-
binding domain (CID) in which mutations block transcription termination, but have 
no effects on pre-mRNA 3’ end processing (Sadowski et al., 2003). Finally, even the 
strength of the poly(A) signal was shown to directly influence transcription 
termination efficiency (Osheim et al., 1999).  
 The mechanism of RNAP II termination is not well defined, and two 
alternative models have been proposed for coupling termination to 3’ end processing: 
the “antiterminator” model (or allosteric model) and the “torpedo” model (for 
reviews, see Buratowski, 2005; Luo and Bentley, 2004). The antiterminator model 
proposes that conformational changes in RNAP II or loss of an antiterminator factor 
are mediated by the recognition of the poly(A) site, leading to gradual termination 
(Calvo and Manley, 2001; Greenblatt et al., 1993; Logan et al., 1987). The torpedo 
model suggests that endonucleolytic cleavage of the pre-mRNA at the poly(A) site is 
required to initiate termination. The downstream cleavage product, still attached to the 
elongating polymerase, is degraded by a 5’-3’ exonuclease that targets RNAP II. In 
this model, the exonuclease catches up the polymerase and provokes termination 
(Connelly and Manley, 1988).  Unlike the antiterminator model, endonucleolytic 
cleavage is an obligatory step in the torpedo model.   
 There is evidence for and against both models. Supporting the antiterminator 
model, the presence of some 3’ end processing factors interacting with the CTD could 
induce conformational changes in the polymerase (Calvo and Manley, 2005; Kim et 
al., 2004a; Licatalosi et al., 2002). The CTD phosphorylated on S2 provides a kind of 
platform on which protein factors can bind, which could transmit a termination signal 
to the polymerase. Furthermore, it was shown in both mammals and yeast that optimal 
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termination requires the CTD. Also consistent with the antiterminator model is the bi-
functional Pcf11p subunit of CF IA. Mutant strains deficient for CTD binding were 
shown to impair termination whereas cleavage activity remained unaffected 
(Sadowski et al., 2003). In contrast, mutant strains carrying a disrupted poly(A) site 
but an intact CID still supported termination. These observations indicate that pre-
mRNA 3’ end processing and termination functions of Pcf11p can be uncoupled 
(Sadowski et al., 2003). Thus, cleavage is not required for its termination function. 
Moreover, Pcf11p can dismantle transcription elongation complexes in vitro in a 
poly(A) site-independent manner, probably by bridging the CTD to the RNA and thus 
inducing a conformational change in the polymerase (Zhang et al., 2005).  
 On the other hand, a strong evidence for the torpedo model resides in the 
finding that the yeast 5’-3’ exonuclease Rat1p and the mammalian hXrn2, are 
required for transcription termination (Kim et al., 2004b; West et al., 2004). In rat1 
mutants, cleavage and polyadenylation of pre-mRNAs are not affected, whereas a 
strong defect is observed in transcription termination. Furthermore, loss of Rat1p 
stabilizes the downstream cleavage products, suggesting that Rat1p is the exonuclease 
that usually degrades RNAs downstream of the poly(A) site.   
 A recent study showed that Rat1p contributes to the cotranscriptional 
degradation of the nascent RNA, which is however not sufficient to direct 
transcription termination (Luo et al., 2006). Moreover, it showed that Rat1p has a role 
in both 3’ end formation and termination processes, as it allows recruitment of 3’ end 
processing factors. Finally, recruitment of Rat1p itself required the presence of 3’ end 
processing factors. Thus, the results of this study suggest a combined 
antiterminator/torpedo model in which Rat1p acts as a component of the 3’ end 
processing machinery.  
 The complexity of the eukaryotic gene expression is reflected by the fact that 
the different mechanisms of the pathway are interconnected. These coupling events 
make sure that extensive controls ensure accurate and efficient expression of the 
genes and appropriate processing of the mRNAs.  
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1.5 Aims of this thesis 
 
The past few years have brought progress in determining the detailed biochemistry of 
pre-mRNA 3’ end processing and its connection with other processes of mRNA 
synthesis. Despite all of these efforts, the molecular mechanism by which pre-mRNAs 
are cleaved and polyadenylated is still unclear. One aim of this thesis is to provide 
structural information of the yeast 3’ end processing machinery, in particular CPF, to 
better understand the mechanism of action of the complex. Another question is the 
characterization of Cpf11p, a putative new subunit of CPF. Finally, many in vitro data 
demonstrate that pre-mRNA 3’ end formation and transcription are coupled, but very 
little is known about the in vivo situation. Another aim of this thesis is to investigate 
directly in living cells the relevance of the coupling between the two processes.  
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Chapter 2: Investigating in vivo coupling between yeast pre-mRNA 3’ end 
processing factors and the CTD of RNAP II  
 
This part of our work will not be treated as a complete chapter, since we are still in 
the process of constructing the appropriate tools that are required for the fluorescence 
microscopy studies. Instead, we present the yeast strains we have generated and show 
the obstacles we encountered to obtain fluorescent signals strong enough to perform 
fluorescence resonance energy transfer (FRET) and fluorescence recovery after 
photobleaching (FRAP) in yeast.   
 
2.1 Introduction  
 
Transcription and 3’ end formation of pre-mRNAs transcribed by RNAP II are tightly 
coupled processes. First studies revealed that the poly(A) signal, which directs 3’ end 
cleavage of the pre-mRNA, also acts as a transcription termination signal for RNAP II 
(Connelly and Manley, 1988; Whitelaw and Proudfoot, 1986; Zaret and Sherman, 
1982). In addition, yeast strains with temperature-sensitive mutations in cleavage 
factors were shown to have a defect in terminating transcription at non-permissive 
temperatures, indicating that 3’ end processing factors are also required for 
termination. Pcf11p, Rna14p and Rna15p subunits of CF IA and Yhh1p subunit of 
CPF were shown to be required for transcription termination, supporting the 
functional connection between 3’ end formation factors and RNAP II (Birse et al., 
1998; Dichtl et al., 2002a).  
 The connection between the transcription complex and the 3’ end processing 
machinery is mediated by the C-terminal domain (CTD) of the largest subunit 
(Rpb1p) of RNAP II (McCracken et al., 1998). Deletion of the CTD strongly inhibits 
cleavage of pre-mRNAs in metazoan cells. In yeast, it reduces the efficiency of 
cleavage and the length of poly(A) tails (Licatalosi et al., 2002). The CTD is an 
unstructured domain that protrudes from RNAP II and consists of several heptad 
repeats of the highly conserved sequence YSPTSPS. A key feature of the CTD is the 
presence of serine residues at positions 2 and 5 of the heptapeptide repeat, which can 
be phosphorylated by Ctk1p and Kin28p, respectively. The phosphorylation status is 
critical for CTD function, as phospho-CTD directly activates pre-mRNA processing 
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reactions and acts as a platform where processing factors can bind (Hirose and 
Manley, 2000; Proudfoot and O'Sullivan, 2002; Proudfoot et al., 2002). CF IA 
subunits Pcf11p, Rna15p and Rna14p and CPF components Yhh1p, Ydh1p and Pta1p 
specifically interact with phospho-CTD (Ansari and Hampsey, 2005; Barilla et al., 
2001; Dichtl et al., 2002a; Kyburz et al., 2003; Rodriguez et al., 2000; Steinmetz and 
Brow, 1996). 
 Pcf11p has a specific N-terminal CTD-binding domain (CID). Mutations in 
this domain affect transcription termination but not 3’ end processing of the pre-
mRNA, thus it has been proposed that both functions can be uncoupled (Sadowski et 
al., 2003). Via its CID, Pcf11p has been shown to preferentially bind to the CTD 
phosphorylated on serine 2 in vitro (Licatalosi et al., 2002). A co-crystal structure of 
this interaction has been reported and shows that there is no direct contact between 
Pcf11p and the phospho-serine 2 (Meinhart and Cramer, 2004). Instead, the CTD 
adopts a stabilized conformation that fits onto the Pcf11p surface. 
 Yhh1p is the yeast homologue of the mammalian AAUAAA interacting 
protein CPSF-160. Yhh1p is an RNA-binding protein, which participates in the 
poly(A) site recognition by binding sequences surrounding the cleavage site (Dichtl et 
al., 2002a). The RNA-binding domain is composed of β-propeller repeats. Yhh1p was 
shown to specifically bind to the phosphorylated CTD in vitro and to be involved in 
transcription termination (Dichtl et al., 2002a).  
 Surprisingly, the recruitment of 3’ end processing factors to RNAP II not only 
occurs at the 3’ end, but also at the 5’ end and throughout the length of the genes 
during transcription (Kim et al., 2004a; Licatalosi et al., 2002). A yeast two-hybrid 
screen identified an interaction between the 3’ end processing factor Rna15p and the 
transcriptional coactivator Sub1p (Calvo and Manley, 2001). Furthermore, a network 
of interactions between 3’ end processing and general transcription factors was found 
at the promoter region, as TF IIB was shown to interact both with Ssu72p, a subunit 
of CPF, and Sub1p (Sun and Hampsey, 1996; Wu et al., 1999). The multitude of 
protein-protein interactions between components of the pre-mRNA 3’ end formation 
machinery and transcription complexes at all stages (initiation, elongation and 
termination) indicates that the two processes are physically and functionally 
connected.  
 So far, most of the data supporting coupling between transcription and 3’ end 
formation come from in vitro studies, but there is little evidence for contact between 
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the protein factors involved in both processes in vivo. Our aim is to provide direct 
evidence that both protein machineries truly interact in vivo, by using fluorescence 
microscopy based techniques, such as FRET and FRAP. We first want to investigate 
the association between the CTD and the 3’ end processing factors Yhh1p and Pcf11p 
in living cells, as these interactions are already well described in vitro. The 
confirmation of these associations in vivo would validate our approach, which would 
then be used to test interactions of other pre-mRNA 3’ end processing factors with the 
CTD in vivo.  
 
2.2 Experimental design 
 
2.2.1 Using fluorescence microscopy to investigate protein-protein interactions 
 
FRET is a powerful technique for measuring interactions between two proteins 
directly in living cells. FRET involves the non-radiative transfer of photon energy 
from a fluorescent molecule (fluorophore) in an excited state (the donor) to another 
fluorophore (the acceptor) when both are located within close proximity. For this 
transfer to take place, the donor and acceptor molecules must be less than 10 nm apart 
and the emission spectrum of the donor fluorophore must overlap with the excitation 
spectrum of the acceptor fluorophore. The technique has grown in popularity thanks 
to the emergence of green fluorescent protein (GFP) mutants with blue, yellow or red-
shifted spectral properties. FRAP is another live-cell imaging technique that provides 
information about the mobility and dynamics of fluorescent molecules by measuring 
the recovery of fluorescence in a defined region after a bleaching event. Interestingly, 
FRAP can also be used to address questions about protein interactions in living cells. 
If both transcription and 3’ end processing machineries interact, FRAP is predicted to 
show that the proteins belonging to these apparatus behave similarly or follow the 
same movements in the cell. Thus, combination of both techniques provides an 
interesting tool to analyze in vivo protein-protein interactions.   
 Using both techniques involves the covalent fusion of the proteins of interest 
with compatible fluorescent proteins visible in a fluorescent light microscope. The 
protein fusions were genetically obtained by inserting the coding sequences of the 
fluorophores directly into the genome of a host cell, in-frame to and immediately 
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downstream of the open reading frame (ORF) of interest. With this strategy, wild type 
levels of protein expression are minimally perturbed. For FRAP, we used Aequorea 
victoria GFP (S65T), an enhanced form of GFP (Tsien, 1998), to tag several proteins 
involved in transcription (Rpb1p, Rpb3p, Spt5p; For a better understanding, Rpb1p 
will be referred as CTD in the following text) and pre-mRNA 3’ end processing 
(Yhh1p, Ysh1p, Pta1p, Pap1p, Mpe1p, Pfs2p, Glc7p, Pti1p, Pcf11p, Rna14p and 
Nab4p). As a pair of fluorophores suitable for FRET, we used cyan fluorescent 
protein (CFP) as the donor (Zacharias et al., 2002) and yellow fluorescent protein 
(YFP) as the acceptor (Tsien, 1998). CFP and YFP molecules both derive from GFP 
by several point mutations, changing the emission color to blue and yellow, 
respectively. We also used other GFP variants such as Cerulean (CFP variant), Venus 
(YFP variant) and mCherry (red variant).  
 FRET and FRAP methods require strong fluorescent signals that are difficult 
to obtain in yeast, as the yeast cell is not a system of choice for fluorescence 
microscopy visualization. First, yeast cells are rather small (few micrometers in 
diameter) in comparison to mammalian cells, and consequently more difficult to 
observe through a microscope. Second, 3’ end processing proteins are expressed at 
low levels in yeast cells. Many of the proteins, including essential proteins and most 
transcription factors, are present at levels that are not readily detectable by 
conventional methods (Ghaemmaghami et al., 2003). According to the study of 
Ghaemmaghami et al. (2003), the abundance of proteins ranges from fewer than 50 to 
more than 106 molecules per cell, and only ~600 copies of Yhh1p and 2800 copies of 
Pcf11p were found per cell. Thus, detection of the protein fusions requires strong 
fluorescence signals. Third, unlike mammalian cells, yeast cells display strong 
autofluorescence, which results in high background during observation through the 
fluorescence microscope. In addition, CFP is known to have a dim fluorescence, 
which results in a low signal-to-noise ratio. In accordance with these observations, the 
fluorescence signals generated by the strains we made were mostly too weak for 
FRET and FRAP analyses. To improve the strength of fluorescence signals, we also 
tried to use additional fluorophores (Cerulean, Venus and mCherry), tagged some 
proteins of interest with tandems of fluorophores or tried to use a galactose inducible 
system to overexpress the proteins to be tested. However, all our attempts to get 
sufficient fluorescence suitable for FRET and FRAP failed so far.  
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2.2.2 Generation of yeast strains for testing in vivo association of the CTD with 
Yhh1p and Pcf11p by FRET 
 
A first series of double-tagged yeast strains was constructed in order to carry out 
FRET studies. To maximize chances to obtain suitable fluorescent signals, we 
generated homozygous diploid strains by mating haploids that were modified for both 
genes of interest: α-mated haploid cells containing CTD-YFP and Pcf11-CFP (or 
Yhh1-CFP) were crossed with a-mated haploid cells containing the same fusions. The 
reason for this resides in the facts that diploid strains are larger than haploid cells, and 
that two copies of the modified genes should lead to two times stronger fluorescence 
than only one copy. Thus, homozygous diploid strains (FRET strains) containing the 
following fusions were generated: CTD-YFP/Pcf11-CFP to investigate in vivo 
association between the CTD and Pcf11p; CTD-YFP/Yhh1-CFP to investigate in vivo 
association between the CTD and Yhh1p; CTD-YFP-CFP as control for FRET 
measurement.  
 To verify that the growth of FRET cells was not affected by the insertion of 
the fluorophores, cell cultures were prepared at the standard temperature 30ºC, at low 
(15ºC) and high (37ºC) temperatures. No defect in cell growth was observed at the 
three temperatures, indicating that the insertion of the fluorophores did not affect cell 
metabolism (Figure 2.1).  
 
Figure 2.1. The insertion of the fluorophores did not affect cell growth. 
Ten-fold serial dilutions of the strains indicated on the left were spotted on YPD agar medium 
and incubated at the temperatures indicated at the bottom of the panels for two days at 30°C 
and 37°C or four days at 15°C.  
 
 Furthermore, Western blot analysis was used to verify that the protein fusions 
were correctly expressed (Figure 2.2). The CTD-YFP fusion was well 
immunodetected in protein extracts prepared from the FRET strains by using a 
 -49- 
specific antibody for the CTD phosphorylated on serine 2 (H5, from Covance). The 
presence of YFP was confirmed with an anti-GFP antibody (JL-8, from BD 
Biosciences), which also recognizes the other fluorophores, as they are all GFP 
variants. These observations indicate that the biggest subunit of RNAP II is well 
expressed in the cells. In contrast, neither Pcf11-CFP nor Yhh1-CFP could be 
detected with anti-GFP and protein-specific antibodies, most likely owing to the low 
amount of protein expressed, as mentioned above. However, as Yhh1p and Pcf11p are 
essential proteins, cells would not survive in their absence, suggesting that CFP-
fusions were also expressed.  
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2. CTD-YFP is expressed in FRET cells. 
Protein extracts prepared from FRET strains indicated on top were analyzed by Western 
blotting to verify the expression of the protein fusions. Proteins detected are indicated on the 
right of the panel (CTD refers to Rpb1p and was used instead of Rpb1p for a better 
understanding). The antibodies used are indicated at the bottom (α-P-CTD: antibody for CTD 
phosphorylated on serine 2). Molecular weight marker is indicated on the left (in kDa).  
 
 
 The observation of these yeast strains with the fluorescent microscope 
revealed a strong yellow nuclear fluorescent signal corresponding to CTD-YFP but a 
weak signal from CFP, only little stronger than the background fluorescence (Figure 
2.4).  
 To improve the fluorescence signal from CFP, we used a variant form called 
Cerulean (Rizzo et al., 2004), which is 2.5-fold brighter than CFP. Cerulean was 
genetically fused to the C-terminus of the CTD. YFP, which is a brighter fluorophore 
relative to Cerulean, was attached to the C-terminus of Yhh1p and Pcf11p, expressed 
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at a lower level than the CTD. Western blotting analysis of these strains, containing 
Pcf11-YFP/CTD-Cerulean or Yhh1-YFP/CTD-Cerulean constructs, showed that 
CTD-Cerulean was readily detected with the anti-GFP and the anti-serine 2 phospho 
CTD antibodies (Figure 2.3). In contrast, Pcf11-YFP was only weakly detected and 
no signal was seen for Yhh1-YFP, confirming that these two proteins are expressed at 
a much lower level than the CTD. The microscopic inspection of these cells revealed 
that they show only weak nuclear fluorescence from YFP and a brighter fluorescence 
from Cerulean (Figure 2.4). However, fluorescence signals were not strong enough 
for FRET studies.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3. Western blotting analysis of strains containing Cerulean protein fusions. 
Protein extracts from strains indicated on top were analyzed by Western blot. Antibodies used 
are indicated on the left and proteins detected on the right of the panels. 
 
 
 In another attempt to improve fluorescence, YFP was replaced by Venus, a 
brighter variant (Nagai et al., 2002), and new strains containing Pcf11-Venus/CTD-
Cerulean or Yhh1-Venus/CTD-Cerulean were constructed. Nevertheless, also these 
improved variants did not show sufficient fluorescence for FRET experiments (data 
not shown). Unable to obtain enough fluorescence to test in vivo interactions between 
our proteins of interest by FRET, we then tried to make strains allowing inducible 
overexpression of the 3’ end processing factors. The genes YHH1, PCF11, RNA14 
and NAB4 were cloned into a plasmid allowing the expression of N-terminally GFP-
tagged protein fusions from a galactose-inducible promoter (pGREG576; Jansen et 
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al., 2005). GFP and mCherry (Shaner et al., 2004), a red variant, is another pair of 
fluorescent proteins suitable for FRET. New yeast strains containing chromosomal 
CTD-mCherry fusions were transformed with inducible plasmids carrying the genes 
of 3’ end processing factors Yhh1p, Pcf11p, Rna14p and Nab4p. These strains were 
not tested yet but are now available for fluorescence microscopy studies.   
 
 
Figure 2.4. Microscopic analysis of live yeast strains expressing FRET constructs. 
Representative images of strains indicated on top of the panels showing a strong nuclear 
fluorescence of the CTD fusions and a weak fluorescence of Pcf11p and Yhh1p fusions. 
Trans: transmission channel; CFP/Cerulean: fluorescence channel for CFP or Cerulean; YFP: 
fluorescence channel for YFP. 
 
 
2.2.3 Yeast strains expressing GFP-tagged versions of 3’ end processing and 
transcription factors for FRAP analysis 
 
Combined with FRET experiments, FRAP analysis can also be used to analyze 
protein-protein interactions. Similar characteristics in the way different proteins move 
would suggest that they interact or belong to one large functional unit in vivo. A 
collection of yeast haploid strains expressing full-length, chromosomally tagged GFP 
fusion proteins was constructed to analyze localization of proteins in cell 
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compartments (Huh et al., 2003). Exploiting this library, we tried to perform FRAP 
analysis using several strains expressing GFP fusions of 3’ end processing factors and 
proteins of the transcription machinery (Table 2.1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.1. Transcription and 3’ end processing proteins used for FRAP studies. 
 
 
 Microscopic observation of these strains revealed that all the strains 
expressing GFP fusions with 3’ end processing factors showed too weak fluorescence 
signals for FRAP analysis (Figure 2.5). Pta1p, Pti1p and Pcf11p fusions with GFP 
showed weak fluorescence in the nucleus, whereas fluorescence of the other strains 
containing pre-mRNA 3’ end processing protein fusions was too low to be precisely 
localized. In contrast, GFP fusions with proteins belonging to the transcription 
complex (CTD, Rpb3p, Spt5p) showed quite strong nuclear fluorescence. This 
fluorescence pattern could be correlated with Western blotting analysis showing that 
the proteins having the strongest fluorescence were also the proteins expressed at the 
highest level in the cells (Figure 2.6).  
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Figure 2.5. Microscopic observation of live yeast strains expressing FRAP constructs. 
Proteins tagged with GFP are indicated on the left and the right of the images. Fluorescent 
(GFP, excitation 488 nm/emission 505-530 nm) and transmission channels (trans) were used 
to visualize cells, as indicated on the top of the panels.  
 
 
 We also verified that the insertion of GFP tags did not affect the ability of the 
cells to perform pre-mRNA 3’ end processing. Therefore, we tested protein extracts 
prepared from GFP strains for their ability to cleave and polyadenylate pre-mRNA 
substrates in vitro. 3’ end processing activities can be reconstituted in vitro using 
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protein extracts or purified 3’ end processing factors with a synthetic RNA substrate 
that was in vitro transcribed and radioactively labeled by incorporation of 32P α-UTP. 
For the cleavage assay, we used the CYC1 precursor that corresponds to the 3’ 
untranslated region (3’ UTR) of the iso-1-cytochrome c gene, which contains all the 
cis-acting sequence elements required for proper 3’ end formation (Butler and Platt, 
1988). For the in vitro polyadenylation assay, we used the pre-cleaved CYC1 (pre-
CYC1) precursor that corresponds to the upstream cleavage product of CYC1. Most of 
the extracts tested were competent in both pre-mRNA 3’ end processing activities, 
except for Rna14-GFP and Ysh1-GFP extracts (Figure 2.7). The Rna14-GFP extract 
displayed weak cleavage activity and almost no polyadenylation. Surprisingly, the 
Ysh1-GFP extract showed a strong defect in polyadenylation, whereas cleavage was 
normal, although Ysh1p is believed to be the endonuclease (Mandel et al., 2006; Ryan 
et al., 2004). In both cases, it is possible that the addition of the GFP tag disrupts 
some important interactions or prevents conformational changes required for correct 
3’ end formation activities.  
 
 
 
Figure 2.6. Western blotting analysis of GFP protein fusions in FRAP cells.  
GFP antibody was used to verify the expression of GFP protein fusions in the protein extracts 
prepared from the GFP strains indicated on top. WT: wild type (no GFP-containing strain). 
The molecular weight marker is indicated on the left (in kDa).  
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Figure 2.7. In vitro analysis of 3’ end processing activities of GFP strains.  
Protein extracts from the strains indicated on top of the panels were prepared and tested in 
vitro for cleavage and polyadenylation activities. RNA substrate used for cleavage (CYC1), 5’ 
and 3’ cleavage products (5’ and 3’ CP) are indicated on the left. RNA substrate used for 
polyadenylation (Pre-CYC1) and polyadenylation products [poly(A)] are indicated on the 
right. -: mock-treated sample; WT: wild type protein extract.  
 
 
 To obtain stronger fluorescent signals, we constructed diploids of the 
concerned strains. The mating type of the original haploid strains was switched and 
both a- and α-types were mated. Nevertheless, the new diploid strains did not show 
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stronger fluorescent signals. Another approach consisting of the addition of a second 
GFP tag to the pre-existing protein fusions in the original strains also did not give a 
stronger signal.  
 As endogenous expression of 3’ end processing factors is too weak to provide 
sufficient fluorescence, overexpression of these proteins could be a successful 
alternative. For this, we started to clone the genes encoding for the proteins to be 
tested into a galactose-inducible expression vector (pGREG576), permitting the 
formation of amino-terminal fusions to GFP (Jansen et al., 2005). 
 
2.2.4 Experimental procedures 
 
Genotypes of yeast strains used in this study 
 
FRET strains 
CEN.PK2: Mat a/α ura3-52/ura3-52 leu2-3,112/leu2-3,112 trp1-289/trp1-289 
his3∆1/his3∆1 (Wach et al., 1997) 
YBP11: Mat a/α ura3-52/ura3-52 leu2-3,112/leu2-3,112 trp1-289/trp1-289 
his3∆1/his3∆1 PCF11-CFP/PCF11-CFP CTD-YFP/CTD-YFP 
YBP12: Mat a/α ura3-52/ura3-52 leu2-3,112/leu2-3,112 trp1-289/trp1-289 
his3∆1/his3∆1 YHH1-CFP/YHH1-CFP CTD-YFP/CTD-YFP 
YBP17: Mat a/α ura3-52/ura3-52 leu2-3,112/leu2-3,112 trp1-289/trp1-289 
his3∆1/his3∆1 PCF11-CERULEAN/PCF11-CERULEAN CTD-YFP/CTD-YFP 
YBP18: Mat a/α ura3-52/ura3-52 leu2-3,112/leu2-3,112 trp1-289/trp1-289 
his3∆1/his3∆1 YHH1-CERULEAN/YHH1-CERULEAN CTD-YFP/CTD-YFP 
YBP23: Mat a/α ura3-52/ura3-52 leu2-3,112/leu2-3,112 trp1-289/trp1-289 
his3∆1/his3∆1 PCF11-YFP/PCF11-YFP CTD-CERULEAN/CTD-CERULEAN  
YBP24: Mat a/α ura3-52/ura3-52 leu2-3,112/leu2-3,112 trp1-289/trp1-289 
his3∆1/his3∆1 YHH1-YFP/YHH1-YFP CTD-CERULEAN/CTD-CERULEAN  
YBP29: Mat a/α ura3-52/ura3-52 leu2-3,112/leu2-3,112 trp1-289/trp1-289 
his3∆1/his3∆1 PCF11-VENUS/PCF11-VENUS CTD-CERULEAN/CTD-CERULEAN  
YBP30: Mat a/α ura3-52/ura3-52 leu2-3,112/leu2-3,112 trp1-289/trp1-289 
his3∆1/his3∆1 YHH1-VENUS /YHH1-VENUS CTD-CERULEAN/CTD-CERULEAN  
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YBP31: Mat a/α ura3-52/ura3-52 leu2-3,112/leu2-3,112 trp1-289/trp1-289 
his3∆1/his3∆1 CTD-mCherry [pGREG576-PCF11] 
YBP32: Mat a/α ura3-52/ura3-52 leu2-3,112/leu2-3,112 trp1-289/trp1-289 
his3∆1/his3∆1 CTD-mCherry [pGREG576-YHH1] 
YBP33: Mat a/α ura3-52/ura3-52 leu2-3,112/leu2-3,112 trp1-289/trp1-289 
his3∆1/his3∆1 CTD-mCherry [pGREG576-RNA14] 
YBP34: Mat a/α ura3-52/ura3-52 leu2-3,112/leu2-3,112 trp1-289/trp1-289 
his3∆1/his3∆1 CTD-mCherry [pGREG576-NAB4] 
 
FRAP strains 
ATCC 201388: MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 
YBP40: MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 RPB1-GFP 
YBP41: MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 RPB3-GFP 
YBP42: MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 SPT5-GFP 
YBP43: MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 YHH1-GFP 
YBP44: MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 YSH1-GFP 
YBP45: MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 PTA1-GFP 
YBP46: MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 PAP1-GFP 
YBP47: MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 MPE1-GFP 
YBP48: MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 PFS2-GFP 
YBP49: MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 PTI1-GFP 
YBP50: MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 GLC7-GFP 
YBP51: MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 PCF11-GFP 
YBP52: MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 RNA14-GFP 
YBP53: MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 NAB4-GFP 
YBP54-YBP67: isogenic to YBP40-YBP53, but (2n) 
YBP68-YBP81: isogenic to YBP40-YBP53, but with GFP-GFP instead of GFP 
YBP82: MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 [pGREG576-PCF11] 
YBP83: MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 [pGREG576-YHH1] 
YBP84: MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 [pGREG576-RNA14] 
YBP85: MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 [pGREG576-NAB4] 
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Plasmids used in this study 
pDH18: pYFP-CFP-his3 (Yeast Resource Center, University of Washington) 
pDH5: pYFP-his3 (Yeast Resource Center, University of Washington) 
pDH3: pCFP-kanamycin (Yeast Resource Center, University of Washington) 
pBS10: pCerulean-hygromycin (Yeast Resource Center, University of Washington) 
pBS7: pVenus-kanamycin (Yeast Resource Center, University of Washington) 
pGREG576-PCF11: pGAL-GFP-PCF11  
pGREG576-YHH1: pGAL-GFP-YHH1 
pGREG576-RNA14: pGAL-GFP-RNA14 
pGREG576-NAB4: pGAL-GFP-NAB4 
pGREG plasmids derived from pGREG576: N-ter GFP, URA3 (Jansen et al., 2005)  
pFA6a-mCherrry-his3MX6 (Scott Emr’s laboratory) 
pFA6a-GFP(S65T)-his3MX (Longtine et al., 1998) 
pGAL-HO: HO endonuclease expression vector 
 
Oligonucleotides used in this study 
For FRET constructs 
YHH1-FOR: 5’-ataaatattgaattttcaatgagatctttatgccagggtaagggtcgacggatccccggg-3’ 
YHH1-REV: 5’-ggttcttattcactactcgaatgcctagtgatagatagatgatcgatgaattcgagctcg-3’ 
PCF11-FOR: 5’-ggcaaggtcggtttggatgacttaaagaaattggtcacaaaaggtcgacggatccccggg-3’ 
PCF11-REV: 5’-aatgagcaacccatcaaataccaagaacaaagaatttaataatcgatgaattcgagctcg-3’ 
CTD-FOR: 5’-aagcaagacgaacaaaagcataatgaaaatgaaaattccagaggtcgacggatccccggg-3’ 
CTD-REV: 5’-ttatgatacaaaaataaactagaaatattatttgagaaactatcgatgaattcgagctcg-3’ 
These oligonucleotide primers are suitable with GFP and its different variants used in 
this study, such as CFP, YFP, Cerulean, Venus and mCherry.  
 
For verification of FRET constructs 
YHH1-for1: 5’-aaaccctcgcatggaaagat-3’ 
YHH1-rev4: 5’-taaaggcaccgtttgcactt-3’ 
CFP-rev2: 5’-ccccaagtcaaagtagtgac-3’ 
CFP-for3: 5’-ttttcaagaacttgtcatttgtatag-3’ 
PCF11-for1: 5’-acggggaaaatatgttgttg-3’ 
PCF11-rev4: 5’-cagtaacgaagtgtaccctg-3’ 
CTD-forA: 5’-catgccagaacaaaaaataa-3’ 
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CTD-revD: 5’-ccaatgctctgcggatataa-3’ 
YFP-rev2: 5’-catggcactcttgaaaaagt-3’ 
YFP-forC: 5’-agcgtagttgacttgtcggg-3’ 
YFP-CFP-forC: 5’-aagcgtagttgacttgtcgg-3’ 
mCherry-rev2: 5’-tgtcggcggggtgcttcacg-3’ 
mCherry-for3: 5’-agcgtagttgacttgtcggg-3’ 
 
For FRAP constructs 
5'-GFP-GFP: 5’-attacacatggcatggatgaactatacaaaggcgccagtaaaggagaagaactttt-3’ 
3'-GFP-GFP: 5’-agaaattcgcttatttagaagtggcgcgccctatttgtatagttcatcca-3’ 
YHH1-rec1: 5’-gaattcgatatcaagcttatcgataccgtcgacaatgaatgtatatgatgatgt-3’ 
YHH1-rec2: 5’-gcgtgacataactaattacatgactcgaggtcgactcacttaccctggcataaag-3’ 
PCF11-rec1: 5’-gaattcgatatcaagcttatcgataccgtcgacaatggatcacgacacagaagt-3’ 
PCF11-rec2: 5’-gcgtgacataactaattacatgactcgaggtcgacttattttgtgaccaatttct-3’ 
RNA14-rec1: 5’-gaattcgatatcaagcttatcgataccgtcgacaatgtccagctctacgactcc-3’ 
RNA14-rec2: 5’-gcgtgacataactaattacatgactcgaggtcgacttaacctgacttggtgctct-3’ 
NAB4-rec1: 5’-gaattcgatatcaagcttatcgataccgtcgacaatgagctctgacgaagaaga-3’ 
NAB4-rec2: 5’-gcgtgacataactaattacatgactcgaggtcgacttacctattatatggatggt-3’ 
 
For verification of FRAP constructs 
GFP(S65T)-rev2: 5’-cttgaaaagcattgaacacc-3’ 
GFP(S65T)-for3: 5’-gaagatggaagcgttcaact-3’ 
One4all-A: 5’-gaattcgatatcaagcttatcgatacc-3’ 
One4all-D: 5’-gcgtcccaaaaccttctcaagcaag-3’ 
Yhh1-rec-B: 5’-gattcatgctatggattaat-3’ 
Yhh1-rec-C: 5’-tgcggcaacagatgctgaca-3’ 
Pcf11-rec-B: 5’-ttagcctttcactagttaaa-3’ 
Pcf11-rec-C: 5’-atcacaaaacacagcaaata-3’ 
Rna14-rec-B: 5’-atggcttccactgctctaaa-3’ 
Rna14-rec-C: 5’-tatttgaaacatcagtggaa-3’ 
Nab4-rec-B: 5’-tatcttccgtagtgtcccaa-3’ 
Nab4-rec-C: 5’-cggttacaacccaatgatga-3’ 
 
 
 -60- 
Construction of fluorophores-tagged yeast strains 
To construct chromosomally fluorophore-tagged strains, pairs of gene-specific 
oligonucleotide primers were synthesized, each of which had been designed to share 
complementary sequences to the fluorophore tag-marker cassette at the 3' end and 
contain 40-45 base pairs (bp) of homology with a specific gene of interest to allow in-
frame fusion of the fluorophore tag at the C-terminal coding region of the gene. Gene-
specific cassettes containing a C-terminally positioned fluorophore tag were then 
generated by PCR using appropriate plasmid templates, which contain the his3, 
kanamycin or hygromycin genes and permit selection of transformed strains in 
histidine-free, kanamycin or hygromycin-containing media (Longtine et al., 1998). 
The haploid parent yeast strain CEN.PK2 was transformed with the PCR products, 
and strains were selected in SD medium (synthetic medium plus glucose) lacking 
histidine. Insertion of the cassette by homologous recombination was verified by 
genomic PCR of samples from individual colonies with two pairs of control primers. 
For each pair, one primer is internal to the fluorophore tag and the other is ORF-
specific, both being designed to produce a product of approximately 500 bp. 
 
Mating type switching 
To switch the mating type, haploid cells were transformed with the pGAL-HO 
plasmid according the lithium acetate method (Gietz et al., 1995). Cells were grown 
over night on selective medium (0.67% yeast nitrogen base without amino acids, 2% 
glucose) supplemented with appropriate amino acids. Medium was removed and 
replaced by YPG-lactate medium (1% yeast extract, 2% bacto-peptone, 3% lactate, 
2% galactose) for 3h to induce expression of HO endonuclease. 2% glucose was then 
added in the cultures to down-regulate HO induction and prevent re-cutting of the 
MAT site. Cells were finally plated on the appropriate agar selective medium and 
mating type switching of single colonies was verified by mating with α- and a-tester 
strains.  
 
Droplet test 
Yeast strains were grown overnight on YPD medium (1% yeast extract, 2% bacto-
peptone, 2% glucose) and ten-fold serial dilutions were prepared from an initial OD600 
of 0.1. 5µl of each dilution was then spotted on YPD agar-medium and incubated at 
30°C and 37°C for two days, or at 15°C for four days.  
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Microscopy 
FRAP cells were loaded on coverslips and images were acquired on a Zeiss LSM 510 
confocal microscope using the PlanApochromat 63×/1.4 objective. GFP fluorescence 
was detected using the 488-nm line of the argon ion laser.  
 FRET cells were loaded on coverslips, which were placed on the stage of an 
inverted microscope (Leica DMIRBE, Leica France, Rueil Malmaison, France). A 
mercury lamp (50 W) was the excitation source for fluorescence. Cells were imaged 
through a 100x oil objective (Leica PL Fluotar, NA=1.3). The fluorescence 
corresponding to the different tagged proteins was selected using one of the filter set 
combinations (Omega; Optophotonics, Eaubonne, France): 440AF35 excitation 
filter/460DRLP dichroic beam splitter/480AF30 emission filter (CFP); 480AF30 
excitation filter/520DRLP dichroic beam splitter/540AF40 emission filter (YFP) and 
535DF35 excitation filter/570DRLP dichroic beam splitter/OG590 emission filter 
(mCherry). The steady-state fluorescence images were acquired with a cooled slow 
scan high-resolution (1024 x 1024 pixels) charge-coupled device (CCD) camera 
(Silar, St Petersburg, Russia).  
 
Extract preparation and Western blot analysis  
Protein extracts from yeast cells were prepared as described previously (Ohnacker et 
al., 2000). Western blot analysis was performed according to standard procedures. 
Briefly, protein samples were separated on either 10 or 12% SDS polyacrylamide gels 
(Laemmli, 1970). After transfer of proteins to nitrocellulose membranes, the blots 
were treated according to standard procedures. Primary antibodies used were anti-
GFP (JL-8, BD Biosciences) diluted 1:2000 in blotting buffer and anti-phospho serine 
2-CTD (H5, Covance) diluted 1:5000 in blotting buffer. Peroxidase-conjugated swine 
anti-mouse immunoglobulins (DAKO) were used as secondary antibody and 
chemiluminescence (ECL kit, Amersham) was used for detection.  
 
In vitro cleavage and polyadenylation assays 
32P-labelled CYC1 RNA was prepared as run-off transcripts and gel purified as 
described previously (Minvielle-Sebastia et al., 1994; Preker et al., 1995).  
 A standard in vitro processing reaction was carried out in a 25 µl reaction 
volume containing up to 5 µl of protein extract or purified protein factors. For 
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polyadenylation assay, the reaction mixture contained 2% polyethylene glycol, 75 
mM potassium glutamate, 0.01% NP-40, 2 mM ATP, 1.8 mM magnesium acetate, 20 
mM creatine phosphate, 1 mM DTT, 0.2 mg/ml creatine kinase and 0.2 units of 
RNAguard (Amersham Biosciences). The volume was brought to 25 µl upon addition 
of buffer E-50 (20 mM Tris-HCl pH 7.9, 0.2 mM EDTA, 50 mM Kac, 0.02% NP-40, 
10% glycerol) if was necessary. When the cleavage reaction was assayed, EDTA was 
used instead of magnesium acetate to prevent poly(A) addition, and degradation of the 
downstream cleavage fragment (Chen and Moore, 1992). The reactions were 
incubated 1h at the temperatures indicated in the figure legends. They were then 
stopped by addition of 75 µl of a stop mix (100 mM Tris-HCl pH7.9, 12.6 mM 
EDTA, 150 mM NaCl, 1% SDS, 0.2 µg/µl of proteinase K and 0.05 µg/µl glycogen) 
and incubated for 1h at 42°C. The RNAs were recovered by ethanol precipitation, 
dried and resuspended in 6 µl of formamide buffer (95% formamide, 20 mM EDTA, 
0.05% Bromophenol Blue, 0.05% Xylene Cyanol FF). Samples were heated at 95°C 
for 5 min and loaded on a denaturing 6% polyacrylamide gel. The gel was exposed 
overnight to an X-ray film at -70°C. 
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Chapter 3: Characterization of Cpf11p, a potential new subunit of CPF 
 
3.1 Introduction  
 
In eukaryotes, accurate processing of the 3’ end of most pre-mRNAs is accomplished 
by a tightly coupled two-step reaction. The first step consists of a site specific 
endonucleolytic cleavage of the primary transcript, catalyzed by Ysh1p (Mandel et 
al., 2006; Ryan et al., 2004). Subsequently, the upstream cleavage product is 
polyadenylated by poly(A) polymerase (Pap1p; Colgan and Manley, 1997; Keller and 
Minvielle-Sebastia, 1997; Zhao et al., 1999a). Although the process requires only two 
enzymatic reactions, the specific reaction involves a complex protein machinery that 
is highly conserved from yeast to mammals (see figure 1.5; For reviews, see Keller 
and Minvielle-Sebastia, 1997; Wahle and Ruegsegger, 1999; Zhao et al., 1999a). 
Numerous trans-acting factors specifically bind to cis-acting elements located in the 
3’ untranslated region (3’ UTR) of the primary transcript to ensure accurate 3’ end 
processing (Dichtl and Keller, 2001; Graber, 2003; Zhao et al., 1999a). Interestingly, 
they not only exhibit similarities in their sequences but also display equivalent 
functions in pre-mRNA 3’ end maturation (Keller and Minvielle-Sebastia, 1997; 
Manley and Takagaki, 1996). In contrast, cis-acting polyadenylation signals are more 
conserved in mammals than in yeast, where they are redundant and degenerate.  
 The separation of the yeast processing factors can be obtained by fractionation 
of whole-cell extracts. Pre-mRNA 3’ end processing in yeast involves four protein 
factors that can be separated by column chromatography: CPF, which is a multi-
protein complex combining the two originally identified 3’ end processing factors CF 
II and PF I (Chen and Moore, 1992; Stumpf and Domdey, 1996; Zhao et al., 1997), 
CF IA, CF IB and finally Pab1p. The complete pre-mRNA 3’ end processing activity 
can be reconstituted in vitro upon combination of these functionally distinct factors 
(Chen and Moore, 1992). The use of an in vitro system has revealed that the cleavage 
and polyadenylation activities can be physically separated. CPF, CF IA and CF IB are 
required and sufficient for site-specific cleavage activity, whereas the addition of 
Pab1p is necessary for specific polyadenylation to occur (Kessler et al., 1996; 
Minvielle-Sebastia et al., 1997; Preker et al., 1997).  
 By affinity purification via tagging of one of the CPF subunits, an attempt to 
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find new components of CPF identified six novels proteins in addition to the nine 
previously described components (Dichtl et al., 2002b). The role of these new 
polypeptides, Ref2p, Pti1p, Swd2p, Glc7p, Ssu72p and Cpf11p in pre-mRNA 3’ end 
formation was then analyzed. The non-essential Ref2p (RNA end formation 2) protein 
is an RNA-binding protein, and was shown to stimulate processing at weak poly(A) 
sites (Russnak et al., 1995). A possible involvement of Ref2p in the regulation of the 
poly(A) tail length has also been proposed (Mangus et al., 2004). Another novel 
protein, Pti1p, was originally isolated as an interactor with PTA1 in a yeast two-
hybrid screen (Hübner and Keller, unpublished data). A role for Pti1p in 3’ end 
processing has been proposed as alterations in the cleavage site choice have been 
revealed in pti1 mutant strains (Skaar and Greenleaf, 2002). Interestingly, while Pti1p 
and Ref2p display only minor roles in pre-mRNA 3’ end processing, both have been 
shown to be involved in cleavage-dependent/polyadenylation-independent 3’ end 
formation of snoRNAs (Dheur et al., 2003; Nedea et al., 2003). Pti1p probably 
uncouples cleavage and polyadenylation and may function in coordination with the 
Nrd1p-dependent pathway for 3' end formation of the snoRNA transcripts (Dheur et 
al., 2003). Also involved in snoRNAs 3’ end formation, Swd2p is an essential WD-40 
repeat protein, as temperature sensitive swd2 strains were shown to be defective in 3’ 
end formation of specific mRNAs and snoRNAs (Dichtl et al., 2004). Moreover, 
Swd2p plays a role in RNAP II transcription termination (Cheng et al., 2004), a 
process which is dependent on the association of CPF and CF IA with elongating 
RNAP II and the recognition of the poly(A) signals by these factors (Barilla et al., 
2001; Birse et al., 1998; Dichtl et al., 2002b). Hence, as a component of CPF, Swd2p 
could help to coordinate the activities of both the transcription and 3’ end processing 
machineries. Interestingly, Swd2p has been found to be physically associated not only 
with CPF but also with the SET1 complex (SET1C), which functions in the 
methylation of histone 3 lysine 4 (Miller et al., 2001; Nagy et al., 2002; Roguev et al., 
2001). It was proposed that Swd2p is required for the stability and the integrity of 
SET1C and that it is probably part of the core complex (Dehe et al., 2006). Hence, 
Swd2p has a dual function in pre-mRNA processing and histone tail modification. 
However, the roles of Swd2p as a component of CPF or of SET1C are functionally 
independent (Dichtl et al., 2004). Another protein involved in regulating a wide range 
of cellular processes in yeast and also found in CPF is Glc7p, the catalytic subunit of 
protein phosphatase 1. Recently, it has been demonstrated that a subunit of CPF, 
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Pta1p, is a substrate of Glc7p (He and Moore, 2005), suggesting that CPF activity can 
be autoregulated by cycles of phosphorylation and dephosphorylation. A second 
phosphatase in CPF is Ssu72p, an essential tyrosine phosphatase that specifically 
dephosphorylates serine 5 of the C-terminal domain of largest subunit of RNAP II 
(Krishnamurthy et al., 2004). Ssu72p is stably associated with CPF and bridges the 
CPF subunits Pta1p and Ydh1p/Cft2p, the general transcription factor TFIIB, and 
RNAP II via Rpb2p (Dichtl et al., 2002b; Ganem et al., 2003). The last protein 
identified is a novel 20 kDa protein that was named Cpf11p. It is encoded by the 
YDL094c gene, which has been shown to be non-essential since a systematic deletion 
of this gene is not lethal for the cell (Giaever et al., 2002). Instead of Cpf11p and not 
identified by Dichtl et al. (2002b), Syc1p is another 20 kDa non-essential protein that 
was found by other groups to copurify with CPF (Gavin et al., 2002; He et al., 2003; 
Nedea et al., 2003). Syc1p is highly homologous to the C-terminal domain of Ysh1p, 
the endonuclease subunit of CPF. Thus, except for Cpf11p, all of the newly identified 
polypeptides have been studied to a greater detail and have been shown to have a role 
in pre-mRNAs 3’ end processing. Herein we report our investigations aimed to verify 
the presence of Cpf11p in CPF and to characterize the role of this putative new CPF 
subunit in the context of 3’ end formation. We showed that mutant strains depleted for 
Cpf11p still efficiently processed RNA substrates at their 3’ end. We could also 
demonstrate by TAP tag purification that Cpf11p does not co-purify the known 
components of CPF, indicating that Cpf11p is unlikely to be an integral constituent of 
the CPF complex.  
 
3.2 Results  
 
3.2.1 Cpf11p is a non-essential protein with no homologues in other organisms 
 
The 20 kDa protein that copurified with CPF in the experiment presented in (Dichtl et 
al., 2002b) was analyzed by mass spectrometry. Results indicated a protein that 
corresponds to the gene product of the open reading frame YDL094c, named CPF11 
(for cleavage and polyadenylation factor number eleven). This gene, which is located 
on chromosome IV, encodes a predicted protein composed of 169 amino acids and 
with a molecular weight of 19.6 kDa. To analyze the importance of the protein for cell 
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viability, it is sufficient to generate null mutants of the gene of interest. A systematic 
gene-deletion approach of S. cerevisiae has revealed that CPF11-depleted strains are 
still viable, indicating that this gene is not essential (Giaever et al., 2002). According 
to the fact that this is a newly discovered protein, nothing was known about the 
molecular function and the cellular localization of Cpf11p when we initiated this 
work.  
 In order to make functional prediction for the uncharacterized Cpf11p and to 
analyze whether sequence similarities can be found with polypeptides in other 
species, we performed sequence homology searches. We used the BLASTP and 
TBLASTN algorithms (Altschul et al., 1997) of the NCBI server 
(http://www.ncbi.nlm.nih.gov/blast) to analyze the S. cerevisiae Cpf11p protein 
sequence. Results revealed that Cpf11p shares 38% identity in amino acids with 
another uncharacterized S. cerevisiae protein, encoded by the YDL096c ORF, also 
located on chromosome IV. Most of the CPF components have homology 
counterparts in other species (Keller and Minvielle-Sebastia, 1997; Manley and 
Takagaki, 1996). Surprisingly, no polypeptide sequences in other species were found 
to have significant similarities with CPF11 (data not shown). Furthermore, with the 
exception of a central predicted transmembrane domain, no similarity with any known 
conserved domain was revealed, thus providing no information for a potential 
function of the protein. Taken together, these data indicate that Cpf11p is not 
conserved throughout evolution and suggest that the protein does not carry an 
essential function in the cells.  
 
3.2.2 Cpf11p is not involved in pre-mRNA 3’ end processing  
 
A powerful way to determine gene function is the phenotypic analysis of mutants in 
which the gene has been deleted. In order to investigate the role of Cpf11p in 3’ end 
processing of pre-mRNAs, we used the yeast strain BY4742 in which the gene 
CPF11 was replaced by a kanamycine gene (referred as cpf11∆). The null mutant of 
CPF11 was generated by a PCR-based approach in which a kanamycine marker 
cassette, carrying flanking short sequences that are homologous to the target locus, 
replaced the CPF11 target gene by exploiting the high rate of homologous 
recombination in yeast.  
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3’ end processing activities can be reconstituted in vitro using protein extracts 
or purified 3’ end processing factors with a synthetic RNA substrate that was in vitro 
transcribed and radioactively labeled by incorporation of 32P α-UTP (Butler and Platt, 
1988). We prepared protein extracts from the cpf11∆ strain and tested them for their 
ability to cleave and polyadenylate in vitro the RNA substrates CYC1 and pre-CYC1, 
respectively, at 15°C, 30°C and 37°C. The absence of Cpf11p did not affect pre-
mRNA 3’ end processing in vitro because protein extracts from mutant strains 
displayed wild type-like cleavage and polyadenylation activities (Figure 3.1). These 
results suggest that Cpf11p is not required for pre-mRNA 3’ end formation in vitro.  
 
 
Figure 3.1. The cpf11∆ strain is not deficient in pre-mRNA 3’ end processing. 
In vitro cleavage (lanes 1-7) and polyadenylation assays (lanes 8-14) were carried out with 
the CYC1 and pre-CYC1 RNA precursors, respectively, in the presence of wild type (WT) or 
Cpf11p lacking protein extracts (∆) at the temperatures indicated on top of the figure. The 
RNA precursors (CYC1 and pre-CYC1), 5’ cleavage product (5’ CP), 3’ cleavage product (3’ 
CP) and polyadenylated product [poly(A)] are indicated on the right. The molecular marker 
(in number of nt) is shown on the left. 
 
3.2.3 Cpf11p is not a new component of the cleavage and polyadenylation factor 
 
The identification of Cpf11p by MS in CPF does not necessarily mean that this 
protein is a stable part of the complex. We have previously shown that the protein has 
no influence on pre-mRNA 3’ end processing activities (see 3.2.2) and thus could 
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very well be a contaminant of the purification. To test whether Cpf11p stably interacts 
with CPF, we constructed TAP-tagged (TAP: tandem affinity purification) versions of 
Cpf11p by inserting the TAP tag to the C-terminal end of the protein. 
 
3.2.3.1 Cell viability of Cpf11-TAP strains is not affected by the insertion of the 
TAP tag  
 
We have used the BMA41 (Baudin-Baillieu et al., 1997) haploid yeast cells to 
construct strains expressing a C-terminally TAP-tagged version of Cpf11p (see 
experimental procedures). The TAP tag method is a very useful procedure that allows 
fast purification of macromolecular complexes under native conditions and when 
expressed at their natural level (Puig et al., 2001; Rigaut et al., 1999). Combined with 
mass spectrometry, the TAP strategy permits the identification of proteins interacting 
with the protein of interest. Several clones were obtained from which only three 
(Cpf11-TAP-1, Cpf11-TAP-2 and Cpf11-TAP-3) were used for further analysis.  
 In order to control whether the insertion of the TAP tag downstream of CPF11 
did affect the cells in their ability to grow, wild type and modified strains were grown 
at different temperatures, in the presence of glucose or galactose. Serial dilutions of 
the cultures were prepared and spotted on YPD (yeast peptone dextrose; rich medium 
plus glucose) and YPG (yeast peptone galactose; rich medium plus galactose) agar 
plates, which were incubated at 30°C and 37°C for two days, or at 15°C for five days. 
As shown in figure 3.2, the insertion of the TAP tag did not affect cell growth of the 
modified strains as no growth defect was observed in comparison to the wild type 
cells. This data indicate that the TAP tag cassette integrated into the genome has no 
undesirable effects on the host cells and resulted in the generation of new viable yeast 
strains that harbor a C-terminal TAP-tagged version of CPF11.  
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Figure 3.2. TAP tagging of Cpf11p did not affect cell growth. 
Ten-fold serial dilutions of the strains indicated on the left were spotted on YPD or YPG agar 
medium and incubated at the temperatures indicated at the bottom of the panels for two days 
(30°C and 37°C) or five days (15°C).  
 
 
3.2.3.2 Expression of Cpf11-TAP is regulated in a sugar-dependent manner 
 
The fact that the TAP tag is inserted at the appropriate site does not necessarily mean 
that the fusion protein will be correctly expressed by the modified strains. Hence, we 
wanted to compare the expression level of Cpf11-TAP in modified strains with the 
endogenous expression level of Cpf11p in WT strains. This approach however was 
not feasible, as no antibody raised against Cpf11p was available and as several 
attempts to produce antisera were not successful. Thus, the only conceivable approach 
was to verify that Cpf11-TAP is indeed expressed in the modified strains. For this, we 
took advantage of the presence of protein A (ProtA) domains in the TAP tag to test 
the expression of Cpf11-TAP by Western blotting using an antibody raised against 
ProtA. We therefore prepared total protein extracts from the modified strains Cpf11-
TAP-1, Cpf11-TAP-2 and Cpf11-TAP-3. Despite repeated attempts, we could not 
detect any signal that would suggest that Cpf11-TAP is indeed expressed (Figure 3.3 
lanes 2-4). We consequently tested different growth conditions under the assumption 
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that the expression of Cpf11p might be conditional. For example, Cpf11p could be 
expressed in response to a stress or an environmental change. The strain Cpf11-TAP-
1 was grown at different conditions that generate a stress for the cells: (i) heat shock 
at 42°C was tested to verify whether Cpf11p is anyhow related to heat shock proteins; 
(ii) growth in the presence of potassium acetate, which forces cells to sporulate; (iii) 
cells were grown over a long incubation time of five-days to examine the effect of a 
lack of oxygen; (iv) finally, cells were grown in the presence of galactose instead of 
glucose to analyze the effect of a change in the carbon source (Figure 3.3 lanes 5-8). 
Surprisingly, a clear signal in Western blot with at a size that corresponds to Cpf11-
TAP (about 35-40 kDa due to the fusion with the TAP tag) was detected with protein 
extracts prepared from cultures grown in the presence of galactose only (Figure 3.3 
lane 8). In contrast, no signals were detected in the other extracts (Figure 3.3 lanes 5-
7), suggesting that only the type of sugar present in the medium enables regulation of 
Cpf11p expression. Thus, one possibility could be that galactose induces Cpf11p 
expression. In the contrary, the presence of glucose would silence the expression of 
the gene, or would keep it at a basal level that would render the protein undetectable 
by Western blotting. So far, none of the CPF subunits showed such a regulation. This 
finding raises the question whether this type of regulation is biologically relevant.  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3. Cpf11-TAP expression is induced by galactose.  
Protein extracts prepared from the strains indicated on top were analyzed by Western blotting 
with an antibody directed against ProtA. Yeast cells anlyzed in lanes 1-7 were grown in the 
presence of glucose, whereas galactose was used in lane 8. The strain Cpf11-TAP-1 was 
grown at different conditions: lane 5, the culture was subjected to a one-hour heat shock at 
42°C; lane 6, potassium acetate was added to the medium; lane 7, cells were grown for five 
days; lane 8, galactose was used as the carbon source instead of glucose. The protein detected 
is indicated on the right of the panel and the molecular weight marker on the left (in kDa).    
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3.2.3.3 Affinity purification of Cpf11-TAP does not pull down CPF 
 
To determine whether Cpf11p is an integral component of the CPF complex, we 
affinity purified TAP-tagged Cpf11p. Because Cpf11p expression seems to be 
dependent on the nature of the sugar used as carbon source, purifications of Cpf11-
TAP were performed in parallel using protein extracts prepared from the strain 
Cpf11-TAP-1 that was grown either in the presence of glucose or in the presence of 
galactose. If Cpf11p is a genuine subunit of CPF, purification of the TAP-tagged 
version of the protein should result in the co-purification of the other components (at 
least of the strongest interacting partners) of the 3’ end processing factor, as it is the 
case when the purification is performed from the ProtA-Pfs2p strain (see 4.2.1 of 
Chapter 4 and figure 3.4A lanes 3-4). Surprisingly, purifications from Cpf11-TAP-1 
protein extracts prepared from cells that were grown either in the presence of glucose 
or galactose, failed to pull down CPF subunits in both cases (Figure 3.4A lanes 5-8). 
None of the bands corresponding to the CPF subunits were detected when the final 
eluates were analyzed by gel electrophoresis followed by silverstaining. In contrast, 
purification from protein extracts containing ProtA-Pfs2p, which was used as positive 
control, resulted in the elution of the whole CPF complex (Figure 3.4A lanes 3-4). It 
has to be noticed here that Yth1p stains poorly with silver (Preker et al., 1997) and is 
therefore not visible on the protein gel presented in figure 3.4A.  
 Yet, purification of Cpf11-TAP yielded some proteins that are different from 
those characterized in CPF (Figure 3.4A lanes 5-8). The pattern of bands obtained 
with the strain Cpf11-TAP-1 appeared to be significantly different from the mock 
purification obtained with protein extract from a wild type strain (Figure 3.4A, 
compare lanes 5-8 with 1-2). Indeed, four polypeptides were found to coelute 
specifically with Cpf11-TAP (Figure 3.4A lane 7, asterisks). Interestingly, these 
proteins were detected when the cells were grown both with glucose or galactose, but 
signals were more weakly stained when glucose was used, indicating lower amounts 
of proteins (compare the intensity of the bands in lanes 7-8 and 5-6). Furthermore, 
Cpf11-CBP, which is the remaining part of the fusion protein after cleavage by the 
TEV protease (see experimental procedures), could not be detected on the 
silverstained gel: it is most likely hidden by the strong TEV protease signal which 
runs approximately at the same size at ~25 kDa (Figure 3.4A lanes 7-8). 
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 To confirm the observations of figure 3.3A, we have searched for the presence 
of several subunits of CPF in the Cpf11-TAP eluates by Western blotting. For this, 
specific antibodies against Ysh1p, Pfs2p and Ssu72p were used to screen for the 
presence of the corresponding proteins. Pfs2p was readily detected in protein extracts 
from the Cpf11-TAP strains (Figure 3.4B lanes 1-3). The shift in size of the band 
corresponding to the immunodetection of Pfs2p in the ProtA-Pfs2p protein extract is 
due to the presence of the ProtA tag (Figure 3.4B lane 1). The signal for Ysh1p was 
weak but clearly visible (Figure 3.4B lanes 1-3). In contrast, Ssu72p was not 
immunodetected neither in ProtA-Pfs2p protein extracts nor in Cpf11-TAP protein 
extracts (Figure 3.4B lanes 1-3). Actually, we observed that the Ssu72p antibody was 
rather inefficient to detect Ssu72p in protein extracts. Indeed, while this antibody did 
not immunodetect Ssu72p in ProtA-Pfs2p protein extract (Figure 3.4B lane 1), it 
nicely revealed the presence of Ssu72p in the eluate obtained after purification from 
the same extract (Figure 3.4B lane 4). Ysh1p, Pfs2p and Ssu72p were readily 
immunodetected in the eluate obtained from the positive control ProtA-Pfs2p protein 
extract, indicating that CPF was efficiently purified by this procedure (Figure 3.4B, 
lane 4). Moreover, the IgG matrix was tested after the elution to verify that no 
material was still bound to it. No protein was detected from the matrix used for the 
purification from Cpf11-TAP-1 protein extracts (Figure 3.4B lanes 8-9), whereas only 
very weak immunolabeling was still detectable in the fraction obtained from ProtA-
Pfs2p extracts, showing that CPF was not totally recovered by TEV proteolytic 
cleavage (Figure 3.4B lane 7). In contrast, none of the tested CPF subunits could be 
observed in the eluates obtained from Cpf11-TAP cells that were grown with glucose 
or with galactose (Figure 3.4B, compare lanes 5-6 with lane 4). This correlates well 
with the results described in figure 3.4A. To further look for the presence of Cpf11p 
in the eluates of the purifications obtained from Cpf11-TAP-1 extracts, we have used 
an antibody that specifically recognizes the CBP part of the TAP tag when cleavage 
by the TEV protease as occured. As shown in figure 3.4D, a signal corresponding 
well to Cpf11-CBP was immunodetected in eluates obtained from galactose extracts 
(lane 4). The same but weaker band was also present in the glucose fraction (lane 3). 
We have previously shown that Cpf11-TAP was not detected in Cpf11-TAP-1 
extracts prepared from cells grown in the presence of glucose (Figures 3.3 and 3.4C, 
lane 3). Thus, the result shown in figure 3.4D, lane 3, suggests that Cpf11-TAP 
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expression is not completely silenced by glucose, but instead repressed to a basal 
level in the absence of galactose.  
 Taken together, these results confirm: (i) our finding that Cpf11-TAP 
expression is induced by galactose; (ii) our hypothesis that Cpf11-TAP is expressed at 
a basal level in the presence of glucose. More importantly, these results show that 
Cpf11-TAP is not associated with CPF, but instead with other (unkown) proteins.  
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Figure 3.4. TAP-tagged purification of Cpf11-TAP does not pull down CPF.  
(A) Purification products obtained from protein extracts prepared from strains indicated on 
top (WT: wild type). Elution fractions 1 and 2 (as indicated on top) were analyzed on a 10% 
denaturing gel and stained with silver. Cpf11-TAP-1 strain was grown either in glucose (lane 
5-6) or galactose containing medium (lane 7-8). Proteins detected are indicated on the right of 
the panel. Proteins that coelute with Cpf11-TAP are indicated by an asterisk (*). The 
molecular weight marker is indicated on the left (in kDa).  
(B) Immunodetection of Ysh1p, Pfs2p and Ssu72p CPF subunits by their specific antibodies 
in protein extracts (lanes 1-3), eluates (lanes 4-6) and IgG matrices (lanes 7-9) obtained from 
strains indicated on the top of the panel. The ProtA-Pfs2p strain was grown in the presence of 
glucose (lanes 1, 4 and 7). The Cpf11-TAP-1 strain was grown either with glucose (lanes 2, 5 
and 8) or with galactose (lanes 3, 6 and 9), as indicated on the top of the panel. Proteins 
immunodetected are indicated on the right of the panel, the antibodies used and the molecular 
weight marker on the left (in kDa).  
(C) Immunodetection of ProtA-fusions by the anti-ProtA antibody in protein extracts 
prepared from the strains indicated on the top of the panel (WT: wild type). Cells were grown 
in the presence of glucose (lanes 1-3) or galactose (lane 4). Proteins immunodetected are 
indicated on the right of the panel, the antibody used and the molecular weight marker on the 
left (in kDa). 
(D) Immunodetection of Cpf11-CBP in the eluates obtained from the strains indicated on top 
of the panel (WT: wild type). The antibody used recognizes the remaining portion (CBP) of 
the TAP tag after cleavage by the TEV protease. The antibody used and the molecular weight 
marker are indicated on the left (in kDa). 
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3.3 Discussion  
 
In the last few years, MS analyses of CPF have identified new proteins associated 
with the previously known subunits (Dichtl et al., 2002b; Gavin et al., 2002; Nedea et 
al., 2003). Interestingly, a MS study conducted in our laboratory (Dichtl et al., 2002b) 
was the only one that identified the gene product of the YDL094c gene, named 
Cpf11p, as a putative new CPF subunit. We analyzed Cpf11p in order to characterize 
its putative involvement in pre-mRNA 3’ end formation, based on the hypothesis that 
it could be a new CPF component. Therefore we first had to confirm that Cpf11p is a 
real CPF component as its copurification with CPF has been reported only once, 
despite the numerous MS analyses performed by other groups.  
 
Cpf11p has no homologues in other species 
 
Astonishingly, Cpf11p is not conserved among eukaryotes, as sequence similarity 
searches in databases did not lead to the identification of any Cpf11p homologue and 
not even to some significant degree of homology with proteins from any other species 
than S. cerevisiae. This finding strongly contrasts with the fact that most CPF 
components have mammalian homologues, or at least present structural similarities 
with CPSF components that fulfil similar tasks (Barabino et al., 2000; Ohnacker et al., 
2000; Zhao et al., 1999a). In fact, the only protein in the databases that clearly showed 
similarity when performing a BLAST search is encoded by another S. cerevisiae 
gene, the YDL096c gene. It is located on the same chromosome (IV) as CPF11, 
directly downstream of it on the same DNA strand and encodes a putative protein that 
shares 38% identity with Cpf11p. These observations suggest that these two genes 
might have arisen from a common ancestral gene, possibly by duplication and 
subsequent sequence divergence during evolution. It is now well established that S. 
cerevisiae has experienced an ancient genome duplication, which generated many 
protein duplicates (Kellis et al., 2004; Wolfe and Shields, 1997). After genome 
duplication, one copy of most pairs of genes was lost, but some pairs of duplicated 
genes have been preserved. YDL096c and CPF11 could well be such a preserved 
duplicated pair of genes, but it is also conceivable that they arose by domain 
swapping, i.e. a part of a protein may have been duplicated and fused to another 
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protein. Duplicated genes can diverge for generation of new gene functions 
(neofunctionalization) or for subdividing multiple functions (subfunctionalization) 
through complementary degeneration but they can also be functionally redundant in 
yeasts (Guan et al., 2007; van Hoof, 2005). Hence, assuming that both gene products 
could be functionally redundant or functionally complementary, information on the 
YDL096c gene function might help us to predict in which biological process could 
CPF11 be involved. Unfortunately, except the fact that YDL096c, as CPF11 is, a non-
essential gene, its function is not clearly known. Recently, results from a large-scale 
screen of viable yeast deletions have suggested that YDL096c, also now referred to as 
OPI6, may be involved in the pathway that regulates the transcription of the 
phospholipidic biosynthetic structural genes (Hancock et al., 2006). Indeed, the 
YDL096c mutant phenotype corresponds to an Opi- phenotype, an abbreviation for 
mutant that overproduces and excretes inositol (Opi) into the growth medium in the 
absence of inositol and choline (Greenberg et al., 1982). However, this possible 
function of YDL096c remains to be investigated further and has no direct relevance 
for our study of Cpf11p as a putative CPF component. 
 
CPF11 is not involved in pre-mRNA 3’ end processing in vitro 
 
As a non-essential gene, CPF11 was unlikely to be required for the crucial 3’ end 
formation reactions, but its requirement at other levels of the CPF activity, such as in 
modulation of mRNA polyadenylation or in stabilization of the CPF machinery, was 
still conceivable. However, we have shown that depletion of CPF11 is not detrimental 
to 3’ end processing activities in vitro since protein extracts prepared from a depleted 
strain (cpf11∆) are as active in cleavage and polyadenylation as the wild-type extract, 
even at low and high temperatures (Figure 3.1). This suggests that Cpf11p may not be 
involved in pre-mRNA 3’ end formation and thereby may also not be part of CPF. 
Indeed, mutations in proteins involved in pre-mRNA 3’ end processing generally 
result in severe altered phenotypes in cleavage and/or polyadenylation activities when 
tested in vitro (Dichtl et al., 2004; Minvielle-Sebastia et al., 1994; Preker et al., 1997). 
However, there are a few exceptions as some CPF subunits have also been shown to 
be dispensable for proper 3’ end processing activities in vitro. For example, null 
mutation of the non-essential REF2 gene does not significantly affect wild-type RNA 
substrates processing in vitro (Dheur et al., 2003; Russnak et al., 1995). Similarly, 
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Pti1p-depleted extracts, or protein extracts prepared from temperature-sensitive pti1 
mutants, do not exhibit defects in pre-mRNA 3’ end processing activities (Dheur et 
al., 2003; W. Hübner, unpublished data). Nevertheless, both Ref2p and Pti1p 
undeniably belong to CPF and have even been shown to interact with each other and 
also with other CPF subunits (Cheng et al., 2004; Nedea et al., 2003; Skaar and 
Greenleaf, 2002). Moreover, although their essential functions are mostly related to 3’ 
end formation of snoRNAs (Dheur et al., 2003; Nedea et al., 2003), Ref2p and Pti1p 
have also been proposed to be involved in 3’ end formation of pre-mRNAs as a 
negative regulator of the poly(A) synthesis and as a regulator of the cleavage site 
selection of some transcripts, respectively (Mangus et al., 2004; Skaar and Greenleaf, 
2002). Thus, the observation that the depletion of Cpf11p does not affect CPF activity 
in vitro is not sufficient to argue that Cpf11p is not an integral component of CPF. 
Consequently, the role of Cpf11p in mRNA maturation needed to be further 
investigated by analyzing its putative association with the 3’ end processing complex.  
 To test whether Cpf11p stably interacts with CPF, we constructed a yeast 
strain that expresses a TAP-tagged version of CPF11. Surprisingly, when verifying 
that the tagged protein was correctly expressed in the modified strain, we found 
Cpf11-TAP to be regulated in a sugar-dependent manner (Figure 3.3). Indeed, our 
data indicate that Cpf11-TAP was expressed at a basal level in the presence of 
glucose and that the expression increased when galactose was the unique source of 
carbon in the medium. The expression level related to glucose was too low to detect 
the fusion protein in total cell extracts by immunodetection methods. In contrast, 
Cpf11p was immunodetected in the eluates, indicating that its expression was not 
completely switched off by glucose. The regulation of CPF11, as a putative CPF 
component, is striking as none of the previously characterized CPF subunits is 
regulated in such a sugar-dependent manner. Indeed, as being the main factor 
involved in pre-mRNA 3’ end processing, which is an essential process for the cell, 
CPF needs to remain functional independently of environmental changes, such as 
changes of the carbon source. This raises the question of the physiological relevance 
of the presence of a protein regulated in a sugar-dependent manner, such as of 
Cpf11p, into the CPF complex and thus challenges its putative permanent association 
with CPF. 
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Cpf11p does not interact with CPF components 
 
The fact that the purification of TAP-tagged Cpf11p does not yield the known CPF 
subunits strongly suggests that Cpf11p is not stably associated with the complex. It 
remains however possible that the TAP tag situated at the C-terminus of Cpf11p 
prevents some important interactions with other CPF subunits. Such an effect of the 
position of the tag has already been observed with Ssu72p since its C-terminal TAP 
tagged version did not show a stable association with 3’ end factor (Gavin et al., 
2002), whereas the N-terminal TAP tagged version did (Dichtl et al., 2002b). 
Therefore, we tried to fuse the TAP tag to the N-terminus of the protein to investigate 
this hypothesis. Despite of several attempts, no strain expressing a N-terminal TAP 
tagged version of Cpf11p could be obtained. However, in accordance with our results, 
MS analyses preformed by other groups in order to identify new polypeptides 
associated with CPF have never found Cpf11p in close relation with CPF (Gavin et 
al., 2002; Nedea et al., 2003). These MS studies have identified six new subunits of 
CPF. Interestingly, five among these novel proteins, namely Ref2p, Pti1p, Swd2p, 
Glc7p and Ssu72p were also identified by Dichtl et al. (2002b). But, in contrast to 
Dichtl et al. (2002b) who identified Cpf11p as the sixth novel protein associated with 
CPF, the other analyses did not identify Cpf11p but instead another protein of similar 
size (∼20 kDa), Syc1p, which is highly conserved among Saccharomyces species 
(Gavin et al., 2002; He et al., 2003; Nedea et al., 2003; Zhelkovsky et al., 2006). 
Syc1p is a non-essential protein that shows a high degree of similarity with the C-
terminal region of Ysh1p (38% identity and 52% similarity over 188 amino acids). It 
has been proposed to work as a negative regulator of the 3’ end processing by 
possibly competing with sites that interact with the Ysh1p C-terminus (Zhelkovsky et 
al., 2006). Like for the other five new putative CPF-associated factors identified, the 
purification of TAP-tagged Syc1p yielded the polypeptides present in CPF, indicating 
that it is a genuine component of CPF (Nedea et al., 2003). Likewise, if Cpf11p would 
be an integral subunit of CPF, purification of the TAP-tagged version would have 
yielded the polypeptides associated with CPF. Our data show that this is not the case 
(Figure 3.4). Furthermore, additional MS analysis we carried out in order to identify 
other putative new components of CPF, have confirmed the presence of Ref2p, Pti1p, 
Swd2p, Glc7p, Ssu72p and Syc1p proteins in association with the complex (see 4.2.2 
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of Chapter 4). Strikingly, Cpf11p was never identified despite the numerous attempts 
we performed, arguing once more against the presence of this protein in CPF.  
 It is also possible that Cpf11p is able to contact CPF only transiently under 
certain conditions. This would explain why it could have contaminated the CPF 
preparation of Dichtl et al. (2002b) and therefore has been wrongly assigned as a CPF 
component.  
 The CPF protein profile of protA-tagged Pfs2p (Figure 3.4A lanes 3-4) 
coincides with the complex composition obtained with other protA-tagged CPF 
factors, such as with TAP-tagged Yth1p (Barabino et al., 2000; Ohnacker et al., 2000) 
or with TAP-tagged Yhh1p, Ydh1p, Pta1p, Ref2p, Mpe1p and Pti1p (Gavin et al., 
2002; Nedea et al., 2003; Vo et al., 2001). The purification of CPF via the ProtA-
tagged version of the Pfs2p subunit is one of the most efficient ways to obtain 
copurification of all the known CPF subunits in a reproducible manner. In 
comparison, it is possible that the TAP-tagged purification of Cpf11p is less efficient. 
In this case, the amount of proteins recovered from the purification could be too low 
for identification on a gel stained with silver, although silverstaining method has a 
detection limit as low as 10 ng of proteins. In addition, we used an immunodetection 
method to detect potential 3’ end processing factors in the eluates obtained from the 
purification of Cpf11-TAP. The use of specific antibodies is a very sensitive method 
that allows a detection of lower amounts of proteins (less than 1 ng) than any gel 
staining method. But, in accordance with the results of the silver stained gel (Figure 
3.4), the use of antibodies against several CPF subunits has clearly revealed that none 
of the tested 3’ end processing factors was present in the eluates obtained from the 
purification of Cpf11-TAP (Figure 3.4B). In contrast, the CPF subunits we tested 
were all immunodetected in the eluates obtained from ProtA-Pfs2p extracts. Hence, 
the fact that we did not detect CPF subunits in association to Cpf11-TAP should not 
be due to a low sensitivity of the detection methods used.  
 
Cpf11p antibody as a missing tool 
 
We could not analyze the expression of Cpf11-TAP in comparison to the wild type 
expression of Cpf11p, nor directly trace Cpf11p over the whole purification 
procedure, since there is no specific anti-Cpf11p antibody available. We generated 
two types of recombinant proteins, GST-Cpf11p and H6-Cpf11p, but the amount of 
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soluble proteins that we obtained was never sufficient to allow the production of an 
antibody (data not shown). The hydrophobic feature of the protein could be 
responsible for the low solubility of recombinant Cpf11p. As a consequence of the 
lack of a specific antibody for Cpf11p, we have used anti-ProtA and anti-CBP 
antibodies to follow the Cpf11-TAP fusion protein over the purification procedure. 
 A specific anti-Cpf11p antibody would also be needed to verify that Cpf11p 
was indeed truly present in the original fraction of Dichtl et al. (2002b). Although it is 
highly speculative, it is possible that Cpf11p was identified as a false positive (also 
referred to as false identification) of the MS analysis.  
 
Investigating protein-protein interactions of Cpf11p 
 
Other procedures that are widely used to test for protein-protein interactions, like GST 
pull down experiments or two-hybrid screens, were also used in our laboratory to 
search for putative Cpf11p interacting partners. Surprisingly, results from GST pull 
down experiments have found two different potential interacting partners for Cpf11p 
among the CPF components. Both GST-tagged Mpe1p (PhD Thesis of Martin 
Sadowski, 2002) and Ydh1p (Kyburz et al., 2003) were shown to interact with in vitro 
translated Cpf11p. Although these data seem to be in contradiction with our results, 
the results of both experiments, GST pull down and Cpf11-TAP purification cannot 
be directly compared, as their relevance for putative in vivo association between 
Cpf11p and CPF is not the same. Indeed, two proteins known as interacting partners 
will very often give a positive result in GST pull down, whereas a positive signal 
obtained when testing two candidates does not necessarily mean that these two 
proteins truly interact under physiological conditions. However, the GST pull down 
approach is very useful to investigate the interaction network created by the different 
subunits in the context of a multiprotein complex, such as CPF. A conditional binding 
of Cpf11p to CPF in response to an appropriate signal cannot be excluded, but it 
would not make Cpf11p an integral subunit of CPF per se. We also tried, in 
collaboration with Hybrigenics S.A. in Paris, a two-hybrid screen approach with 
Cpf11p as bait, which did not reveal any potential protein-protein interactions.  
 In summary, the combined results of our work indicate that Cpf11p is not a 
genuine subunit of CPF. Further work could however be done to investigate whether 
Cpf11p can be transiently associated to CPF. We have shown that Cpf11-TAP 
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copurified with four polypeptides, suggesting that Cpf11p displays specific 
interactions in vivo. Thus, it would be interesting to identify these interacting partners, 
for example by MS, to further characterize the function of Cpf11p. The analysis of 
double mutants of CPF11 and OPI6 could also be informative on the biological role 
of Cpf11p.  
 
3.4 Experimental procedures 
 
Yeast strains, plasmids and media  
 
Yeast strains were grown on YPD/YPG (1% yeast extract, 2% bacto-peptone, 2% 
glucose/galactose), on SD-TRP medium (synthetic medium plus 2% glucose without 
tryptophan) or on YPD supplemented with 200 µg/ml of kanamycine, as indicated in 
the text or figure legends.  
 Yeast strains used in this study and their genotypes are the following: 
YWK192 (MATα; his3∆1; leu2∆0; lys2∆0; ura3∆0), BY4742 (MATα; his3∆1; 
leu2∆0; lys2∆0; ura3∆0; ydl094c::KanMX4), BMA41 (MATa/α; ura3-1/ura3-1; 
leu2-3,112/leu2-3,112; trp1∆/trp1∆; his3-11,15/his3-11,15; ade2-1/ade2-1; can1-
100/can1-100), BMA41α (MATα; ura3-1; leu2-3,112; trp1∆; his3-11,15; ade2-1; 
can1-100), BMA41a (MATa; ura3-1; leu2-3,112; trp1∆; his3-11,15; ade2-1; can1-
100), YBP101 (MATa; ura3-1; leu2-3,112; trp1∆; his3-11,15; ade2-1; can1-100; 
Cpf11 C-ter. TAP-11, K.l. TRP1), YBP102 (MATα; ura3-1; leu2-3,112; trp1∆; his3-
11,15; ade2-1; can1-100; Cpf11 C-ter. TAP-7, K.l. TRP1), YBP103 (MATα; ura3-1; 
leu2-3,112; trp1∆; his3-11,15; ade2-1; can1-100; Cpf11 C-ter. TAP-12, K.l. TRP1), 
MO20 (ura3-1; trp1∆; ade2-1; leu2-3,112; his3-11,15; pfs2::TRP1 pNOP-PFS2 
[ProtA-PFS2-LEU2-CEN]).  
 The pBS1479 plasmid (Puig et al., 2001) was used to amplify by PCR the C-
terminal TAP tagging cassette.   
 
Preparation of yeast cell free extracts 
 
This method is adapted from the liquid nitrogen method of Ansari and Schwer (Ansari 
and Schwer, 1995). 5 liter cultures were grown in YPD (1% yeast extract, 2% bacto-
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peptone, 2% glucose) to an OD600 of 2-3. The following procedure was done at 4°C. 
The cells were harvested by centrifugation at 5000 rpm for 5 min in a Sorvall SLA-
3000 rotor and washed once with 200 ml of ice-cold water and once with 200 ml of 
ice-cold AGK buffer [10 mM Tris-HCl pH 7.9, 200 mM KAc, 10% glycerol and 1 
mM dithiothreitol (DTT)]. Then, the cells were resuspended in 20 ml AGK buffer and 
frozen as drops in liquid nitrogen. The frozen cells were stored at -70°C until they 
were homogenized. For homogenization, the frozen yeast cells were ground with a 
pestle in a mortar that was previously cooled with liquid nitrogen to avoid thawing. 
Grinding was continued until a fine powder was obtained. The frozen powder was 
transferred to a fresh tube and thawed under cold running water. Immediately after 
thawing, protease inhibitors were added to the following concentrations: 1 mM 
phenylmethylsulfonyl fluoride (PMSF), 0.4 µg/ml leupeptin and 0.7 µg/ml pepstatin. 
The suspension of broken cells was gently mixed for 30 min on ice and was then 
centrifuged at 10000 rpm for 30 min in a Sorvall SS-34 rotor. The supernatant was 
removed and centrifuged at 41000 rpm in a Kontron TST 41.14 rotor for 2 h. After 
removing lipids layer, the pale yellow aqueous phase was carefully saved and solid 
ammonium sulfate was added to reach 40% saturation. Proteins were precipitated 
overnight with gentle stirring and the precipitated material was pelleted by 
centrifugation at 10000 rpm in a Sorvall SS-34 rotor during 30 min. The pellet was 
finally resuspended in 1 ml of buffer E-50 (20 mM Tris-HCl pH 7.9, 0.2 mM EDTA, 
50 mM Kac, 0.02% NP-40, 10% glycerol, 0.5 mM DTT, 1 mM phenylmethylsulfonyl 
fluoride (PMSF), 0.4 µg/ml leupeptin and 0.7 µg/ml pepstatin) and dialyzed three 
times 2 h against 2 l of buffer E-50.  
 
In vitro cleavage and polyadenylation assays 
 
32P-labelled CYC1 RNA was prepared as run-off transcripts and gel purified as 
described previously (Minvielle-Sebastia et al., 1994; Preker et al., 1995).  
 A standard in vitro processing reaction was carried out in a 25 µl reaction 
volume containing up to 5 µl of protein extract. For polyadenylation, the reaction 
mixture contained 2% polyethylene glycol, 75 mM potassium glutamate, 0.01% NP-
40, 2 mM ATP, 1.8 mM magnesium acetate, 20 mM creatine phosphate, 1 mM DTT, 
0.2 mg/ml creatine kinase and 0.2 units of RNAguard (Amersham Biosciences). The 
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volume was brought to 25 µl upon addition of buffer E-50 (20 mM Tris-HCl pH 7.9, 
0.2 mM EDTA, 50 mM Kac, 0.02% NP-40, 10% glycerol) when it was necessary. 
When only the cleavage reaction was assayed, EDTA was used instead of magnesium 
acetate to prevent poly(A) addition, and degradation of the downstream cleavage 
fragment (Chen and Moore, 1992). The reactions were incubated 1h at the 
temperatures indicated in the figure legends. They were then stopped by addition of 
75 µl of a stop mix (100 mM Tris-HCl pH7.9, 12.6 mM EDTA, 150 mM NaCl, 1% 
SDS, 0.2 µg/µl of proteinase K and 0.05 µg/µl glycogen) and incubated for 1h at 
42°C. The RNAs were recovered by ethanol precipitation, dried and resuspended in 6 
µl of formamide buffer (95% formamide, 20 mM EDTA, 0.05% Bromophenol Blue, 
0.05% Xylene Cyanol FF). Samples were heated at 95°C for 5 min and loaded on a 
denaturing 6% polyacrylamide gel. The gel was exposed overnight to an X-ray film at 
-70°C. 
 
Droplet test 
 
Yeast strains were grown overnight on YPD or YPG medium and ten-fold serial 
dilutions were prepared from an initial OD600 of 0.1. 5µl of each dilution was then 
spotted on YPD or YPG agar-medium and incubated at 30°C and 37°C for two days, 
or at 15°C for five days.  
 
Western blot analysis  
 
For immunoblots, protein samples were separated on either 10 or 12% SDS 
polyacrylamide gels (Laemmli, 1970). After transfer of proteins to nitrocellulose 
membranes, the blots were treated according to standard procedures with antibodies 
diluted in TBS-tween buffer: anti-ProtA antibody (from Sigma) was diluted 1:4000; 
anti-CBP antibody (from Open Biosystems) was diluted 1:2000; specific antibodies 
for 3’ end processing factors were diluted 1:2000. Peroxidase-conjugated swine anti-
rabbit immunoglobulins (DAKO) were used as secondary antibody and 
chemiluminescence (ECL kit, Amersham) was used for detection.  
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Tandem affinity purification (TAP) 
 
The TAP tag procedure involves the fusion of the TAP tag to the protein of interest. 
The TAP tag consists of two IgG binding domains of Staphylococcus aureus ProtA 
and a calmodulin binding peptide (CBP), which are separated by a tobacco etch virus 
(TEV) protease cleavage site (Figure 3.5 and 3.7A). The fusion protein and 
interacting partners are recovered from cell protein extracts by only two affinity 
purification steps (Figure 3.7B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5. TAP tag sequence. 
The TAP tag consists of a calmodulin binding peptide (CBP, sequence in blue), a TEV 
cleavage site (TEV, in yellow) and two ProtA domains (Protein A, in red) in respect to the 5’ 
to 3’ orientation. The TEV cleavage site is separated from CBP and ProtA by spacer 
sequences that maintain the translation frame (in green).  
 
 
Construction of TAP-tagged Cpf11p 
TAP-tagged strains were constructed as described (Puig et al., 2001; Rigaut et al., 
1999). Briefly, a pair of gene-specific oligonucleotide primers was synthesized, each 
of which had been designed to share complementary sequences to the TAP tag 
cassette at the 3' end and contain 45 base pairs (bp) of homology with the CPF11 
gene to allow in-frame fusion of the TAP tag at the C-terminal coding region of the 
gene. Primers have the following sequences: Oligo1-TAP (5’-GACATTTTT 
TTTATTCATGATGTTTTTTTTGTCTATTTTCGTTTTTCCATGGAAAAGAGAA
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G-3’) and Oligo2-TAP (5’-CGCCACTAGTACAGTTGAAGAAATCACTATAGA 
AGGGGACGGTCCTACGACTCACTATAGGG-3’). The gene-specific cassette 
containing the C-terminally positioned TAP tag was then generated by PCR using the 
plasmid pBS1479 as template (Figure 3.7C), which contains the TRP1 gene and 
permits selection of transformed strains in tryptophan-free media. The haploid parent 
yeast strains BMA41a and BMA41α were transformed with the PCR products 
according to the lithium acetate method (Gietz et al., 1995; Ito et al., 1983), and 
strains were selected in SD-TRP medium. By this way, PCR fragments containing the 
TAP tag sequence can be integrated directly into the genome by taking advantage of 
the high efficiency of homologous recombination in yeast. Insertion of the cassette 
was verified by genomic PCR of samples from individual colonies with two pairs of 
primers designed to produce products of approximately 350 bp with primers ChOl-1 
(5’-GGACAATATAGTCAGCTTCA-3’) and ChOl-2 (5’-GTCATCTTTTAAACT 
TTGGA-3’), and 450 bp with primers ChOl-3 (5’-GGTGAA CTGCAGTTGAAATA-
3’) and ChOl-4 (5’-AAACGTGAATCTCAACCT GC-3’). In each pair of control 
primers, one oligonucleotide is specific for the insert (the TAP cassette) and the other 
one is specific for a yeast genomic DNA sequence located near the insertion site of 
the TAP cassette. The first pair of control primers (ChOl-1 and ChOl-2) and the 
second one (ChOl-3 and ChOl-4) are used to verify the insertion of the 5’ end and of 
the 3’ end of the TAP cassette, respectively (Figure 3.6). If the TAP tag is inserted at 
the correct locus into the host genome, the use of the first pair of primers will generate 
a PCR product of 350 bp, while the use of the second pair of primers will generate a 
PCR product of 450 bp.  
 Expression of Cpf11-TAP was verified by Western blotting using a rabbit 
anti-ProtA primary antibody, and a anti-rabbit horseradish peroxidase-coupled 
secondary antibody. 
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Figure 3.6. Insertion of the TAP tag cassette downstream of CPF11. 
The correct integration of the TAP tag cassette was verified by PCR using two pairs of 
specific primers for the TAP tag and the target locus. Oligonucleotide ChOl-1 is homologous 
to a CPF11 sequence located 50bp upstream of the stop codon. Oligonucleotide ChOl-2 is 
specific for the 5’ end of the TAP sequence, whereas oligonucleotide ChOl-3 is specific for 
the 3’ end of the TAP cassette. Oligonucleotide ChOl-4 has homology with a genomic region 
located 270bp downstream of CPF11.  
 
Affinity purification of CPF and TAP tag purification of Cpf11-TAP 
The CPF complex was affinity purified from an extract of the yeast strain MO20 that 
expresses a ProtA-tagged version of Pfs2p (Ohnacker et al., 2000). The tag included 
two IgG-binding domains of the Staphylococcus aureus protein A followed by the 
recognition sequence of the site-specific TEV protease (Senger et al., 1998).  
 Batch absorption to IgG-sepharose was done to isolate ProtA-Pfs2p or Cpf11-
TAP and associated proteins from protein extracts prepared from yeast strains that 
express these fusions. All incubation steps described below up to the proteolytic 
cleavage were done at 4°C with gentle mixing. A 1 ml aliquot of IgG-sepharose 
(Amersham Biosciences), 4 ml of the extract, 10% glycerol and 10 ml of buffer D-
120 [20 mM Tris-HCl pH 7.9, 120 mM NaCl, 0.02% NP-40, 0.2 mM EDTA, 1 mM 
dithiothreitol (DTT)] including 1 mM phenylmethylsulfonyl fluoride (PMSF), 0.4 
µg/ml leupeptin and 0.7 µg/ml pepstatin were mixed in a 15 ml Falcon tube and 
incubated for 2 h on a rotating arm. After centrifugation, the supernatant was removed 
and the matrix was extensively washed five times for 20 min with 15 ml of D-120 
buffer. After washing, the beads were incubated twice for 10 min with 15 ml of buffer 
TEV (50 mM Tris-HCl pH 7.9, 10% glycerol, 50 mM KCl, 0.5 mM EDTA, 0.02% 
NP-40, 1 mM DTT, 0.4 µg/ml leupeptin). For elution of the bound material, the beads 
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were incubated with 1 ml of buffer Tev containing 400 U of recombinant TEV 
protease (Invitrogen) at 16°C for 90 min. The site-specific proteolytic cleavage 
released Pfs2p and associated proteins from the protein A tag and thereby from the 
IgG-sepharose matrix. After centrifugation, the supernatant was collected in a fresh 
tube and the beads were washed once with 500 µl of Tev buffer.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7. TAP tag strategy (from Puig et al., 2001). 
(A) Schematic representation of the structure of the C- and N-terminal TAP tags. The 
domains constituting the TAP tag are indicated. CBP: calmodulin binding protein, TEV: TEV 
protease cleavage site, ProtA: protein A domain.  
(B) Overview of the TAP procedure. The TAP-tagged protein of interest is incubated with 
IgG matrix, and then, the bound material is eluted by proteolytic cleavage with TEV protease. 
Eluates are further incubated with calmodulin beads to remove contaminants and the TEV 
protease. The final elution is carried out in the presence of EGTA.  
(C) Restriction map of the pBS1479 plasmid that carries the C-terminal TAP cassette. The 
cassette contains a tryptophan marker (TRP1) for selection of the transformants.  
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Chapter 4: Three-dimensional structure of the yeast cleavage and 
polyadenylation factor (CPF) 
 
4.1 Introduction 
 
Pre-mRNA 3’ end processing is a two-step reaction in which each step is catalyzed by 
a different enzyme. The first step consists of the site-specific endonucleolytic 
cleavage of the pre-mRNA, catalyzed by the endonuclease Ysh1p, a subunit of CPF 
(Mandel et al., 2006; Ryan et al., 2004). Two cleavage products are obtained, an 
upstream cleavage fragment carrying the genetic information, and a downstream 
cleavage product, which is still attached to the transcribing RNAP II and is then 
rapidly degraded. In the second step, poly(A) polymerase (Pap1p) adds adenosine 
residues to the 3’ end hydroxyl group of the upstream cleavage product, generating a 
poly(A) tail of about 70 nucleotides in yeast and 250 nucleotides in mammals (Colgan 
and Manley, 1997; Keller and Minvielle-Sebastia, 1997; Zhao et al., 1999a).  
 3’ end formation involves a surprisingly large set of protein factors (Colgan 
and Manley, 1997; Keller and Minvielle-Sebastia, 1997; Zhao et al., 1999a). Four 
protein factors have been shown to participate in pre-mRNA 3’ end processing in 
yeast: CPF (Dichtl et al., 2002b; Gavin et al., 2002; Nedea et al., 2003; Ohnacker et 
al., 2000), CF IA (Chen and Moore, 1992), CF IB/Nab4p/Hrp1p (Kessler et al., 1997; 
Kessler et al., 1996) and Pab1p (Kessler et al., 1997; Kessler et al., 1996; Minvielle-
Sebastia et al., 1997). The majority of yeast 3’ end processing factors displays high 
sequence conservation with metazoan counterparts, suggesting a similar mode of 
action in pre-mRNA 3’ end maturation even if the general organization of these 
factors is different (Keller and Minvielle-Sebastia, 1997; Manley and Takagaki, 1996; 
Shatkin and Manley, 2000). CPF and CF IA contain homologues of mammalian 
CPSF and CstF factors, respectively (see Chapter 1, figure 1.5).  
 Interestingly, both enzymes that catalyze pre-mRNA 3’ end processing 
reactions in yeast are genuine subunits of CPF, the major 3’ end processing factor. 
CPF is a multiprotein complex that consists of a total of 15 polypeptides and is 
essential for both cleavage and polyadenylation reactions (Ohnacker et al., 2000). It is 
composed of the following polypeptides: Yhh1p/Cft1p (Preker et al., 1997; Stumpf 
and Domdey, 1996), Ydh1p/Cft2p (Preker et al., 1997; Zhao et al., 1997), 
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Ysh1p/Brr5p (Chanfreau et al., 1996; Jenny et al., 1996; Preker et al., 1997), Pta1p 
(Preker et al., 1997), Pap1p (Lingner et al., 1991b; Preker et al., 1997), Mpe1p 
(Ohnacker et al., 2000; Preker et al., 1997; Vo et al., 2001), Pfs2p (Ohnacker et al., 
2000), Fip1p (Preker et al., 1995), Yth1p (Barabino et al., 1997) and Swd2p, Glc7p, 
Ssu72p, Pti1p, Ref2p and Syc1p (Dichtl et al., 2002b; Gavin et al., 2002; Nedea et al., 
2003). In total, more than 20 proteins participate in this processing step, CPF acting in 
cooperation with CF IA (which consists of 4 subunits), Nab4p and Pab1p. During the 
last decade, extensive biochemical studies have been carried out on the proteins 
involved in 3’ end formation in order to characterize their role in this process. Why so 
many polypeptides are needed for this seemingly simple two-step reaction remains 
presently unclear. Although the function of numerous components of the 3’ end 
processing machinery has been characterized, further investigations are needed to 
provide better understanding of the complexity of the protein composition. Several 
observations have already helped to tackle this issue. One clue is the involvement of 
some CPF subunits in other cellular processes. For instance, Swd2p also associates 
with the SET1 multiprotein complex that methylates histone 3 lysine 4 to regulate 
gene expression (Dichtl et al., 2004; Miller et al., 2001; Nagy et al., 2002; Roguev et 
al., 2001). Other examples are provided by Glc7p, which is also involved in mRNA 
export and diverse other cellular processes (Gilbert and Guthrie, 2004; Walsh et al., 
2002), and by another phosphatase, Ssu72p, which acts on the phosphorylated serine 
5 of the CTD. In addition, the physical and functional coupling between the 3’ end 
processing machinery and other protein assemblies involved in the gene expression 
pathway (e.g. transcription) also contributes to this complexity. Such a coupling has 
been suggested to maximize the efficiency and specificity of each step in gene 
expression (Maniatis and Reed, 2002). Furthermore, several CPF subunits are RNA-
binding proteins and contribute to this complexity by contacting the pre-mRNA, such 
as Yhh1p (Dichtl et al., 2002a), Ydh1p (Dichtl and Keller, 2001), Mpe1p (Vo et al., 
2001) and Yth1p (Barabino et al., 1997). Finally, the observation that CPF regulates 
its own activity by cycles of phosphorylation and dephosphorylation that require the 
action of the phosphatase Glc7p suggests the presence of an autoregulatory network 
within CPF (He and Moore, 2005). Hence, pre-mRNA 3’ end processing appears to 
be a more complicated process than what was originally anticipated.   
 One of the possible approaches to better understand the function of proteins 
and protein complexes is to reveal their structure and 3D organization. Because CPF 
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is a nonabundant complex in yeast cells, crystallizing the whole CPF is presently not 
feasible. So far, only the crystal structures of Ydh1p (Mandel et al., 2006) and Pap1p 
alone or in complex with ATP have been solved (Bard et al., 2000; Mandel et al., 
2006). In mammals, the structures of PAP (Martin et al., 2000) and CPSF-73 (Mandel 
et al., 2006), the homologue of Ysh1p, were also solved. Another method of looking 
at large protein complexes and requiring less protein amounts is electron microscopy 
(EM). EM is one of the fastest and most direct techniques for elucidating the 
structures of biological macromolecules. 2D electron crystallography is for instance 
well established to study structures of membrane proteins like receptors, channels, 
ions pumps and many others. Detailed 3D structures of individual macromolecules 
can also be obtained by the “single-particle” approach without the need for 
crystallization, provided that they are sufficiently large (>200 kDa). 3D electron 
microscopy has contributed a wealth of information on structural organization and on 
the architecture of large macromolecular assemblies in the last ten years. Single-
particle EM is a powerful technique to generate 3D reconstructions of any object 
imaged in a transmission electron microscope. It gathers many images of the same 
particle (molecule or molecular complex) in various orientations and uses 
computational image processing to reconstruct the 3D structure. Since no crystals are 
needed, the specimen preparation is straightforward, and since the random 
orientations of the particles are exploited without tilting the specimen, the data 
collection is also straightforward. Thus, the emphasis of the studies can be focused 
entirely on the biology of the specimen and its structure-function relationships. 
Accordingly, the bacterial ribosome structure was first solved at ∼20 Å resolution in 
its empty state (Stark et al., 1995), and later, the structure was elucidated in the pre-
translocational and in the post-translocational configurations in association with 
mRNA and tRNAs (Frank et al., 1995; Stark et al., 1997).  
 Our aim was to obtain a 3D model of CPF in order to get a more detailed 
understanding of the 3’ end formation mechanism and the role of each of the CPF 
subunits. We have adapted an efficient method that allows the isolation of highly 
purified native CPF to analyze the structure of the complex by single-particle EM, a 
technique that requires fewer amounts of proteins than X-ray crystallography. We 
have used a yeast strain that expresses a ProtA-tagged version of the Pfs2p subunit of 
CPF to efficiently purify the 3’ end processing factor. Here, we present for the first 
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time a three-dimensional (3D) model of the CPF complex with a resolution of ~25 Å. 
This structure was obtained by negatively stained electron microscopy preparations of 
CPF, angular reconstitution, and random conical tilt (RCT). Our model reveals that 
CPF has a complex asymmetric architecture in which an outer protein wall surrounds 
a large inner cavity. We have also used scanning transmission electron microscopy 
(STEM) to determine the molecular mass of CPF, which we have found to be close to 
one megadalton. Finally, we discuss the possibility that the inside cavity represents a 
reaction chamber in which 3’ end processing reactions could occur.  
 
4.2 Results 
 
4.2.1 Affinity purification method to prepare CPF complexes for EM analysis  
 
To purify the CPF complex, we have adapted an affinity purification method 
commonly used in our laboratory, using the yeast strain MO20 that expresses a 
ProtA-tagged version of Psf2p (Ohnacker et al., 2000). In this strain, 98% of the PFS2 
coding region was replaced by the insertion of a TRP1 deletion cassette. Since PFS2 
is an essential gene, a yeast expression vector encoding a double ProtA-tagged 
version of Pfs2p, controlled by the NOP1 promoter (pNOPATA1L-PFS2), was 
inserted to maintain Pfs2p expression in the cell. The open reading frame of PFS2 
was fused in frame to the ProtA tag that consists of two ProtA domains and a tobacco 
etch virus (TEV) protease cleavage site fused in frame to the start codon of PFS2 
(Figure 4.1).  
 
 
 
 
 
 
Figure 4.1. Schematic representation of the gene construct coding for ProtA-TEV 
cleavage site-Pfs2p fusion protein. 
 
 
 The construction of this strain allowed fast purification of functional CPF in 
only one purification step by incubating protein extract containing ProtA-Pfs2p with 
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an IgG sepharose matrix and by subsequent release of Pfs2p by TEV cleavage (see 
below). However, even if EM requires less material than any other 3D structure 
determining method, significant concentrations of the sample are needed for EM 
analysis. Obtaining a specimen suitable for EM was not as simple as just scaling up 
the purification procedure and required not only very concentrated but also highly 
pure material. Although fully functional, CPF yielded by the single affinity 
purification step on IgG matrix is only partially pure. Furthermore, as determined by 
extensive tests we made and as many other protein complexes, the purification of CPF 
was best achieved in the presence of glycerol and detergents such as NP-40 (data not 
shown). However, these reagents are incompatible with certain EM techniques since 
they lead to severe loss of contrast (presence of glycerol for native cryo-EM 
preparations) or negative stain artefacts (in case of NP-40). Thus, we had to improve 
and modify the purification method in order to obtain highly concentrated and pure 
CPF suitable for further EM studies.  
 We have tested a wide variety of purification conditions, including different 
methods and composition of buffers, before the establishment of a suitable 
purification procedure for CPF. For example, we have found that CPF could not be 
purified with Hepes-containing buffers (Figure 4.2). Purification of ProtA-Pfs2p on 
IgG sepharose matrix yielded the components of CPF when Tris-containing buffers 
were used (Figure 4.2A), whereas no proteins were shown to bind the IgG matrix 
when Hepes was used instead of Tris (Figure 4.2B). The same results were obtained 
when purification was performed with other ProtA-tagged subunits of CPF, as ProtA-
Fip1p (Figure 4.2B).  
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Figure 4.2. Tris-containing buffers are required to purify CPF.  
(A) Protein extracts containing ProtA-Pfs2p, ProtA-Fip1p or wild type protein extract (WT) 
were incubated with IgG sepharose matrix in the presence of Tris-containing buffers. Eluates 
(E1-E3) were analyzed by SDS PAGE followed by silverstaining. CPF components detected 
and TEV protease are indicated on the right (see also figure 4.5B for protein composition of 
CPF) and the molecular weight marker on the left (M, in kDa). 
(B) Same experiment as in (A) but carried out with Hepes-containing buffers. FT: flow-
through. IgGs: Immunoglobulins G dissociated from the matrix. TEV: TEV protease.  
 
 
 In order to obtain clean CPF, we also tried to purify the complex first on IgG 
matrix and subsequently by a FLAG affinity chromatography step. To do this, we 
inserted a FLAG tag between the TEV cleavage site and the Pfs2p sequence of the 
ProtA-Pfs2p construct. Due to its small size (less than 1 kDa), the FLAG tag is 
unlikely to disturb protein interactions mediated by Psf2p, which are important for 
stabilizing the complex (Ohnacker et al., 2000). As described for ProtA-Pfs2p, the 
new ProtA-FLAG-Pfs2p construct yielded CPF components after purification over an 
IgG matrix (Figure 4.3A). The IgG eluates obtained were pooled and then subjected 
to FLAG tag chromatography. As revealed by SDS polyacrylamide gel 
electrophoresis (SDS PAGE) analysis followed by silverstaining of the FLAG eluates, 
this procedure did not result in CPF purification (Figure 4.3B). Only few bands that 
could correspond to some CPF subunits were weakly detected on the gel. 
Nevertheless, the whole complex was not obtained. It is possible that the FLAG tag 
was hidden by a structural element of the CPF complex due to its small size, 
preventing binding to the anti-FLAG affinity gel. A FLAG tagged version of Tad2p, a 
subunit of the tRNA-specific adenosine 34 deaminase, was used as positive control 
for the FLAG tag purification (kindly provided by M. Schaub).  
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Figure 4.3. FLAG tag purification of ProtA-FLAG-Pfs2p did not yield CPF.  
Protein extract containing the ProtA-FLAG-Pfs2p construct was incubated with IgG matrix 
(A). Proteins eluted were analyzed by SDS PAGE and silverstaining. Arrows indicate 
subunits of CPF (see figure 4.5B for protein composition of CPF) and the asterisk indicates 
TEV protease used for the cleavage of the ProtA tag during elution. IgG eluates (E1-E5), wild 
type protein extract (WT) and an extract containing FLAG-Tad2p were then subjected to 
FLAG tag chromatography (B). E1-E4: FLAG eluates. The molecular weight marker is 
indicated on the left (M, in kDa). 
 
 
 After many tests, we have finally established a double affinity purification 
method that allows the isolation of highly pure CPF providing sufficient amounts for 
EM.  
 In the first affinity chromatography step protein extracts were incubated with 
IgG sepharose matrix, which specifically binds to the ProtA epitope of ProtA-Pfs2p 
(Figure 4.4). In this step, the matrix retained ProtA-Pfs2p and all associated proteins. 
After extensive washes, the bound material was eluted from the matrix by site-
specific proteolytic cleavage with the TEV protease, which has been shown to allow 
efficient release under native conditions (Senger et al., 1998). The TEV protease 
specifically recognizes the seven amino acid sequence ENLYFQG, which is not 
encoded by the yeast genome, and cleaves between glutamine (Q) and glycine 
residues (G) (Carrington and Dougherty, 1988). This way Pfs2p and its interacting 
partners are released from the matrix, hence leading to the purification of CPF.  
 The efficiency of the IgG purification was monitored by Western blot with 
specific antibodies against Ysh1p and Pfs2p, two subunits of CPF (Figure 4.5A). Both 
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polypeptides were immunodetected in the protein cell extracts and in the eluates. A 
shift in size was observed for the Pfs2p signal in ProtA-Pfs2p extract due to the 
presence of the ProtA tag (Figure 4.5A lanes 1-2). No signal was observed in the 
unbound and wash fractions (Figure 4.5A, lanes 3, 4 and 9), indicating that the ProtA-
Pfs2p fusion and the associated proteins were efficiently precipitated by the IgG 
sepharose matrix (lanes 3-4). In contrast, both Ysh1p and Pfs2p CPF subunits 
(henceforth free of the ProtA tag) were well immunodetected in the eluate fractions, 
whereas no signal could be observed from the IgG beads after elution, indicating that 
CPF was fully recovered (lanes 5-9). Taken together, these immunodetection data 
show that the first affinity purification step for CPF was very efficient. The advantage 
of this method over conventional purification procedures is that it allows purification 
of a tagged protein directly from a yeast total protein extract under native conditions.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4. Overview of the CPF purification method.  
In the first affinity purification step, ProtA-Pfs2p extracts are incubated with IgG sepharose 
matrix that retains ProtA. The bound material is then eluted by proteolytic cleavage with TEV 
protease and the eluate is further subjected to a second chromatography step over the anion-
exchange MonoQ column. C: protein contaminants bound to CPF.   
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Figure 4.5. Affinity purification of proteins bound to ProtA-Pfs2p yields the CPF 
complex.  
(A) Western blotting analysis of fractions obtained by IgG sepharose purification of extracts 
from the ProtA-Pfs2p strain. The presence of Ysh1p, Pfs2p and ProtA-Pfs2p was tested in 
protein extracts of wild type (WT) and ProtA-Pfs2p strains, and at different steps of the IgG 
purification procedure, as indicated on the top of the panel. (FT: flow-through; W1: first 
wash; IgG matrix: IgG matrix after elution). Specific antibodies were used to detect Ysh1p 
and Pfs2p. Proteins immunodetected are indicated on the right of the panel, and the molecular 
weight marker on the left (in kDa).  
(B) Protein composition of pure CPF revealed by protein gel stained with silver (adapted from 
Dichtl et al., 2002b). The molecular weight marker is indicated on the left (in kDa). 
(C) CPF obtained after IgG sepharose purification of ProtA-Pfs2p from protein extracts was 
analyzed by SDS-PAGE on a 10% gel and stained with silver. 5 µl of the flowthrough (FT), 
the first wash step (W) and the eluates (E1-E5) fractions were loaded on the gel. Arrows 
indicate CPF subunits and the asterisk (*) the TEV protease. The molecular weight marker is 
indicated on the left (M, in kDa). 
 
 However, at this step, CPF is not completely pure, as revealed by a silver 
staining analysis of the IgG eluates after SDS PAGE: figure 4.5C shows a pattern of 
bands similar to the one previously reported for CPF (Figure 4.5B; Dichtl et al., 
 -99- 
2002b; Gavin et al., 2002; Nedea et al., 2003), but additional bands that correspond to 
interacting protein contaminants were also present. These contaminants include the 
TEV protease used for the elution, CF IA (detected by Western blot, data not shown) 
and other proteins. Indeed, CPF and CF IA intimately interact with one another 
(Kyburz et al., 2003; Nedea et al., 2003; Ohnacker et al., 2000; Preker et al., 1995; 
Preker et al., 1997).  
 
 
Figure 4.6. Removal of the CPF interacting contaminants by anion-exchange 
chromatography on MonoQ column. 
(A) Elution profile of proteins (blue curve) obtained from a SMART MonoQ column to 
which CPF obtained after IgG sepharose purification was applied. Proteins were eluted with a 
linear KCl gradient (black line), as indicated on the left of the panel.  
(B) 5 µl of the fractions obtained after elution were separated by SDS-PAGE on a 10% gel 
and analyzed by silver staining. The number of the fractions, the KCl gradient and the 
molecular weight marker (M, in kDa) are indicated on top, below and on the left of the panel, 
respectively. For protein composition of CPF, see also figure 4.5B.  
(C) Immunobloting analysis of the polypeptides present in the CPF peak fraction number 27 
in comparison with a wild type (WT) protein extract. The subunits of CPF that were detected 
with specific antibodies are indicated on the left.  
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 In order to separate these contaminants and to concentrate CPF, eluates 
obtained from this first purification step were pooled and further purified by SMART 
MonoQ anion exchange chromatography (Figures 4.6 and 4.4). Elution of the bound 
material was carried out by applying a linear KCl gradient. Different types of 
gradients were tested, as for instance KCl step gradients to concentrate CPF 
complexes in only one single fraction. Although using such a step gradient resulted in 
the concentration of CPF in one fraction, we also observed that protein contaminants 
were not removed as expected but accumulated in the CPF sample (data not shown). 
Therefore, we used a linear KCl gradient of 50-500 mM and found that the CPF 
complex was released at approximately 320 mM (Figure 4.6A and B). The fractions 
obtained from the MonoQ column were analyzed by SDS PAGE followed by 
silverstaining, which revealed that all the bands corresponding to the polypeptides of 
CPF were found to coelute in the peak fractions 27 and 28 (Figure 4.6B). The 
presence of the known subunits of CPF was verified in the peak fraction 27 by 
Western blotting analysis using specific antibodies for each subunit, with the 
exception of Ref2p and Swd2p for which no antibodies were available (Figure 4.6C). 
In contrast, the TEV protease was separated from CPF and eluted in the early 
fractions of the KCl gradient. (Figure 4.6B, fractions 1-3). Furthermore, the 
application of a linear gradient of salt (Figure 4.6A) allowed the progressive removal 
of other protein contaminants that were eluted at lower concentrations of KCl than for 
CPF release (Figure 4.6B, fractions 1-23), yielding a highly pure protein complex. 
Thus, performing the purification in two steps allowed us to use detergent-containing 
buffers in the first step, and appropriate buffers for EM in the second step, without 
damaging the sample or lowering the purification yield.  
 
4.2.2 Mass spectrometry analysis of CPF 
 
Before analyzing the purified CPF complexes by EM, we confirmed their protein 
composition and 3’ end processing activities.  
 Several MS analyses conducted in our laboratory and by other groups in the 
past have identified the six novel proteins Ref2p, Pti1p, Swd2p, Glc7p, Ssu72p and 
Syc1p among the previously known CPF subunits Yhh1p/Cft1p, Ydh1/Cft2p, 
Ysh1p/Brr5p, Pta1p, Pap1p, Mpe1p, Pfs2p, Fip1p and Yth1p (Dichtl et al., 2002a; 
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Dichtl et al., 2002b; Gavin et al., 2002; Nedea et al., 2003). In our laboratory, Dichtl 
et al. (2002b) also identified Ref2p, Pti1p, Swd2p, Glc7p, Ssu72p, but in contrast to 
the other MS studies, they did not identify Syc1p (Gavin et al., 2002; Nedea et al., 
2003). Instead, they have found another protein of similar size named Cpf11p.  
 In order to identify the composition of the purified CPF, we analyzed proteins 
of the MonoQ peak fractions number 27 and 28 (Figure 4.6B) by peptide 
fingerprinting with MALDI-MS analysis and nanoelectrospray tandem mass 
spectrometry (Figure 4.7). We have identified all previously reported subunits of 
CPF, among which also Syc1p. Moreover, Cpf11p was not detected. This is in 
agreement with our observations described in this thesis in Chapter 3. Furthermore, 
no additional proteins were detected.  
 
 
 
 
 
 
 
 
 
 Figure 4.7. Polypeptide composition of 
 CPF analyzed by mass spectrometry.  
 Polypeptides present in the MonoQ peak 
 fraction were separated on a 10% SDS gel, 
 stained with colloidal blue and identified by 
 MALDI-TOF-MS or nanoelectrospray 
 tandem mass spectrometry. Protein names are 
 indicated on the right and the molecular 
 weight marker on the left (in kDa).  
 
 
4.2.3 Purified CPF is active in 3’ end cleavage and polyadenylation in vitro  
 
Once conditions for efficient purification and recovery of CPF were established, and 
before proceeding to EM analysis, the purified complex was tested for its ability to 
cleave and polyadenylate synthetic radioactively labeled pre-mRNAs. 3’ end 
processing activities can be reconstituted in vitro using protein extracts or purified 3’ 
end processing factors with a synthetic RNA substrate that was in vitro transcribed 
and radioactively labeled by incorporation of 32P α-UTP. For the cleavage assay, we 
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used the CYC1 precursor that corresponds to the 3’ untranslated region (3’ UTR) of 
the iso-1-cytochrome c gene, which contains all the cis-acting sequences elements 
required for proper 3’ end formation (Butler and Platt, 1988). For the in vitro 
polyadenylation assay, we used the pre-cleaved CYC1 (pre-CYC1) precursor that 
corresponds to the upstream cleavage product of CYC1. Site-specific in vitro cleavage 
requires the presence of CPF, CF IA and Nab4p, whereas specific polyadenylation is 
obtained when CPF, CF IA, Nab4p and Pab1p are present. The cleavage assay was 
performed with the peak and selected side fractions from the MonoQ purification of 
CPF in the presence of purified CF IA and recombinant Nab4p (Figure 4.8A and B). 
CF IA was purified on IgG sepharose using protein extracts prepared from a yeast 
strain expressing a ProtA-tagged version of the CF IA subunit RNA15p (see 
experimental procedures and figure 4.8C). Among all the fractions tested, only 
fractions 25-29 showed cleavage activity, as revealed by appearance of both 5’ and 3’ 
cleavage products in the presence of purified CF IA and recombinant Nab4p (Figure 
4.8A lanes 4-8). Cryptic cleavage products were also observed. Cryptic cleavage 
occurs due to the absence of Nab4p or when it is present at low concentrations 
(Minvielle-Sebastia et al., 1998). Thus, in the assay shown in figure 4.8A, Nab4p was 
not present in sufficient concentrations to suppress cryptic cleavage.  
 Next, the same fractions were tested for polyadenylation activity. As expected, 
in the absence of other factors, purified CPF displayed characteristic non-specific 
polyadenylation activity (Figure 4.8B lanes 5-8) (Ohnacker et al., 2000; Vo et al., 
2001). The length of the poly(A) tails generated by Pap1p in the complex was longer 
than in the wild type due to the absence of Pab1p in the reaction mixture. The same 
result was obtained for CPF purified only on IgG sepharose matrix. Only when CF 
IA, Nab4p and Pab1p were added, specific polyadenylation was obtained in fractions 
27 and 28 as compared with polyadenylation generated by wild type yeast extract 
(Figure 4.8B, lanes 12, 13 and 16). Shorter poly(A) tails were observed with the side 
fractions 26 and 29 (lanes 11 and 14) and fractions 24 and 25 did not display 
polyadenylation activity at all (lanes 9 and 10). Taken together, these results show 
that the peak in activity correlates very well with the peak in the protein elution 
profile presented in figure 4.6B. Hence, our purification procedure allows efficient 
isolation of fully active CPF that is suitable for further analysis by EM.  
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Figure 4.8. Purified CPF reconstitutes specific in vitro 3’ end processing activities.  
(A) In vitro cleavage was assayed on the CYC1 substrate with 30 µg of wild type protein 
extract (WT, lane 2), or 1 µl of CPF fractions 24-29 purified from ProtA-Pfs2p extracts, in the 
presence of 1 µl of purified CF IA and 10 ng of recombinant Nab4p, as indicated on the top. 
The input lane (1) represents the mock-treated reaction. The migration positions of CYC1, the 
5’ and 3’ cleavage products (CP) and the cryptic cleavage products are indicated on the right. 
The position and size of the marker bands are indicated on the left (in number of nt).  
(B) In vitro polyadenylation was assayed on the pre-CYC1 substrate with 2 µl of wild type 
protein extract (WT, lane 16), or 1 µl of CPF purified from ProtA-Pfs2p extracts, in the 
absence (lanes 3-8) or in the presence of 1 µl of purified CF IA, 10 ng of recombinant Nab4p 
and 100 ng of Pab1p (lanes 9-14), as indicated on the top. The eluate obtained from the IgG 
sepharose purification step was assayed alone (CPF IgG, lane 2). The input lane (1) represents 
the mock-treated reaction. The migration positions of pre-CYC1 and the polyadenylated 
products [poly(A)] are indicated on the right. The position and size of the marker bands are 
indicated on the left (in number of nt).  
(C) Native CF IA was purified essentially as described for CPF, but from protein extracts 
containing a ProtA-tagged version of the subunit Rna15p.  
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4.2.4 Principle of single-particle electron microscopy  
 
 The principle of single-particle EM is described in figure 4.9A. Several 
thousand molecular images are needed to calculate a 3D structure. Two-dimensional 
projection images of individual macromolecules are obtained by imaging the sample, 
which has previously been spread on a grid, in an electron microscope. Several 
thousands of individual images are extracted from the digitized micrographs and a 3D 
structure of the macromolecule is calculated by exploiting the random orientation of 
the particles. The microscope is almost an ideal projection device that provides many 
projection images of molecules that are randomly oriented on the EM grid. The high 
amount of noise present in electron micrographs of biological samples requires 
extensive computer aided image processing. After digitizing the negatives, 
computational image processing is used to improve the poor signal-to-noise ratio, to 
determine the angular relationship between the different randomly oriented 
molecules, and to calculate a 3D reconstruction (Figure 4.9B). To avoid averaging of 
images that represent different views, multivariate statistical analysis (Frank and van 
Heel, 1982) and classification is carried out and results in groups of images that are 
averaged into so called class averages or characteristic views (Harauz et al., 1987). 
The group members are supposed to be perfectly aligned and should all be 
representative of the same 2D projection image. The angular orientation of these 
“class averages” is then determined (Van Heel, 1987) and a 3D reconstruction is 
finally calculated. In several refinement steps reprojections from the calculated 3D 
model are computed and used for an iterative improvement of the alignment and 
projection angle parameters. After several refinement steps a stable 3D structure can 
finally be obtained.  
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Figure 4.9. Structure determination of single particles by angular reconstitution. 
(A) The electron microscope provides 2D projections of individual macromolecules that are 
randomly oriented on the EM grid. Many images are then extracted from the digitized 
micrographs and are processed with computer programs allowing an initial 3D model to be 
calculated. A backprojection step is used to finally refine the 3D structure.  
(B) Overview of image processing used to calculate a 3D model. Individual images that 
correspond to different views of the macromolecular complex (examplified by a duck) lying 
on the EM grid are extracted from the micrograph, are aligned and classified into groups in 
which they share similarities and represent the same 2D projection of the complex. Members 
of each group are then merged to give rise to class averages. The angular orientation of these 
class averages is determined to finally calculate the 3D reconstruction.  
 
4.2.5 Stabilization of CPF assembly for electron microscopy analysis  
 
4.2.5.1 CPF components dissociate in contact with EM grids 
 
The quality of the purified CPF sample was verified by loading the complex 
preparation on an EM grid and staining with heavy metals salts, such as uranyl acetate 
or uranyl formate, to enhance the contrast. We have observed by negative staining 
studies that CPF is unstable over time. We additionally found that freezing the 
complex for storage caused damage to it, thus considerably reducing the quality of the 
specimen for EM purposes. Consequently, the purified material was applied to EM 
grids immediately after the elution from the MonoQ column. A typical micrograph 
obtained from CPF negatively stained with uranyl acetate is presented in figure 4.10. 
The grid shows a homogeneous and monodisperse population of roughly spherical 
 -106- 
particles that look similar in size and shape. The CPF complex has a predicted mass 
of about 944 kDa, which corresponds to the sum of the masses of each individual 
subunit assuming a 1:1 stoichiometry for all components. As described in the 
literature, one megadalton (MDa) complexes have a size in the range of 20-25 nm. An 
example is the anaphase-promoting complex/cyclosome (APC/C), an ubiquitin ligase 
that has essential functions in mitosis, meiosis, and G1 phase of the cell cycle (Dube 
et al., 2005). This protein complex of at least 12 subunits has a mass of ~1.4 MDa, 
and shows particles with a size ranging from 20 nm to 25 nm (Dube et al., 2005; 
Passmore et al., 2005). Surprisingly, CPF particles in these preparations appeared to 
be smaller than expected and their size was not more than 10 nm (Figure 4.10). This 
suggested that the components of CPF disassembled on the grid. Indeed, large protein 
complexes can have a tendency to fall apart when adsorbed to EM grids, owing to the 
harsh treatment during staining with heavy metals. However, dissociation of the 
subunits could also indicate instability of the CPF complex. Therefore, we 
subsequently tested whether the subunits of CPF are stably associated within the 
complex. 
 
 
Figure 4.10. EM field of disassembled CPF complexes. 
Visualization of CPF by negative stain. The micrograph shows a population of particles with 
a maximun size of ~10 nm, most likely corresponding to parts of broken complexes. Arrows 
point to examples of single particles.  
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4.2.5.2 CPF subunits are stably associated within the complex 
 
We purified CPF under different conditions to test the stability of the interaction 
network of the components. CPF was purified over the two affinity chromatography 
steps described above, but was washed with buffers of increasing ionic strength (120, 
150, 300 and 400 mM KCl) during the first purification step on IgG sepharose matrix 
to verify whether some subunits are more loosely associated to the complex than 
others. Washing with buffers that contained up to 400 mM of KCl did not affect CPF 
stability since the patterns of bands obtained after SDS PAGE analysis of CPF eluates 
was not different than the one obtained under standard conditions (120 mM of KCl; 
Figure 4.11A). Moreover, purification of CPF in the presence of buffers with different 
pH (from pH 6.8 to pH 7.9) also did not affect CPF subunit composition, as revealed 
by protein gel analysis in figure 4.11B. These results indicate that the components of 
CPF were stably associated within the complex. Thus, the dissociation of the CPF 
subunits observed by EM is not due to the dissociation of ionic bonds between the 
components but is rather a consequence of the deposit on the EM grid.  
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Figure 4.11. CPF components are stably associated within the complex. 
(A) Fractions of CPF purified with buffers of increasing ionic strength were analyzed on 10% 
SDS-PAGE followed by silverstaining. 120 mM of KCl represents the standard conditions for 
CPF purification. The number of the CPF fractions eluted from the MonoQ column is 
indicated on the top, the KCl concentration used in washing buffers and the molecular weight 
markers (M, in kDa) on the left of the panels.   
(B) Purifications of CPF in the presence of buffers of different pH values. For each pH tested, 
subunit composition of CPF was analyzed on a 10% gel stained with silver. A buffer at pH 
7.9 represents the standard conditions. Fractions of CPF eluted from the MonoQ column are 
indicated on the top, pH conditions on the right and the molecular weight markers (M, in 
kDa) on the left of the panels. 
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4.2.5.3 Cross-linking with glutaraldehyde stabilizes CPF on EM grids 
 
In order to prevent the separation of the CPF subunits, we first tried to reinforce the 
stability of the CPF structure by incubating the complex with synthetic RNAs and the 
other 3’ end processing factors CF IA and Nab4p. We incubated different amounts of 
protein factors with CYC1 RNAs, but could not find conditions to get stabilized 
complexes (data not shown). Therefore, we chemically stabilized the interactions 
within the complex by cross-linking the components with glutaraldehyde. This 
technique involves the formation of covalent bonds between two interacting proteins 
by linking primary amines of amino acid residues. We tested different concentrations 
of glutaraldehyde on purified CPF to determine the optimal concentration. The 
reagent concentration should be sufficient to allow cross-link of all the CPF 
components but should not lead to the formation of aggregates. Purified CPF was 
incubated with different concentrations of glutaraldehyde for 15 min on ice and then 
loaded on an SDS gel to visualize the effect of glutaraldehyde treatment (Figure 
4.12A). The bands that correspond to the subunits of CPF progressively disappeared 
in the presence of increasing amounts of glutaraldehyde, and a slowly migrating band 
appeared in the upper part of the gel (compare lanes 2-6 with lane 1). The upper band 
corresponds to the cross-linked product and has a molecular mass that is too high to 
be resolved on the gel. Concentrations of 0.01% and 0.05% of glutaraldehyde were 
not sufficient to cross-link all the CPF components (lane 2 and 3). Traces of 
individual proteins were still visible with 0.1% of cross-linker but they disappeared 
with 0.2% (lanes 4 and 5). We therefore used 0.2% of glutaraldehyde to cross-link 
CPF for EM analysis and, as shown in figure 4.12B, a field of larger particles was 
now observed on the EM grids compared to the grids loaded with untreated CPF. 
Although some particles resemble others and seem to be similar in size, the 
micrograph rather shows a population that is not monodisperse due to the presence of 
incomplete cross-linked products and aggregates (Figure 4.12C). Such a field of 
heterogeneous molecules considerably complicated single-particle selection for image 
processing. We carefully extracted more than 1000 images of appropriate size from 
the micrographs obtained with cross-linked CPF, and tried to classify them into 
different groups of particles sharing similar features. But, owing to the high 
heterogeneity in size and shape of the sample, it was not possible to obtain class 
averages from the gallery of particles that was made. We therefore tried to further 
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improve the homogeneity of cross-linked CPF preparation, by adding a third step in 
the purification procedure of CPF.  
 
Figure 4.12. Glutaraldehyde cross-link stabilizes the interactions between CPF subunits. 
(A) Purified CPF (fraction number 26 eluted from the MonoQ, figure 4.6B) was incubated 
with different amount of glutaraldehyde as indicated on the top of the panel, and analyzed by 
SDS-PAGE on a 8% gel stained with silver. The molecular weight marker (M) is indicated on 
the left of the panel (in kDa). 
(B) Comparison of EM raw images of CPF not cross-linked (on the left) and CPF cross-
linked with 0.2% of glutaraldehyde (on the right).  
(C) Region of the micrograph that contains cross-linked CPF showing the presence of 
aggregates and incomplete cross-linked products among particles of similar size. 
 
4.2.5.4 Combining density and cross-linker gradients to obtain homogenous CPF 
 
In order to improve the homogeneity of cross-linked CPF populations, we added 
another step to the double affinity purification procedure of CPF. This final 
purification step consists of combining a glycerol gradient and a glutaraldehyde 
gradient in the same tube. This way, in one centrifugation step, CPF is subjected at 
 -111- 
the same time to a density and a fixation gradient. This method was called “GraFix” 
for gradient and fixation (Holger Stark, unpublished data). During centrifugation, the 
complex travels across the gradients and encounters an increasing amount of fixative 
reagent. Thus, there is a higher probability of stabilizing individual macromolecules 
instead of fixing aggregates. Moreover, performing both fixation and centrifugation at 
the same time helps to dissolve aggregates since complexes are exposed to slightly 
higher pressure during centrifugation. Thus, there is no need for fixation by 
glutaraldehyde after the final elution step, which can lead to various problems such as 
aggregation of protein complexes (Holger Stark, personal communication). CPF 
eluted from the MonoQ column was applied to a combined linear gradient of 10-30% 
glycerol and 0-0.15% glutaraldehyde. After centrifugation, the gradient was 
fractionated from the bottom of the tube into ~180 µl fractions with a peristaltic 
pump. Aliquots were immediately loaded on EM grids to look for the cleanest and 
most concentrated fraction, and were negatively stained by the double carbon-
sandwich method (see experimental procedures). The electron microscopic images of 
fractions obtained after GraFix revealed a homogenous, monodisperse population of 
complexes very similar in size (Figure 4.13). No aggregates and particles of small size 
were detected, indicating a high efficiency of this method in obtaining a homogenous 
population of cross-linked CPF.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.13. GraFix centrifugation improved the homogeneity of cross-linked CPF. 
Electron micrographs of negatively stained CPF cross-linked with glutaraldehyde without 
GraFix centrifugation (left panel), and with GraFix centrifugation showing a more 
monodisperse and more homogeneous population of particles (right panel, fraction 15 of 
figure 4.14).  
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 Fractions were also analyzed by gel electrophoresis followed by silverstaining 
to verify their protein composition. For this purpose, a gradient centrifugation without 
glutaraldehyde was run in order to enable the resolution of proteins on the gel and 
further activity tests. The absence of glutaraldehyde had no effect on the migration of 
the complexes during the centrifugation and very pure CPF was obtained since all the 
known polypeptides of CPF were detected without any contaminant (Figure 4.14). 
The presence of the subunits for which the bands were not visible because they stain 
poorly with silver (Yth1p; Preker et al., 1997) or because the signal was too weak 
(Pti1p, Glc7p, Ssu72p and Syc1p), was verified by Western blotting (data not shown). 
Hence, GraFix centrifugation as final purification step greatly improved the quality of 
purified CPF for EM analysis.   
 
 
 
 
 
 
 
 
 
 
 
Figure 4.14. GraFix centrifugation yielded highly pure CPF. 
Fractions obtained after fractionation of the GraFix gradient were separated by SDS-PAGE 
on a 10% gel and analyzed by silverstaining. The gel revealed a pattern of bands that is 
characteristic for the subunit composition of CPF. The numbers of the tested fractions are 
indicated on the top of the panel, and the molecular weight marker on the left (M, in kDa).  
 
 
4.2.6 CPF purified after GraFix displays pre-mRNA 3’ end processing activities 
 
In order to verify that CPF purified via the GraFix procedure was still functional, we 
tested the complex for its ability to direct in vitro cleavage and polyadenylation of 
synthetic pre-mRNAs in a reconstituted system with purified 3’ end processing 
factors. For this, we used the control fractions without glutaraldehyde, as cross-
linking of CPF results in inactivation of its enzymatic activities (data not shown). We 
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first monitored cleavage of the CYC1 pre-mRNA with purified CF IA and 
recombinant Nab4p (Figure 4.15A). CPF fractions alone were inactive to cleave the 
pre-mRNA precursor, in contrast to the wild type extract (compare lanes 3-12 with 
lane 2). However, the cleavage reaction was reconstituted when CPF was combined 
with purified CF IA and recombinant Nab4p, as shown by the appearance of both 5’ 
and 3’ cleavage products (lanes 13-22). Cleavage activity was present in several 
fractions (lanes 13-22) with a peak activity at fraction 17 for which most of the 
precursor was processed (lane 17).  
 In addition to cleavage, polyadenylation on the pre-CYC1 precursor was also 
reconstituted in the presence of purified CF IA, recombinant Nab4p and Pab1p 
(Figure 4.15B). As already described, CPF displays non-regulated polyadenylation 
activity in the absence of the other 3’ end processing factors (lanes 3-12) (Ohnacker et 
al., 2000; Vo et al., 2001). The addition of the other 3’ end processing factors to CPF 
restored specific polyadenylation as shown by the size of the poly(A) tails generated, 
comparable to those obtained with wild type extract (compare lanes 16-19 to lane 2). 
Thus, CPF preparation after the three purification steps is fully competent for pre-
mRNA 3’ end processing.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 -114- 
 
 
 
Figure 4.15. CPF purified via the GraFix procedure specifically cleaves and 
polyadenylates synthetic RNA substrates in vitro. 
(A) 3 µl of the fractions obtained from GraFix centrifugation were tested for reconstitution of 
specific in vitro cleavage activity on the CYC1 RNA precursor, in the presence (lanes 13-22) 
or in the absence (lanes 3-12) of 1 µl of purified CF IA and 80 ng of recombinant Nab4p. 3 µl 
of wild type protein extract (30 µg of proteins) were tested in parallel as positive control (lane 
2). The input represents the mock-treated sample. The positions of the RNA substrate (CYC1) 
and of the 5’ and 3’ cleavage products (5’ and 3’ CP) are indicated on the right. The 
molecular weight marker is indicated on the left (M, in nt).  
(B) 3 µl of the fractions obtained from GraFix centrifugation were also tested for 
reconstitution of specific in vitro polyadenylation activity on the pre-CYC1 RNA precursor, 
in the presence (lanes 13-21) or in the absence (lanes 4-12) of 1 µl of purified CF IA, 80 ng of 
recombinant Nab4p and 100 ng of Pab1p. 3 µl of wild type protein extract were tested in 
parallel as positive control (lane 2). The input represents the mock-treated sample. The 
positions of the RNA substrate (Pre-CYC1) and of the polyadenylated product [poly(A)] are 
indicated on the right. The molecular weight marker is indicated on the left (M, in nt). 
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4.2.7 Molecular mass measurement of CPF by scanning transmission electron 
microscopy (STEM) 
 
In scanning transmission electron microscope (STEM) the electron beam is focused to 
a spot a few Angstroms in diameter and raster scanned over the sample (Muller and 
Engel, 2001). The electrons pass through the sample and are collected by a series of 
detectors. Those scattered without loss of energy, elastic scattering, diverge at large 
angles and are collected by an annular dark-field detector capable of single electron 
counting. Each pixel of the resulting digital image is, therefore, a quantitative 
measurement from which in a calibrated image the mass of the protein particle 
imaged can be calculated. STEM provides “quantitative microscopy”, since the digital 
STEM image not only provides just a picture, but also data that are used in mass 
analysis. This ability to provide simultaneously both images and quantitative data is 
of great value for the investigation of protein structures. One of its most successful 
applications is the mass determination of individual molecules or assemblies of 
molecules from a range of 100 kDa to several MDa. The importance of the STEM for 
mass determination resides in its ability to analyze biological structures regardless of 
their shape and at the same time to provide an image from which the quality and 
homogeneity of the specimen may be independently assessed. Today, only two 
STEMs are routinely used in biological research, one at the Maurice E. Müller 
Institute at the Biozentrum of Basel, Switzerland and the other one at the Brookhaven 
National Laboratory, Upton, USA.  
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Table 4.1. Summary of the STEM mass analyses of CPF. 
The table presents the conditions of each experiment (no fixation: CPF not cross-linked; glut., 
in test tube: glutaraldehyde fixation of CPF directly after MonoQ elution; glut., gradient: 
glutaraldehyde fixation of CPF by GraFix), the grid treatment, the masses obtained (in kDa; 
the main peak is in bold when several peaks are yielded), the number of particles 
corresponding to each single peak (npeak) and the total number of particles used in every 
experiment (total n). 
 
 
 To obtain accurate molecular mass values for CPF, we analyzed by STEM 
preparations of glycerol-free, freeze-dried and air-dried unstained CPF isolated by 
GraFix, and freeze-dried CPF cross-linked with glutaraldehyde directly after the 
elution from the MonoQ column (Figure 4.16). Table 4.1 shows a summary of seven 
independent STEM mass analyses of CPF. The non cross-linked CPF had a mass of 
453 kDa (Table 4.1 experiment 1), a value that was lower than the expected mass 
(∼940 kDa by adding up the sizes of all subunits). We have observed that uncross-
linked CPF is not stable on EM grids (Figure 4.10), thus this mass likely corresponds 
to stable CPF sub complexes. Different analysis of CPF cross-linked directly after 
elution from the MonoQ column gave concordant results with a main peak around 
973 kDa as the average value of the main peaks obtained in experiments 2, 4 and 5. 
Experiment 3 was not taken into account due to the large difference obtained in 
comparison to the other experiments. A typical dark field image of the representative 
experiment 5 is shown in figure 4.16A together with the mass histogram that 
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represents the final evaluation. The digital image shows a population of particles that 
is not homogenous in size and in shape, due to the presence of aggregates and non-
complete cross-linked products. Particles of similar size were however carefully 
selected for mass measurement. The histogram shows a major peak at 976 ± 206 kDa 
among minor peaks (around 500, 750 and 1400 kDa). The presence of multiple peaks 
and the large standard deviation of the measurement reflect protein heterogeneity 
observed in the sample. With cleaner CPF obtained after gradient centrifugation, the 
population of particles observed was now homogenous and monodisperse, although 
more diluted due to the gradient fractionation (Figure 4.16B and C). No small 
particles or aggregates that disturb the measurement were present in the samples and 
both freeze-dried and air-dried unstained CPF gave similar results. A total of 360 
particles from the air-dried grids yielded a single peak at 956 ± 126 kDa (Table 4.1 
and figure 4.16B). Additionally, 373 particles from the freeze-dried grids also yielded 
a unique peak centered at 1006 ± 119 kDa (Table 4.1 and figure 4.16C). The 
measured mass for the particles on the air-dried grids is slightly lower, but the 
difference is within the standard deviation of the measurements and in the range of 
the variations observed in the earlier experiments. Nevertheless, although unlikely, 
the loss of weakly cross-linked components upon air-drying cannot be entirely ruled 
out. Interestingly, the agreement between these data and the previous experiments is 
very good, since merging the results of experiments 6 and 7 gives a single peak at 982 
± 126 kDa (Figure 4.16D), whereas merging the results of experiments 2, 4 and 5 
gives a major peak at 976 kDa (see above). These data indicate that the functional 
CPF has a size close to one megadalton, consistent with the predicted mass obtained 
by the sum of the masses of the individual subunit. This suggests a one to one relative 
stoichiometry of subunits within the complex.  
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Figure 4.16. STEM mass 
measurement of cross-
linked CPF complexes. 
(A) Image of unstained 
freeze-dried CPF not purified 
by GraFix (left panel) and the 
corresponding histogram 
showing the mass distribution 
obtained from 319 CPF 
selected particles (right 
panel). The Gaussian curve 
indicates one main peak at 
976 ± 206 kDa.  
(B) Image of unstained air-
dried CPF purified by GraFix 
(left panel) and the 
corresponding histogram 
showing the mass distribution 
obtained from 360 CPF 
selected particles (right 
panel). The Gaussian curve 
indicates one unique peak at 
956 ± 126 kDa.  
(C) Image of unstained 
freeze-dried CPF purified by 
GraFix (left panel) and the 
corresponding histogram 
showing the mass distribution 
obtained from 373 CPF 
selected particles (right 
panel). The Gaussian curve 
indicates one unique peak at 
1006 ± 119 kDa.  
(D) Histogram of the final 
mass evaluation of CPF 
obtained by merging the 
results of (B) and (C). After 
correction for beam-induced 
mass-loss, a unique peak with 
a mass of 982 ± 126 kDa was 
obtained.  
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4.2.8 Single-particle electron microscopy analysis of negatively stained CPF  
 
4.2.8.1 Three-dimensional structure of CPF determined by angular 
reconstitution and random conical tilt 
 
To obtain insights into the 3D structure of CPF, we have analyzed CPF fractions 
purified by the previously described three-step method by negative stain EM. EM 
grids were prepared by the double carbon foil sandwich technique (Golas et al., 2003) 
and were stained with uranyl formate, revealing particles with a maximum diameter 
of approximately 20 nm (Figure 4.17A). The particles appeared to be similar in size, 
confirming that intact CPF complexes were isolated, whereas the shape of the 
particles was rather heterogeneous, suggesting an intricate overall structure of CPF.   
 To determine an initial 3D structure of CPF, we used angular reconstitution 
(Van Heel, 1987) and RCT (Radermacher et al., 1987). In EM preparations, 
macromolecules can adopt many stable positions on the grid depending on their 
shape. The basic goal for solving the 3D reconstruction is to obtain many views of the 
object in different orientations and then to determine the relative positions and 
angular orientations of the different projections of the object. Angular reconstitution 
is a zero-tilt reconstruction method that exploits the random orientations of the 
molecules on the EM grids (Van Heel, 1987). This approach is based on finding one 
common line projection between 2D projection images of the same 3D structure 
(central section theorem). In addition, noise reduction by MSA, classification and 
averaging of the raw EM projections, which is used to obtain characteristic views of a 
molecule, is an integral part of this approach. Indeed, raw electron microscopic 
images of individual particles are usually very noisy and sometimes molecules are 
hardly visible. Therefore, averaging procedures are required to improve the signal-to-
noise ratio. First, 2D projection images of randomly oriented individual particles are 
aligned to provide an inventory of the different views present on the micrographs. 
Images that resemble each other are aligned together with the help of correlation 
procedures. Multivariate statistical classification procedures are then used to identify 
similar images and to sort them into groups in which all the members share 
similarities and are representative of the same 2D projection image. Then, all the 
images of a same group are averaged together, thereby increasing the signal-to-noise 
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ratio. Finally, the relative angular orientations of the class averages obtained are 
calculated and from these data a 3D reconstruction can be determined.  
 In the random conical tilt method, the different views are obtained by 
recording tilted image pairs of the specimen, providing the relative angle information 
needed to combine the views in three dimensions. The specimen is therefore imaged 
twice, first at a high tilt angle and then untilted. Tilting methods require more 
experimental effort, but provide the handedness of the structure. In contrast, angular 
reconstitution methods are simpler experimentally, but require more computational 
work. Finally, once a first 3D map is available from either approach, the structure is 
refined by projection matching, which means that reprojections computed from the 
3D structure are used iteratively at an increasingly smaller angular grid to improve the 
alignment and orientation parameter.  
 
Figure 4.17. Electron microscopy of CPF.  
(A) Electron micrograph of negatively stained CPF. Particles were sandwiched between two 
carbon films in 2% uranyl formate. The EM field shows a monodisperse population of 
particles with a size of ~20 nm.  
(B) Gallery of class averages of CPF obtained by alignment, multivariate statistical analysis 
and classification of single particles. 
 
 
 About 6000 molecular images of randomly oriented CPF particles from 
digitized micrographs were collected and furthermore subjected to image processing 
procedures described above to generate an initial 3D model. A total of 400 class 
averages, each consisting of 10 to 20 class members, were used to compute the initial 
3D structure of the CPF complex. A gallery displaying some of these class averages 
of CPF is presented in figure 4.17B. These images show some interesting 
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characteristic views, like the slightly elongated shape of CPF, and also the presence of 
negative stain in the central part of the structure, suggesting the presence of at least 
one cavity or deep groove in the complex. Figure 4.18 displays another gallery of 
additional ten class averages (upper panel) that are depicted together with their 
corresponding reprojections (lower panel), showing excellent agreement at all 
projection angles. Moreover, consistent with the gallery presented in figure 4.17B, the 
same fine structural details were observed. The class average 1 seems to show a 
depression from the outside to the center of the structure, which could correspond to a 
large groove at the surface of the structure. Other prominent structural features are 
revealed by the presence of negative stains in the central part of the structure, as 
shown by projection views 2, 4 and 5 of figure 4.18: the negative stains in 2 and 4 are 
quite large and may indicate the presence of a central cavity in the complex. In some 
projections more than one negative stain dots are observed on one face of the 
structure (class 5). This is consistent with the potential presence of a central cavity, 
but it could also suggest the presence of several smaller cavities or grooves in which 
metal ions accumulated. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.18. Gallery of class averages of CPF and their corresponding reprojections.  
The class averages (two rows on top) determined from the 2D projections images used to 
calculate the 3D structure of CPF and the corresponding reprojections (two rows below) show 
very good agreement, demonstrating the validity of the 3D structure. Negative stain spots in 
the center of the structure are indicated by arrows.   
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4.2.8.2 General architecture of CPF 
 
The method described above allowed us to determine the 3D structure of CPF to a 
resolution close to 25 Å (Figure 4.19). As the shape of CPF is rather asymmetric, 
complexes can adopt many possible orientations on the EM grid, consistent with the 
relative heterogeneity in shape observed on the micrographs. The stereo view shown 
in figure 4.19 is referred to the front view and describes the most prominent structural 
features of the complex. The inner contour (white and opaque) well represents the 
inner surface of the molecules. A gallery of different CPF views that explore the 
structure is depicted in figure 4.20. The general architecture of CPF revealed a quite 
elongated, globular appearance with an outer protein wall that surrounds a strikingly 
large central cavity, and shows several openings of different sizes (Figures 4.19 and 
4.20). Thus, the overall assembly appears quite fragile. Interestingly, the presence of 
the central cavity is entirely consistent with the interpretation of the class averages 
that have shown negative stain in the central region of the molecule (Figures 4.17B 
and 4.18).  
 
 
Figure 4.19. Three-dimensional model of native CPF at a resolution of ~25 Å obtained 
by single particle EM. 
Front view of the CPF reconstruction showing the most prominent features (head, central 
cavity, wall 1 and 2, protuberance) of the structure. The maximun dimension of the complex 
is ~20 nm as indicated on the right.  
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 The protein wall can be divided in two major parts that roughly look like two 
overlapping “half-shells” separated by the inner cavity (Figures 4.19, black dotted 
lines, and figure 4.20) and connected by thin density elements located around the 
cavity. One moiety is constituted by the bottom part of the particle that is a compact 
density element with a channel appearing on one side (Figure 4.20, bottom and lateral 
2 views), and is extended upward by a roughly annular-like structure (Figure 4.20, 
side 2 view) from which emerges a thick protuberance denoted “bulk” (Figure 4.20, 
back view). The other main part of the protein wall is a massive claw-like structural 
element that includes the top region covering the structure (Figure 4.20, top view) and 
which is best seen from the side 1 view (Figure 4.20). In addition, the upper region of 
CPF contains two protruding elements, one big head-like element that we called 
“head” (Figure 4.19) and a smaller protuberance on the other side of the structure 
(both can be seen on the side 1 view of the figure 4.20) denoted “protuberance”. 
Furthermore, the front view and the lateral 1 view revealed the presence of two deep 
grooves, that could accommodate single-stranded pre-mRNA (Figure 4.21B and C), 
although this speculation is not supported by any data. The diameter of these grooves 
can be estimated at 20-40 Å, which would be sufficient to accommodate a single 
stranded RNA molecule (about 8-12 Å wide, depending on the nucleotides). The blue 
and white lines on figures 4.21B and C represent two examples for putative paths for 
pre-mRNA, assuming that the grooves are large enough to accommodate RNA 
molecules (see also discussion). Beginning from the upper left (Figure 4.20, front 
view), a long and rather straight groove is surrounded by the upper part of the wall 1, 
and the head on the other side (Figure 4.20, lateral 1 view), and continues on the 
surface of the molecule toward the lower right (Figure 4.20, front view). Branching 
off from this long groove toward the upper right is a narrow, smaller and curved 
groove that is capped by the top region of the molecule (figure 4.20, front and side 1 
views). Furthermore, this smaller groove is nearly completely surrounded by a clamp-
like structure located on the left of the protuberance in the top region of wall 1 (Figure 
4.20, side 1 view).  
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Figure 4.20. Gallery of views of the 3D CPF complex reconstruction.  
Surface views of CPF showing the main structural features of the complex: the central cavity 
surrounded by the two moieties of the protein wall (wall 1 and 2), the head, the protuberance, 
the bulk, the grooves and channels. The side 1, back and side 2 views are obtained by tilting 
the front view stepwise along the vertical axis by 90° (first row). The top view was obtained 
by tilting the side 1 view along the horizontal axis by 90°. The lateral (lateral 1 and 2) views 
were obtained by tilting the top view along the vertical axis by 120° (second row), whereas 
tilting the lateral 2 view along the vertical axis gave the bottom view. The maximum size of 
the particle is indicated on the right.  
 
 
 The presence of several openings and holes in the wall structure provides 
contacts with the exterior to the central cavity. At least five large openings are visible, 
two from the front view, one from the side 1 view separating the wall moieties, the 
biggest one from the back view, and a fifth one in the annular-like structure from the 
side 2 view (Figure 4.20). Interestingly, they seem large enough to fit an RNA 
molecule, as they are few nanometers wide. In addition, two channels of smaller size 
are also present. One is easily visible by turning the molecule to the lateral 2 view, 
which shows a ring-like element at the bottom extremity (Figure 4.20, lateral 2 view). 
The ring-like structure is extended toward the left by a mass density that encloses a 
depression (Figure 4.21A). The entry of the depression is formed by a cleft that 
progressively narrows, ending with another channel of about the same size, which we 
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called “engulfed channel” due to its deeper location (Figure 4.21A). All of these 
openings represent possible paths for the pre-mRNA and suggest that the inner cavity 
could be the site of one or both enzymatic 3’ end processing reactions. Although 
speculative at this stage, this hypothesis is supported by the finding that many inner 
cavities described in other macromolecular machines are the site of enzymatic 
reactions, e.g. the exosome (Lorentzen and Conti, 2006), the 26S proteasome (Groll et 
al., 1997; Lowe et al., 1995) and chaperone complexes such as GroEL and TRIC 
(Bukau and Horwich, 1998; Leroux and Hartl, 2000; Martin and Hartl, 1997). 
Furthermore, the inner cavity is completely free of any density element, thus 
providing enough space for the pre-mRNA to be correctly accommodated.  
 
Figure 4.21. Grooves and channels at the surface of CPF are putative paths for pre-
mRNA substrates. 
(A) View of CPF showing two channels that may accommodate RNA molecules or perhaps 
nucleotides.  
(B) and (C) Front and lateral 1 views showing the presence of two branching grooves at the 
surface of the complex. The blue and white lines represent potential path for the pre-mRNA 
in the larger groove and in the narrower groove, respectively.  
 
 
 In conclusion, the negative staining studies performed in this work have 
yielded a low-resolution 3D reconstitution of CPF. This gross 3D model is 
nevertheless sufficient to describe the most prominent features of the 3’ end 
processing complex. On the other hand, a higher resolution 3D structure would allow 
us to do subunit localization and atomic structure fitting in order to understand the 
structural organization of the complex. As a first goal, localizing the Ysh1p and 
Pap1p enzymes that catalyze 3’ end processing activities into the 3D structure would 
allow us to understand how CPF and the RNA substrate associate to form an active 
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complex. Furthermore, the interpretation of the CPF structure can be used together 
with biochemical data to better understand the molecular mechanism of the complex 
in the context of pre-mRNA 3’ end processing. 
 
4.3 Discussion 
 
CPF is the main protein factor of the 3’ end processing machinery in yeast and 
catalyzes the essential cleavage and polyadenylation of pre-mRNAs. As major part of 
this machinery, CPF has a key role in 3’ end formation. Indeed, it contains both 
enzymes that catalyze the 3’ end processing reactions, the site-specific endonuclease 
Ysh1p (Mandel et al., 2006) and the poly(A) polymerase Pap1p (Lingner et al., 
1991a; Lingner et al., 1991b; Preker et al., 1997). Therefore, obtaining insight into the 
structure of CPF is crucial to decipher the molecular mechanism. So far, the crystal 
structures of Pap1p and Ydh1p, two of the fifteen subunits of CPF, were the only 
structural informations on the complex available for the scientific community (Bard et 
al., 2000; Mandel et al., 2006). Here, we have purified native, functional CPF by 
using a two-step affinity purification method followed by a combined density and 
fixation gradient centrifugation and have analyzed the structure of this complex by 
single-particle EM. Using STEM experiments we have calculated an overall size of 
almost one megadalton for the CPF complex. Furthermore, we report for the first time 
the 3D structure of CPF at a resolution of ~25 Å, which we obtained by angular 
reconstitution and random conical tilt analysis of negatively stained preparations of 
CPF (Figure 4.19).  
 
Using electron microscopy to solve the 3D structure of CPF 
 
Low-abundance, multisubunit complexes like CPF are difficult to study by traditional 
structural and analytical techniques such as X-ray crystallography and nuclear 
magnetic resonance (NMR). Despite both techniques can provide atomic model, they 
are limited to tackle very large multiprotein complexes close to or greater than one 
megadalton. In contrast, EM offers advantages for determining the structures of large 
biological machines. Indeed, specimen can be analyzed in many forms and shapes, 
i.e., two- or three-dimensional crystals, and single-particles with or without 
symmetry. Furthermore, protein assemblies can undergo conformational changes to 
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carry out a specific function (Alberts, 1998; Alberts and Miake-Lye, 1992). Thus, 
native structures of proteins can be different from those in the crystallized form. In 
such cases, EM studies can provide structures of multiprotein complexes in their 
native conformations or interacting states that are relevant to their cellular functions. 
In addition, sample preparation for EM is quick and simple compared to NMR or 
crystallography, which require higher amounts of material than those required for EM 
by a factor of at least 100 (usually 0,1 to 1 ng of protein is sufficient for EM). Finally, 
large protein complexes are often unstable during purification and crystal growth. At 
present, a number of protein complexes have been preferentially studied by EM 
because of these reasons: recent examples are the anaphase-promoting 
complex/cyclosome (Dube et al., 2005; Passmore et al., 2005), the spliceosomal 
components (Sander et al., 2006; Stark and Luhrmann, 2006), or the yeast RNA 
polymerase III (Fernandez-Tornero et al., 2007).  
 So far, no high-resolution structure is available for any of the multiprotein 
factors involved in pre-mRNA 3’ end processing, although crystal structures of 4 
individual components out of the 21 known have been obtained: until today structures 
were published for Pap1p (Bard et al., 2000), Pcf11p (Meinhart and Cramer, 2004), 
Ydh1p (Mandel et al., 2006) and Clp1p (Noble et al., 2007). Hence, this work 
contributes to the knowledge of structure and mechanism of the pre-mRNA 3’ end 
processing machinery.  
 
Purification of native CPF and preparation for EM 
 
One crucial step in investigating structures of protein complexes is sample 
purification. The quality and resolution of the final 3D reconstruction strongly 
depends on the purification procedure. Here, we have used an affinity purification 
method followed by a density gradient centrifugation to isolate native CPF by tagging 
the Pfs2p subunit with a ProtA tag. As for most macromolecular complexes, 
purification conditions are critical for CPF recovery and require the presence of 
glycerol and NP-40. In the absence of glycerol, protein complexes may dissociate or 
aggregate. We have extensively searched for buffer conditions that allow the isolation 
of highly pure, concentrated and functional CPF. Although the absence of glycerol 
did not dramatically reduce the purification efficiency in terms of protein amounts, 
purifying the complex in the absence of NP-40 strongly reduced the rate of protein 
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recovery after the first affinity chromatography step over IgG matrix. Although EM of 
CPF molecules in the presence of low concentrations of glycerol (below 10%) was 
feasible, preparations of CPF in the presence of NP-40 (negative stain artefacts) 
resulted in severe loss of contrast, as it was already shown for other proteins. 
Interestingly, in our purification procedure, both glycerol and NP-40 could be 
included in the buffers during the first affinity chromatography step, since they could 
later be removed in the subsequent purification steps without affecting the efficient 
isolation of CPF.  
 Most purified multiprotein complexes are damaged when they are frozen for 
storage over long periods, hence reducing the quality of the sample for EM studies. 
Likewise, the sample for EM analysis should be prepared as quickly as possible after 
the final elution in order to prevent degradation inherent to stability problems that can 
affect most of the protein assemblies. Therefore, after purification of CPF, the 
material was immediately loaded on EM grids for single-particle EM studies. In spite 
of the high stability of protein interactions within CPF, first observations of EM grids 
revealed dissociation of the components of the complex. To counteract this problem, 
we first tried to reinforce the stability of the CPF structure by incubating the complex 
with synthetic RNAs and the other 3’ end processing factors CF IA and Nab4p (data 
not shown). The assumption was that the whole pre-mRNA 3’ end processing 
machinery, thus generated by the assembling of all the factors involved in the process, 
would be more stable as functional machinery. However, incubating CPF with the 
CYC1 substrate, which we used for in vitro cleavage assays and which contains all the 
cis-acting elements required for 3’ end formation, did not overcome the problem (data 
not shown). When Nab4p and CF IA were added to the CPF sample, the particles on 
EM grids did not increase in size, possibly because the added factors and the CYC1 
RNA were unable to stabilize the whole machinery. We therefore artificially 
stabilized the CPF structure by cross-linking the subunits with glutaraldehyde, which 
is a widely used method to avoid disassembling of molecular complexes.  
 
The CPF complex has a mass of almost one megaDalton  
 
The size of the functional CPF complex has not been investigated so far. To 
determine the overall mass of the complex, we performed STEM mass analysis, 
which revealed the intact CPF complex to have a global mass of 982 ± 126 kDa 
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(Figure 4.16D). This value is in good agreement with the predicted mass calculated by 
the sum of the masses of all individual components of ∼940 kDa. This suggests that 
each subunit is present only once per complex. Inspection of the band pattern of CPF 
subunits on an SDS gel stained with silver also suggest a 1:1 stoichiometry. However, 
we cannot exclude that few components are not present in stoichiometric amounts. 
The mass difference observed between the mass calculated by STEM and the 
predicted mass could also be imputed to the glutaraldehyde fixation treatment of CPF. 
Indeed, such a cross-link adds the mass of aldehyde groups reacting with accessible 
arginine and lysine residues of the complex. The extent of the addition of mass due to 
glutaraldehyde cross-link is highly variable and depends on the specimen that is 
studied: as examples, no mass increase was observed for the tobacco mosaic virus 
(TMV), but 19% mass increase was measured for the fd phage (Muller et al., 1992). 
The size of CPF calculated by STEM also correlates well with gelfiltration data 
obtained with yeast protein extracts. When wild type protein extract was subjected to 
size exclusion chromatography on a calibrated Superose 6 column (Pharmacia), 
Western blotting analysis showed that CPF eluted over several fractions with a peak 
corresponding to a molecular weight of roughly one megaDalton (data not shown).  
 
Structure of the CPF complex: where is the site of pre-mRNA 3’ end processing 
reactions? 
 
We present in this work an initial 3D reconstruction of CPF at a resolution of 25 Å 
determined by single-particle EM and the location of some of its major structural 
elements. It is the first example of a 3D structure obtained for a multiprotein complex 
involved in pre-mRNA 3’ end processing. Negative staining EM of CPF preparations 
has revealed an overall shape rather globular and slightly elongated with a maximum 
diameter of ~ 20 nm (Figure 4.19).  
 The most prominent structural feature of CPF is the presence of a strikingly 
large central cavity defined by a surrounding protein wall. This characteristic element 
of the structure was already suggested by the observation of negative stain in the 
center of some class average images (Figures 4.17B and 4.18). The inner cage is 
connected to the outside of the structure by several openings and channels of various 
sizes in the protein wall (Figures 4.19 and 4.20). Hence, the whole assembly seems 
fragile with no core or body density that would confer hardiness to the structure, 
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probably explaining why the complex disassembles on EM grids. Five wide holes and 
two channels with roughly the same diameter are revealed by the structure. However, 
the number of openings may vary with a higher resolution model, which could also 
reveal additional structural features. It is nevertheless remarkable to find such a large 
space inside a multiprotein assembly and so many possibilities for the inner cavity to 
communicate with the exterior of the structure. Although the function of this cavity is 
not known, its relative importance in terms of size and location in the structure tempts 
us to speculate that it may be the site where 3’ end processing reactions take place. 
Other multiprotein complexes, such as the 26S proteasome, chaperone complexes and 
the exosome use similar cage mechanisms. The proteolytic active site of the 26S 
proteasome, which degrades proteins, is enclosed in a cylindrical arrangement of 
subunits (Groll et al., 1997; Lowe et al., 1995), an architecture that is similar to the 
barrel-like conformation of the exosome, which degrades mRNAs (Lorentzen and 
Conti, 2006). In addition, chaperonins such as GroEL and CCT are also known to use 
inner cavities to fold the polypeptides they contain (Leroux and Hartl, 2000; Martin 
and Hartl, 1997). Likewise, the cavity within CPF, assuming it is spacious enough, 
could represent a reaction chamber in which pre-mRNAs would be cleaved and 
polyadenylated by the complex. Because polyadenylation occurs immediately after 
cleavage of the RNA substrate, both enzymes would be predicted to be close to one 
another within the structure. The inner cavity thus could provide an excellent 
configuration to bring together both enzymes and RNA that have a direct role in the 
reactions. Other subunits could regulate access to the cavity by interacting with 
protein factors required for accurate 3’ end formation, such as Nab4p and CF IA. 
How the pre-mRNA enters the cavity to undergo cleavage would have to be 
determined. A traditional view of cleavage by CPF represents the complex sitting on 
the linear single-stranded RNA. However, supposing that CPF uses a cage 
mechanism, this conception would appear too simple. It could be necessary for the 
RNA substrate to fold somehow, in order for the cleavage site to reach the inner 
cavity. Furthermore, it is not clear at present whether the openings in the protein wall 
of the structure would be wide enough to accommodate a folded RNA. This question 
could be however addressed with a higher resolution model.  
 Another possibility would be that the cleavage reaction occurs at the surface 
of CPF, and that the upstream cleavage product enters the cavity by a hole to undergo 
polyadenylation. In accordance with this scenario, the two large grooves at the surface 
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of CPF might serve as rails to place the RNA in the appropriate position (Figure 
4.21B and C). As for the openings, it is difficult to calculate the size of these grooves 
at the present low resolution of the structure. However, grooves seem to be wide 
enough to accommodate a single-stranded RNA molecule. It has been shown that 
many other protein machineries utilize grooves to accommodate RNAs. Examples are 
RNA polymerases in general, such as the E. coli RNA polI (Ollis et al., 1985) and the 
yeast RNAP II (Darst et al., 1991). Thus, the cleaved RNA could then reach the inner 
cavity by passing through one of the holes that are localized on the bottom of the 
grooves. A role for the channels (Figure 4.21A) in RNA binding could also be 
possible if they are wide enough to accommodate it. However, they are relatively 
narrow in comparison to the other openings, and so another possibility is that they 
could serve as a passage for small molecules such as substrate nucleotides like ATP.  
 Another potential involvement of the holes could be in the accommodation of 
other proteins. CPF intimately interacts with CF IA to cooperatively process pre-
mRNAs at their 3’ end. On the other hand, several CPF subunits associate with the 
CTD to couple 3’ end formation and transcription. It is thus possible that some 
protein-protein interactions are mediated by the holes to stabilize association.  
 At the present, these hypotheses are highly speculative and many other 
scenarios are conceivable. In the next studies it will be important to determine the 
position of the different subunits within the CPF complex to better understand its 
mechanism of action. One would also have to measure precisely the diameter of the 
openings and of the grooves, which is difficult at the present low resolution of our 
model, to verify whether they can accommodate RNA molecules. Together with 
subunit localization, it should be then possible to understand how the pre-mRNA 
contacts CPF.  
 
Protein localization and atomic structure fitting 
 
The purpose of studying an entire protein complex is to understand the relationship 
between its parts as this affects the function of the complex. So far, none of the 
domains of our CPF structure can be assigned to known components of CPF. Further 
interpretation of CPF function and mechanism requires higher resolution structures 
and subunit localization. In the present work, a resolution of ~25 Å was obtained, but 
this resolution will most likely be improved by ongoing cryo-EM studies, which 
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usually provide higher resolution models. With a better resolution, immuno or genetic 
labeling and structure fitting should allow the localization of the components of the 
complex by further EM studies. Antibodies directed against specific subunits can be 
very informative to analyze the position of these subunits, as the antibodies are large 
enough to be seen in EM. However, antibodies can also damage the complex. In such 
a case, immunolabeling experiments would fail like it has for example been shown for 
the localization of some components of the prespliceosomal A complex (Behzadnia et 
al., 2007). Once a certain resolution has been obtained, it is also possible to localize a 
complex component directly by fitting its known atomic resolution structure into the 
3D model of the complex. Although cryo-EM structures can yield significant 
information on the fold of a subunit of a protein complex, it is still advantageous to fit 
the crystal structure of individual components to a map of the complex. It may reveal 
subunit location and orientation, but also subunit contacts. Using this method, 
localization of both catalytically active subunits of CPF should be feasible. Although 
the atomic structure of Pap1p is available (Bard et al., 2000), the structure of Ysh1p is 
not solved yet. Instead of using antibodies to localize Ysh1p, one approach would be 
to fuse the enzyme with a tag, such as a 20 kDa SNAP tag (from Covalys) that 
provides additional density to the protein. This approach would prevent possible 
damages of the complex by using antibodies or failure in subunit localization if the 
epitope is not accessible. It is then possible to localize the additional mass contributed 
by the fusion protein in the 3D structure or to add an even larger label to the SNAP 
tag. For those labeled components with known high-resolution X-ray or NMR 
structure, fitting can be performed, avoiding systematic tagging of each subunit: 
successful examples are described by Dube et al. (2005), with the docking of a WD40 
domain into the APC/C structure allowing the localization of the coactivator Cdh1, 
and by Golas et al. (2003) with the fitting of the RNA-recognition motif (RRM) 
domains of the p14 and SF3b49 proteins of the splicing factor SF3b.  
 Finally, we cannot exclude the possibility of conformational changes in the 
CPF complex upon RNA binding or during the processing reactions. Catalyzing a 
chemical reaction often requires multiprotein assemblies to be dynamic and additional 
EM studies could help to resolve this issue. Indeed, structural rearrangements can be 
investigated with reasonable precision by cryo-EM studies (Golas et al., 2005). 
Hence, the future work could help us to understand better the mode of action of CPF 
and the whole protein machinery in 3’ end formation at a molecular level.  
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4.4 Experimental procedures  
 
Strains used in this study 
 
The following S. cerevisiae strains were used in this study: W303-1B (MATa; ade2-1; 
leu2-3,112; ura3-1; trp1-1; his3-11,15); MO20 (ura3-1; trp1∆; ade2-1; leu2-3,112; 
his3-11,15; pfs2::TRP1 pNOP-PFS2 [ProtA-PFS2-LEU2-CEN]); YMS 162 (ura3-1; 
trp1-1; ade2-1; leu2-3,112; his3-11,15; rna15::TRP1 pNOP-RNA15 [ProtA-RNA15-
LEU2-CEN]); MO7 (ura3-1; trp1∆; ade2-1; leu2-3,112; his3-11,15; pfs2::TRP1 
pFL38-PFS2-URA3); YBP7 (ura3-1; trp1∆; ade2-1; leu2-3,112; his3-11,15; 
pfs2::TRP1 pNOP-FLAG-PFS2 [ProtA-TEV-FLAG-PFS2-LEU2-CEN]).  
 
Construction of a yeast strain expressing ProtA-FLAG-Pfs2p 
 
A 1.47 kb fragment containing the FLAG sequence and the coding region of PFS2 
was PCR amplified from genomic DNA of the W303-1B strain using the following 
oligonucleotides: 5'-NcoI-flag (5’-CATATGGCCATGGTTGACTACAAGGATGAC  
GATGACAAGACTAGTATGGACGGGCATAAT-3’) and 3'-NcoI-flag (5’-
GCTGCAGGTCGACGGATCCCCGGG-3’). The PCR fragment was then digested 
by NcoI and SmaI and inserted in the pNOP-PFS2 plasmid (Ohnacker et al., 2000) 
also digested by the same restriction enzymes. The new plasmid pNOP-FLAG-PFS2, 
which encodes for a ProtA-TEV-FLAG-Pfs2p construct, was verified by sequencing 
and used to transform the haploid PFS2 deletion strain MO7 in which Pfs2p 
expression is maintained by the presence of the pFL38-PFS2-URA3 plasmid 
(Ohnacker et al., 2000). Then, the loss of pFL38-PFS2-URA3 was forced on 5-fluoro-
orotic acid medium and only cells carrying pNOP-FLAG-PFS2 could grow on leucin-
lacking medium. Correct expression of the ProtA-TEV-FLAG-Pfs2p construct was 
verified by Western blotting analysis on protein extracts prepared from the new strain 
generated YBP7.  
 
Preparation of yeast cell free extracts 
 
For the preparation of yeast cell free extracts, a modified version of the liquid 
nitrogen method by Ansari and Schwer (1995) was used. 5 liters cultures were grown 
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in YPD (1% yeast extract, 2% bacto-peptone, 2% glucose) to an OD600 of 2-3. All the 
following procedure were performed at 4°C. Cells were harvested by centrifugation at 
5000 rpm for 5 min in a Sorvall SLA-3000 rotor and washed once with 200 ml of ice-
cold water and once with 200 ml of ice-cold AGK buffer [10 mM Tris-HCl pH 7.9, 
200 mM KAc, 10% glycerol and 1 mM dithiothreitol (DTT)]. Cells were then 
resuspended in 20 ml AGK buffer and frozen as drops in liquid nitrogen. The frozen 
cells were stored at -70°C until they were homogenized. For homogenization, the 
frozen yeast cells were ground with a pestle in a mortar that was previously cooled 
with liquid nitrogen to avoid thawing. Grinding was continued until a fine powder 
was obtained. The frozen powder was transferred to a fresh tube and thawed under 
cold running water. Immediately after thawing, protease inhibitors were added to the 
following concentrations: 1 mM phenylmethylsulfonyl fluoride (PMSF), 0.4 µg/ml 
leupeptin and 0.7 µg/ml pepstatin. The suspension of broken cells was gently mixed 
for 30 min on ice and was then centrifuged at 10000 rpm for 30 min in a Sorvall SS-
34 rotor. The supernatant was removed and centrifuged at 41000 rpm in a Kontron 
TST 41.14 rotor for 2 h. After removing the lipids layer, the pale yellow aqueous 
phase was carefully saved and solid ammonium sulfate was added to reach 40% 
saturation. Proteins were precipitated overnight with gentle stirring and the 
precipitated material was pelleted by centrifugation at 10000 rpm in a Sorvall SS-34 
rotor for 30 min. The pellet was finally resuspended in 1 ml of buffer E-50 (20 mM 
Tris-HCl pH 7.9, 0.2 mM EDTA, 50 mM Kac, 0.02% NP-40, 10% glycerol, 0.5 mM 
DTT, 1 mM phenylmethylsulfonyl fluoride (PMSF), 0.4 µg/ml leupeptin and 0.7 
µg/ml pepstatin) and dialyzed three times 2 h against 2 l of buffer E-50.  
 
Affinity purification of CPF  
 
The CPF complex was affinity purified from an extract of the yeast strain MO20 that 
expresses a ProtA-tagged version of Pfs2p (Ohnacker et al., 2000). The tag included 
two IgG-binding domains of the Staphylococcus aureus ProtA followed by the 
recognition sequence of the site-specific TEV protease (Senger et al., 1998).  
 Batch absorption to IgG-sepharose was done to isolate ProtA-Pfs2p or Cpf11-
TAP and associated proteins from protein extracts prepared from yeast strains that 
express these constructs. All incubation steps described below up to the proteolytic 
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cleavage were done at 4°C with gentle mixing. A 1 ml aliquot of IgG-sepharose 
(Amersham Biosciences), 4 ml of the extract, 10% glycerol and 10 ml of buffer D-
120 [20 mM Tris-HCl pH 7.9, 120 mM NaCl, 0.02% NP-40, 0.2 mM EDTA, 1 mM 
dithiothreitol (DTT)] including 1 mM phenylmethylsulfonyl fluoride (PMSF), 
0.4 µg/ml leupeptin and 0.7 µg/ml pepstatin were mixed in a 15 ml Falcon tube and 
incubated for 2 h on a rotating arm. After centrifugation, the supernatant was removed 
and the matrix was extensively washed five times for 20 min with 15 ml of D-120 
buffer. After washing, the beads were incubated twice for 10 min with 15 ml of buffer 
TEV (50 mM Tris-HCl pH 7.9, 10% glycerol, 50 mM KCl, 0.5 mM EDTA, 0.02% 
NP-40, 1 mM DTT, 0.4 µg/ml leupeptin). For elution of the bound material, the beads 
were incubated with 1 ml of buffer TEV containing 400 U of recombinant TEV 
protease (Invitrogen) at 16°C for 90 min. The site-specific proteolytic cleavage 
released Pfs2p and associated proteins from the ProtA tag and thereby from the IgG-
sepharose matrix. After centrifugation, the supernatant was collected in a fresh tube 
and the beads were washed four times with 500 µl of buffer TEV.  
 Elution fractions were pooled and applied to a SMART MonoQ column (100 µl 
column volume). The column was developed with a linear KCl gradient (50–500 mM) 
and 80 µl fractions were collected. CPF peak fractions eluted at approximately 320 
mM KCl.  
 For GraFix centrifugation, 200 µl of the peak fraction and a side fraction were 
pooled and loaded onto a 4 ml linear (10%-30%) glycerol and (0-0.15%) 
glutaraldehyde gradient prepared with 50 mM Hepes, 120 mM KCl and 0.5 mM 
EDTA. After 18 h centrifugation in a Sorvall TH660 rotor at 34000 rpm at 4°C, the 
gradient was fractionated from the bottom to the top with a peristaltic pump in 5 drops 
(~180 µl) aliquots. For electrophoretic gel analysis, a gradient centrifugation step was 
conducted without glutaraldehyde to allow the proteins to be resolved on the gel.  
 
Affinity purification of CF IA  
 
CF IA was natively affinity purified essentially as described for CPF, except that the 
extract was prepared from a yeast strain that expresses a ProtA-tagged version of the 
CF IA subunit Rna15p. CF IA eluted from the MonoQ column at approximately 180 
mM KCl.  
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FLAG tag purification  
 
Purification of FLAG tagged Pfs2p and FLAG-Tad2p were performed using anti-
FLAG M2 affinity gel following the manufacturer’s instructions (Sigma). Briefly, 50 
µg of total protein extract from FLAG-Tad2p strain and 3 ml of FLAG-Pfs2p 
obtained by IgG purification of ProtA-FLAG-Pfs2p were incubated for 2h at 4ºC with 
0.5 ml of anti-FLAG M2 affinity gel previously washed with 0.1M glycine pH 3.5 
and equilibrated 3 times with 10 ml TEK120 buffer (50 mM Tris-HCl pH 7.9, 120 
mM KCl, 0.5 mM EDTA). Unbound proteins were removed by washing 5 times with 
TEK120 and captured proteins were eluted in 5 fractions with 0.5 ml of TEK120 and 
150 ng/µl of 3xFLAG peptide. Eluates were then analyzed by SDS PAGE and 
sliverstaining.   
 
Western blotting analysis 
Proteins were separated on 10% SDS polyacrylamide gels, transferred to 
nitrocellulose membranes, and incubated according to standard procedures with the 
antibodies indicated in the legends to the figures. Peroxidase-conjugated swine anti-
rabbit immunoglobulins (DAKO) were used as secondary antibody for detection of 
the primary antibodies. 
 
Identification of polypeptides in CPF by mass spectrometry analysis  
 
Bands were excised from SDS gels, destained with 30% acetonitrile in 0.1 M 
ammonium bicarbonate, and washed with water. The gel pieces were reswollen with 4 
ml of 1 mM Tris-HCl (pH 8.8) containing 0.2 mg of trypsin (Promega) after drying in 
a speedvac evaporator. The digestion was carried out overnight at room temperature. 
7 ml 50% acetonitrile containing 0.3% trifluoroacetic acid (TFA) was added, and the 
content was vortexed, centrifuged for 2 min, and sonicated for 5 min. 1 ml of the 
supernatant was mixed with 1 ml of saturated alpha-cyano cinnamic acid in 50% 
acetonitrile/0.1% TFA in water and applied to the MALDI target. The samples were 
analyzed in a time-of-flight Bruker mass spectrometer (Reflex 3) equipped with a 
reflector and delayed extraction. An acceleration voltage of 20 kV was used. 
Calibration was internal to the samples. Des-Arg-1 bradykinin (Sigma) and ACTH 
(18-38) (Sigma) were used as standard peptides. The peptide masses obtained for each 
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individual polypeptide were used to search SwissProt, TREMBL, and 
DDBJ/EMBL/GenBank databases. NanoElectrospray Tandem Mass Spectrometry: 
Unseparated peptide mixtures obtained after tryptic in-gel digestion of still unknown 
polypeptides were analyzed by nanoelectrospray tandem mass spectrometry (Wilm 
and Mann, 1996). Tryptic peptides were extracted as described (Fountoulakis and 
Langen, 1997), desalted, and further concentrated on a pulled capillary containing 
approximately 100 nl POROS R2 reverse phase material (Perceptive Biosystems, 
Framingham, MA) and eluted with 1 ml of 60% methanol in 5% formic acid directly 
into the nanoelectrospray needle as described. Electrospray mass spectra were 
acquired on an API 365 triple quadrupole mass spectrometer (Sciex, Toronto, 
Canada) equipped with a nanoES ion source developed by Wilm and Mann (1996). 
Q1 scans were performed with a 0.2 Da mass step. For operation in the MS/MS mode 
Q1 was set to transmit a mass window of 2 Da and spectra were accumulated with 0.2 
Da mass steps. Resolution was set such that the fragment masses could be assigned 
better than 1 Da. 
  
In vitro pre-mRNA 3’ end processing assays 
 
32P-labelled CYC1 and pre-CYC1 RNAs were prepared as run-off transcripts and gel 
purified as described previously (Minvielle-Sebastia et al., 1994; Preker et al., 1995).  
 A standard in vitro processing reaction was carried out in a 25 µl reaction 
volume containing up to 5 µl of protein extract or purified protein factors. For 
polyadenylation assay, the reaction mixture contained 2% polyethylene glycol, 75 
mM potassium glutamate, 0.01% NP-40, 2 mM ATP, 1.8 mM magnesium acetate, 20 
mM creatine phosphate, 1 mM DTT, 0.2 mg/ml creatine kinase and 0.2 units of 
RNAguard (Amersham Biosciences). The volume was brought to 25 µl upon addition 
of buffer E-50 (20 mM Tris-HCl pH 7.9, 0.2 mM EDTA, 50 mM Kac, 0.02% NP-40, 
10% glycerol) if was necessary. When the cleavage reaction was assayed, EDTA was 
used instead of magnesium acetate to prevent poly(A) addition, and degradation of the 
downstream cleavage fragment (Chen and Moore, 1992). The reactions were 
incubated 1h at the temperatures indicated in the figure legends. They were then 
stopped by addition of 75 µl of a stop mix (100 mM Tris-HCl pH7.9, 12.6 mM 
EDTA, 150 mM NaCl, 1% SDS, 0.2 µg/µl of proteinase K and 0.05 µg/µl glycogen) 
 -138- 
and incubated for 1h at 42°C. The RNAs were recovered by ethanol precipitation, 
dried and resuspended in 6 µl of formamide buffer (95% formamide, 20 mM EDTA, 
0.05% Bromophenol Blue, 0.05% Xylene Cyanol FF). Samples were heated at 95°C 
for 5 min and loaded on a denaturing 6% polyacrylamide gel. The gel was exposed 
overnight to an X-ray film at -70°C. 
 
STEM and image analysis 
 
The glutaraldehyde cross-linked CPF sample was diluted 4 times, and 5 µl aliquots 
were adsorbed for 60s to glow-discharged STEM films (thin carbon films that span a 
thick fenestrated carbon layer covering 200-mesh/inch, gold-plated copper grids). The 
grids were then blotted, washed on 5 drops of quartz double-distilled water, and 
freeze-dried at -80 °C and 5 x 10-8 Torr overnight in the microscope. Tobacco mosaic 
virus (TMV) particles (kindly provided by R. Diaz Avalos) were used for absolute 
mass calibration. These particles were similarly adsorbed to separate STEM films, 
washed on 4 drops of 10 mM ammonium acetate, and air-dried. 
 A STEM HB-5 vacuum generator interfaced to a modular computer system 
(Tietz Video and Image Processing System GmbH, Gauting, Germany) was 
employed. Series of 512 x 512-pixel, dark-field images were recorded from the 
unstained sample at an acceleration voltage of 80 kV and a nominal magnification of 
200,000x. The recording dose ranged from 300 to 900 electrons/nm2. The digital 
images were evaluated using the program package IMPSYS (Muller et al., 1992). 
Accordingly, the projections were selected in circular boxes, and the total scattering 
of each region was calculated. The background scattering of the carbon support film 
was then subtracted, and the mass was calculated. The results were scaled according 
to the mass measured for TMV and corrected for beam-induced mass loss on the basis 
of the behavior of proteins in a similar mass range (Muller and Engel, 2001). The 
mass values were displayed in histograms and described by Gauss curves. The overall 
experimental uncertainty of the results was estimated from the corresponding SE (SE 
= SD/√n) and the  ~5% uncertainty in the calibration of the instrument. 
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EM of CPF  
 
Grid and negative stain preparations 
The CPF complexes were sandwiched in 2% uranyl formate between two layers of 
thin carbon using holey carbon grids as support. The samples were imaged with a 
Philips CM200 FEG electron microscope (high tension 160 kV, magnification 
154000x, temperature –179 °C) equipped with a Gatan cryoholder. Images were taken 
under low-dose conditions at various defoci (0.7–1.5 µm) on a 4x4k CCD camera 
(TVIPS, Gauting, Germany) in 2x binning mode. The Imagic-5 software package 
(Image Science, Berlin, Germany) was used for image processing of 6000 individual 
molecular images.  
 
Angular reconstitution 
A total of 6000 molecular images of CPF were selected. The raw images were 
corrected for the contrast transfer function by phase flipping as described (Sander et 
al., 2003a). Standard image processing procedures, including alignment (Sander et al., 
2003b), multivariate statistical analysis (van Heel, 1984), classification, and angular 
reconstitution (Van Heel, 1987), were used as implemented in the Imagic-5 image 
processing software (van Heel et al., 1996). The final resolution of the 3D maps was 
~25 Å as determined by the Fourier-shell-correlation function using the 5 sigma 
criterion (or the FSC 0.5 criteria). 
 
Random conical tilt 
Tilted image pairs of CPF were recorded at a magnification of 154000x and a defocus 
of ~2 µm first with a tilt of 45° and afterwards at a tilt of 0°. Images were taken on a 
4k × 4k CCD camera using two-fold pixel binning. Particles were selected manually 
from the untilted and from the corresponding tilted images. Untilted images were 
aligned by using iteratively refined class averages as references and subsequent MSA 
for classification into class averages. Angles of the tilted images of the five largest 
classes were determined according to (Radermacher, 1988). A 3D map was calculated 
independently for each class, and an average 3D of the five largest classes was 
obtained after 3D alignment of individual 3D structures by using the 3D alignment 
tool of the software AmiraDev 2.3 (TGS Europe, Merignac Cedex, France). 
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5. General discussion 
 
Pre-mRNA 3’ end processing is the last maturation step that the primary transcripts 
synthesized by RNAP II have to undergo during maturation. This processing event 
consists of the specific endonucleolytic cleavage at the poly(A) site and subsequent 
poly(A) tail addition at the 3’ end of the upstream cleavage product. At first sight, this 
two-step reaction looks simple, nevertheless, a surprisingly complex protein 
machinery is required to complete the task. Interestingly, protein factors involved in 
3’ end formation are highly conserved from yeast to mammals, suggesting that the 
reaction mechanism is similar.  
 In S. cerevisiae, CPF, CF IA, Nab4p and Pab1p are the protein factors 
required for specific 3’ end processing of a primary transcript. During the last years, 
every polypeptide involved in the process was characterized by numerous 
biochemical and genetic studies. This was greatly facilitated by the establishment of 
in vitro assays that allowed researchers to test for 3’ end processing phenotypes of 
mutant strains, and by efficient affinity purification methods that allowed analysis of 
the protein composition of each factor. CPF is an important factor for pre-mRNA 3’ 
end processing, as this multiprotein complex is required for both cleavage and 
polyadenylation reactions and contains 75% of the polypeptides involved in 3’ end 
formation. Until recently, CPF was believed to comprise nine subunits. Then, several 
affinity purification studies combined with MS identified six novel components of 
CPF (Dichtl et al., 2002b; Gavin et al., 2002; Nedea et al., 2003; Walsh et al., 2002). 
One of these studies identified Cpf11p, a non-essential protein with unknown 
function, to interact with CPF (Dichtl et al., 2002b). In this study we show that 
Cpf11p is not a genuine subunit of CPF and has no role in 3’ end processing activities 
in vitro. TAP tag purification of Cpf11p did not yield the components of CPF, 
whereas TAP-tagging of any other subunit of the complex resulted in CPF 
purification. Also intriguing is the fact that we did not find any homologue of Cpf11p 
in other species, whereas most of the proteins involved in pre-mRNA 3’ end 
processing are evolutionary conserved. Furthermore, protein extracts from mutants 
lacking Cpf11p did not show any defect in cleavage and polyadenylation in vitro. 
Finally, MS analyses we did on highly purified CPF never found Cpf11p to copurify 
with the known components of the complex. There is however the possibility that 
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Cpf11p only transiently interacts with CPF, which would explain its copurification 
with the 3’ end processing complex by Dichtl et al. (2002b). As it was shown for the 
CTD and other processing factors, Cpf11p could contact CPF under certain 
conditions. To test this hypothesis, further work concerning the identification of 
Cpf11p function and additional binding tests with CPF components would be 
necessary. To characterize Cpf11p, one could identify the proteins that specifically 
interact with TAP tagged Cpf11p. This information could provide indications on the 
pathway or cellular process Cpf11p is involved in.  
 Although all the proteins involved in pre-mRNA 3’ end processing have been 
characterized and numerous protein-protein and protein-RNA interactions were 
identified, the complexity of the 3’ end processing machinery is such that no model 
was proposed so far to explain the assembly with the pre-mRNA and the mechanism 
of the 3’ end processing reactions. One way leading to a better understanding of the 
molecular mechanisms of the 3’ end processing reactions is to analyze the three-
dimensional structure of the factors involved in the process. In this study, we 
attempted to investigate this issue and as a result we report the first 3D structure of 
CPF at a 25 Å resolution. Interestingly, the structure revealed a large central cavity 
that could serve as a reaction chamber in which processing reactions could occur. 
Such cage-like protein complexes with enzymatic activities have already been 
described, like the 26S proteasome (Groll et al., 1997; Lowe et al., 1995), chaperone 
complexes (Martin and Hartl, 1997) or the exosome (Hernandez et al., 2006). 
However, the overall structure of CPF is not sufficient to understand how and where 
reactions exactly take place. For this, it would be important to localize the different 
subunits in the structure to understand how they are arranged. We are currently trying 
to localize Ysh1p and Pap1p, the two enzymes responsible for cleavage and 
polyadenylation reactions, respectively. The crystal structure of Pap1p can be used to 
fit the polymerase directly into the CPF structure. For Ysh1p, we use another 
approach, by fusing the protein to a SNAP tag, which allows localization of Ysh1p by 
visualization of the additional mass provided by the SNAP tag on the 3D structure. 
This method is preferred to immunolocalization for two reasons. First, the use of 
antibodies can damage the complex. Second, if the epitope of Ysh1p is localized 
inside the structure, it is unlikely to be recognized by the antibody. For subunit 
localization, it is necessary to use a 3D structure with a high resolution to minimize 
multiple possible fittings caused by a too low-resolution model. Currently, we are 
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using cryo-EM to improve the resolution of the 3D model described in this work. In 
addition to subunit localization, incubation of pure CPF with a synthetic RNA 
molecule that contains all the polyadenylation signals required for 3’ end formation 
and further observation by EM could reveal how CPF accommodates pre-mRNAs.  
 Furthermore, it is likely that CPF is subjected to conformational changes 
during processing of the pre-mRNA, so not only one but probably several 3D models 
corresponding to different stages of the 3’ end formation could be obtained. Indeed, 
protein complexes that have enzymatic activities need to be dynamic to fulfil the 
reactions they are assigned to, and single-particle cryo-EM is the method of choice to 
study conformational changes in multiprotein assemblies.  
 It would also be very interesting and informative to integrate the 3D structure 
of CF IA in the model, as CF IA is another important factor involved in pre-mRNA 3’ 
end processing. Consistent with its requirement for specific cleavage and 
polyadenylation, CF IA contacts the pre-mRNA and displays a network of protein-
protein interactions with CPF components (Nedea et al., 2003). Thus, a complete 
understanding of the molecular mechanism of pre-mRNA 3’ end processing probably 
involves CF IA. Smaller than CPF, CF IA is composed of only four polypeptides and 
can be natively affinity purified to homogeneity through ProtA tagging of the Rna15p 
subunit. Thus, solving a 3D structure of CF IA should be feasible. Then, a three-
dimensional model of a tripartite reconstituted system comprising CPF, CF IA and a 
synthetic pre-mRNA could be generated, which would provide information on the 
molecular mechanism of 3’ end formation.  
 A 3D structure of CPF could also help to understand the basis of the 
association with RNAP II, as many CPF components were shown to interact with the 
CTD. Indeed, the analysis of CPF structural features could show how the CTD 
enhances the efficiency of pre-mRNA cleavage. One possibility could be that the 
interaction of the CTD with CPF would induce conformational changes that favor 
enzymatic activity.  
 Moreover, as mainly in vitro studies demonstrated that pre-mRNA 3’ end 
processing and transcription are interconnected, we started to investigate the 
relevance of this coupling in vivo. We tagged proteins expected to be involved in 
these processes with fluorophores (GFP and some variants) and generated a series of 
yeast strains in order to perform FRET and FRAP experiments. So far, the 
fluorescence signals obtained from the strains we have constructed were too low to 
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use these techniques. Despite the recent expansion in the diversity of available 
fluorophores, none of those we used was bright enough to provide a signal 
sufficiently above the autofluorescence of yeast cells. In addition, the small size of 
yeast cells requires us to systematically construct diploid strains, which is time 
consuming. Finally, we are currently testing an overexpression system for the tagged 
versions of the 3’ end processing proteins to increase the amount of proteins of 
interest and thus to improve the fluorescence signals.  
 Future work could also investigate in more detail the functional relationship of 
pre-mRNA 3’ end processing to other pre-mRNA processing events, such as capping 
and splicing. For example, splicing and 3’ end processing are well conserved from 
yeast to mammals and were shown to be coupled, as revealed by several studies in 
mammals (Kyburz et al., 2006; Wassarman and Steitz, 1993). Recent work suggests 
that coupling also occurs in yeast (A. Kyburz, unpublished data). The resolution of 
the 3D structure of factors involved in pre-mRNA processing events and the 
investigation of effects caused by mutant forms of these factors would help to 
understand the mechanism by which the maturation events are connected.  
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